PharmGKB Accession Id;Drug;ATC Identifiers;Type;Clin_Var_Pathway
PA164712302;2-AMINO-1-PHENYLETHANOL DERIVATIVES;C04AA;Drug Class;0:0:0
PA134967247;2-METHOXYESTRADIOL;;Drug, Biological Intermediate;0:0:1
PA165958321;3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE;;Drug;0:0:0
PA165858618;3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE;;Drug;0:0:0
PA451993;3-BETA-HYDROXY-5-ANDROSTEN-17-ONE;A14AA07;Drug;0:0:0
PA166123047;3-CYANO-7-ETHOXYCOUMARIN;;Drug;0:2:0
PA166305281;3-HYDROXY DARIFENACIN;;Drug, Metabolite;0:0:0
PA164712303;3-OXOANDROSTEN (4) DERIVATIVES;G03BA;Drug Class;1:8:0
PA166262141;(3R,5R)-FLUVASTATIN;;Drug;0:0:0
PA166262142;(3R,5S)-FLUVASTATIN;;Drug;0:0:0
PA166122786;4,6,4'-TRIMETHYLANGELICIN;;Drug;0:0:0
PA166224244;4''-HYDROXYCANNABIDIOL;;Drug;0:0:1
PA151958637;4-METHYLTHIOAMPHETAMINE;;Drug;0:0:0
PA154081778;4-METHYLUMBELLIFERONE;;Drug;0:0:0
PA164712304;5-ANDROSTANON (3) DERIVATIVES;G03BB;Drug Class;0:0:0
PA166131299;5'-DEOXY-5-FLUOROURIDINE;;Drug, Metabolite;0:3:1
PA151958362;6,7-DIHYDROXYBERGAMOTTIN;;Drug;0:0:0
PA130230922;6-O-PHOSPHORYL INOSINE MONOPHOSPHATE;;Drug;0:0:0
PA152530740;8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE;;Drug;0:0:0
PA164754915;ABARELIX;L02BX01;Drug;0:0:0
PA164747080;ABATACEPT;L04AA24;Drug;0:2:0
PA448006;ABCIXIMAB;B01AC13;Drug;0:1:1
PA166116241;ABEXINOSTAT;;Drug;0:0:0
PA166338841;ABIVERTINIB;;Drug;0:0:0
PA166272921;ABROCITINIB;D11AH08;Drug;0:1:1
PA166198581;ACALABRUTINIB;L01EL02;Drug;0:2:0
PA448010;ACARBOSE;A10BF01;Drug;0:0:0
PA166340542;ACEBILUSTAT;;Drug;0:0:0
PA448011;ACEBUTOLOL;C07AB04;Drug;0:1:0
PA166049185;ACECLOFENAC;;Drug;0:1:0
PA164712305;ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS;C09BB;Drug Class;0:0:0
PA164712306;ACE INHIBITORS AND DIURETICS;C09BA;Drug Class;0:0:0
PA164712307;ACE INHIBITORS, COMBINATIONS;C09B;Drug Class;0:0:0
PA166049184;ACEMETACIN;;Drug;0:0:0
PA452632;ACENOCOUMAROL;B01AA07;Drug;17:231:1
PA164783999;ACEPROMAZINE;N05AA04;Drug;0:0:0
PA164743727;ACEPROMETAZINE;;Drug;0:0:0
PA166246281;ACETAMINOPHEN / CAFFEINE / DIHYDROCODEINE;N02AJ01;Drug;0:0:0
PA166184061;ACETAMINOPHEN / CODEINE;;Drug;0:0:0
PA165290927;ACETAMINOPHEN / PROPOXYPHENE NAPSYLATE;N02AC54;Drug;0:0:0
PA166184496;ACETAMINOPHEN / TRAMADOL;;Drug;0:6:0
PA448016;ACETANILIDE;;Drug;0:0:0
PA448021;ACETIC ACID;G01AD02, S02AA10;Drug;0:0:1
PA164712309;ACETIC ACID DERIVATIVES AND RELATED SUBSTANCES;M01AB;Drug Class;11:60:0
PA164777011;ACETOHEXAMIDE;A10BB31;Drug;0:0:0
PA164749213;ACETOHYDROXAMIC ACID;G04BX03;Drug;0:0:0
PA164781360;ACETOPHENAZINE;N05AB07;Drug;0:0:0
PA164746246;ACETYLDIGITOXIN;C01AA01;Drug;0:0:0
PA164712311;ACIDIFIERS;G04BA;Drug Class;0:0:0
PA164712310;ACID PREPARATIONS;A09AB;Drug Class;0:0:0
PA448039;ACITRETIN;D05BB02;Drug;0:2:0
PA166360341;ACORAMIDIS;;Drug;0:0:0
PA164712312;ACRIDINE DERIVATIVES;D08AA;Drug Class;0:0:0
PA166345481;ACT-1004-1239;;Drug;0:0:0
PA164712313;ACTH;H01AA;Drug Class;0:0:0
PA164712314;ACTINOMYCINES;L01DA;Drug Class;0:12:0
PA448045;ACYCLOVIR;D06BB03, J05AB01, S01AD03;Drug;0:2:1
PA164712315;ADAMANTANE DERIVATIVES;N04BB;Drug Class;1:2:0
PA448047;ADAPALENE;D10AD03;Drug;0:0:0
PA166306541;ADAVOSERTIB;;Drug;0:0:0
PA448048;ADENINE;;Drug;0:0:1
PA448049;ADENOSINE;C01EB10;Drug, Biological Intermediate;0:1:2
PA166178281;ADENOSINE DIPHOSPHATE;;Drug, Biological Intermediate;0:0:3
PA164744376;ADENOSINE MONOPHOSPHATE;;Drug, Biological Intermediate;0:0:2
PA164743471;ADENOSINE TRIPHOSPHATE;;Drug, Biological Intermediate;0:0:2
PA164783813;ADINAZOLAM;N05BA07;Drug;0:0:0
PA164712316;ADRENERGIC AND DOPAMINERGIC AGENTS;C01CA;Drug Class;5:20:0
PA164712318;ADRENERGICS AND OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03AK, R03CK;Drug Class;0:0:0
PA164712317;ADRENERGICS FOR SYSTEMIC USE;R03C;Drug Class;23:74:0
PA165981139;AFATINIB DIMALEATE;;Drug;0:0:0
PA452609;AFLATOXIN B1;;Drug;0:0:1
PA166118342;AFLIBERCEPT;L01XX44;Drug;0:0:1
PA164746527;AGALSIDASE BETA;A16AB04;Drug;0:0:0
PA164712320;AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09;Drug Class;122:343:0
PA164712321;AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01A;Drug Class;1:3:0
PA164712322;AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01C;Drug Class;0:0:0
PA164712323;AGENTS FOR TREATMENT OF HEMORRHOIDS AND;C05A;Drug Class;22:94:0
PA164776839;AJMALINE;C01BA05;Drug;0:0:0
PA164746058;ALBENDAZOLE;P02CA03;Drug;0:0:0
PA166285061;ALBIGLUTIDE;A10BJ04;Drug;0:6:0
PA166411921;ALBUVIRTIDE;J05AX33;Drug;0:0:0
PA165958399;ALCAFTADINE;S01GX11;Drug;0:0:0
PA164747650;ALCLOMETASONE;D07AB10, S01BA10;Drug;0:0:0
PA164712324;ALDEHYDES AND DERIVATIVES;N05CC;Drug Class;0:0:0
PA448081;ALDESLEUKIN;L03AC01;Drug;0:0:0
PA164712325;ALDOSE REDUCTASE INHIBITORS;A10XA;Drug Class;0:0:0
PA164712326;ALDOSTERONE ANTAGONISTS;C03DA;Drug Class;8:16:0
PA164748040;ALEFACEPT;L04AA15;Drug;0:0:0
PA164746469;ALFACALCIDOL;A11CC03;Drug;0:0:0
PA164774795;ALFUZOSIN;G04CA01;Drug;0:0:0
PA164748093;ALGLUCERASE;A16AB01;Drug;0:0:0
PA164712327;ALIMENTARY TRACT AND METABOLISM;A;Drug Class;270:1581:0
PA166159961;ALIROCUMAB;C10AX14;Drug;0:0:1
PA166165015;ALISERTIB;;Drug;0:0:0
PA143487910;ALISKIREN;C09XA02;Drug;0:0:1
PA164746900;ALITRETINOIN;D11AH04, L01XX22;Drug;0:0:0
PA164744894;ALIZAPRIDE;A03FA05;Drug;0:0:0
PA164712328;ALKALOIDS, EXCL. RAUWOLFIA;C02KA;Drug Class;0:0:0
PA164712329;ALKALOIDS, EXCL. RAUWOLFIA, IN COMBINATION WITH DIURETICS;C02LK;Drug Class;0:0:0
PA164712330;ALKYL SULFONATES;L01AB;Drug Class;5:19:0
PA164712336;ALLERGEN EXTRACTS;V01AA;Drug Class;0:0:0
PA164712337;ALLERGENS;V01, V01A;Drug Class;0:0:0
PA142320763;ALLOPREGNANOLONE;N06AX29;Drug;0:0:0
PA448320;ALLOPURINOL;M04AA01;Drug;43:208:2
PA164712332;ALL OTHER NON-THERAPEUTIC PRODUCTS;V07, V07A;Drug Class;0:0:0
PA164712334;ALL OTHER THERAPEUTIC PRODUCTS;V03, V03A;Drug Class;120:399:0
PA164745307;ALLYLESTRENOL;G03DC01;Drug;0:0:0
PA164750492;ALMITRINE;R07AB07;Drug;0:0:0
PA133888888;ALMOKALANT;;Drug;0:0:0
PA10246;ALMOTRIPTAN;N02CC05;Drug;0:7:1
PA448322;ALOE;;Drug;0:0:0
PA166368301;ALOGLIPTIN;A10BH04;Drug;0:0:0
PA164745502;ALOSETRON;A03AE01;Drug;0:0:0
PA452626;ALOX5-PATHWAY MODIFIERS;;Drug Class;0:0:0
PA10308;ALPHA-1-PROTEINASE INHIBITOR;;Drug;0:0:0
PA164712344;ALPHA-ADRENORECEPTOR ANTAGONISTS;C02CA, G04CA;Drug Class;0:17:1
PA164712346;ALPHA-ADRENORECEPTOR ANTAGONISTS AND DIURETICS;C02LE;Drug Class;0:0:0
PA164712343;ALPHA- AND BETA-ADRENORECEPTOR AGONISTS;R03CA;Drug Class;1:5:0
PA164712339;ALPHA AND BETA BLOCKING AGENTS;C07AG;Drug Class;7:63:0
PA164712340;ALPHA AND BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CG;Drug Class;0:0:0
PA164712341;ALPHA AND BETA BLOCKING AGENTS AND THIAZIDES;C07BG;Drug Class;0:0:0
PA164712342;ALPHA GLUCOSIDASE INHIBITORS;A10BF;Drug Class;0:0:0
PA449384;ALPHA-LINOLENIC ACID;;Drug;0:0:0
PA147358765;ALPHA-METHYL-PARA-TYROSINE;;Drug;0:0:0
PA164750541;ALPRENOLOL;C07AA01;Drug;0:0:0
PA448334;ALPROSTADIL;C01EA01, G04BE01;Drug;0:0:0
PA164746411;ALSEROXYLON;;Drug;0:0:0
PA164776730;ALTEPLASE;B01AD02, S01XA13;Drug;0:0:0
PA164743136;ALTRETAMINE;L01XX03;Drug;0:0:0
PA164760864;ALUMINIUM;;Drug;0:0:0
PA164712347;ALUMINIUM AGENTS;D08AB;Drug Class;0:0:0
PA164712348;ALUMINIUM COMPOUNDS;A02AB;Drug Class;0:0:0
PA448348;ALUMINUM CHLORIDE;;Drug;0:0:0
PA165958393;ALUMINUM HYDROXIDE;;Drug;0:0:0
PA166234821;ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DRUG COMBINATION;;Drug;0:0:0
PA164764505;ALVERINE;A03AX08;Drug;0:0:0
PA165291491;ALVESPIMYCIN;;Drug;0:0:0
PA164754864;ALVIMOPAN;A06AH02;Drug;0:0:0
PA164764601;AMBENONIUM;N07AA30;Drug;0:0:0
PA165860521;AMBRISENTAN;;Drug;0:7:0
PA164746074;AMCINONIDE;D07AC11;Drug;0:0:0
PA164754807;AMDINOCILLIN;J01CA11;Drug;0:0:0
PA166049186;AMFENAC;;Drug;0:0:0
PA164712349;AMIDES;N01BB;Drug Class;0:3:0
PA166185150;AMIFAMPRIDINE;N07XX05;Drug;0:0:0
PA166182002;AMIFAMPRIDINE PHOSPHATE;;Drug;0:0:0
PA448365;AMIFOSTINE;V03AF05;Drug;0:0:0
PA164744372;AMIKACIN;D06AX12, J01GB06, S01AA21;Drug;1:6:1
PA448372;AMINO ACIDS;;Drug, Biological Intermediate;0:0:0
PA164712351;AMINO ACIDS AND DERIVATIVES;A16AA;Drug Class;1:1:0
PA164712353;AMINO ACIDS/CARBOHYDRATES/MINERALS/VITAMINS, COMBINATIONS;V06DE;Drug Class;0:0:0
PA164712352;AMINO ACIDS, INCL. COMBINATIONS WITH POLYPEPTIDES;V06DD;Drug Class;0:0:0
PA164712354;AMINOALKYL ETHERS;R06AA;Drug Class;0:7:0
PA10247;AMINOBENZOIC ACID;;Drug;0:0:0
PA164774947;AMINOCAPROIC ACID;B02AA01;Drug;0:0:0
PA448375;AMINOGLUTETHIMIDE;L02BG01;Drug;0:0:0
PA452167;AMINOGLYCOSIDE ANTIBACTERIALS;J01G;Drug Class;27:190:0
PA134711723;AMINOHIPPURATE;V04CH30;Drug;0:1:0
PA10015;AMINOLEVULINIC ACID;L01XD04;Drug;0:0:0
PA164748135;AMINOPHENAZONE;N02BB03;Drug;0:0:0
PA164781029;AMINOPHYLLINE;R03DA05;Drug;0:0:0
PA165109541;AMINOPTERIN;;Drug;0:0:0
PA164712355;AMINOQUINOLINES;P01BA;Drug Class;7:61:0
PA448382;AMINOSALICYLIC ACID;J04AA01;Drug;0:1:0
PA164712356;AMINOSALICYLIC ACID AND DERIVATIVES;J04AA;Drug Class;0:1:0
PA164712357;AMINOSALICYLIC ACID AND SIMILAR AGENTS;A07EC;Drug Class;8:27:0
PA448385;AMITRIPTYLINE;N06AA09, N06CA01;Drug;15:75:1
PA164745310;AMLEXANOX;A01AD07, R03DX01;Drug;0:0:0
PA166183785;AMLODIPINE / ATORVASTATIN / PERINDOPRIL ARGININE;C10BX11;Drug;0:0:0
PA166131585;AMMONIA;;Drug, Metabolite;0:0:1
PA448392;AMMONIUM CHLORIDE;B05XA04, G04BA01;Drug;0:0:0
PA165958400;AMMONIUM LACTATE;;Drug;0:0:0
PA448401;AMOBARBITAL;N05CA02;Drug;0:0:0
PA448405;AMOXAPINE;N06AA17;Drug;0:0:0
PA164712358;AMPHENICOLS;J01B, J01BA;Drug Class;1:7:0
PA448415;AMPHOTERICIN B;A01AB04, A07AA07, G01AA03, J02AA01;Drug;0:0:0
PA448419;AMPICILLIN;J01CA01, S01AA19;Drug;0:1:0
PA164746803;AMRINONE;C01CE01;Drug;0:0:0
PA10309;AMSACRINE;L01XX01;Drug;0:0:0
PA166220604;AMUVATINIB;;Drug;0:0:0
PA164750570;AMYL NITRITE;V03AB22;Drug;0:0:0
PA164712360;ANABOLIC AGENTS FOR SYSTEMIC USE;A14;Drug Class;0:0:0
PA164712361;ANABOLIC STEROIDS;A14A;Drug Class;0:0:0
PA165960688;ANACETRAPIB;;Drug;0:0:0
PA164742986;ANAGRELIDE;L01XX35;Drug;0:0:0
PA10799;ANAKINRA;L04AC03;Drug;0:7:0
PA164712363;ANALGESICS AND ANESTHETICS;S02DA;Drug Class;24:81:0
PA166305821;ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS;L01ED;Drug Class;0:5:0
PA166335701;ANAPRAZOLE;;Drug;0:0:0
PA164712364;ANDROGEN, PROGESTOGEN AND ESTROGEN IN COMBINATION;G03EB;Drug Class;0:0:0
PA10381;ANDROGENS AND ESTROGENS;G03EA;Drug Class;0:0:0
PA164712365;ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION;G03E;Drug Class;0:0:0
PA164712366;ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION WITH OTHER DRUGS;G03EK;Drug Class;0:0:0
PA10733;ANDROGENS FOR TOPICAL USE;D11AE, G03B;Drug Class;1:8:0
PA164712367;ANDROSTAN DERIVATIVES;A14AA;Drug Class;0:0:0
PA164712368;ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS;C09DB;Drug Class;0:0:0
PA164712369;ANGIOTENSIN II ANTAGONISTS AND DIURETICS;C09DA;Drug Class;0:0:0
PA164712371;ANGIOTENSIN II ANTAGONISTS, COMBINATIONS;C09D;Drug Class;50:120:0
PA164742938;ANIDULAFUNGIN;J02AX06;Drug;0:0:0
PA166277641;ANIFROLUMAB;L04AA51;Drug;0:0:0
PA164768817;ANILERIDINE;N01AH05;Drug;0:0:0
PA164712373;ANILIDES;N02BE;Drug Class;34:73:0
PA164746467;ANISINDIONE;;Drug;0:0:0
PA164754880;ANISOTROPINE METHYLBROMIDE;;Drug;0:0:0
PA164769075;ANISTREPLASE;B01AD03;Drug;0:0:0
PA166307361;ANLOTINIB;;Drug;0:4:0
PA452298;ANTACIDS;A02A;Drug Class;0:0:0
PA164712377;ANTACIDS, OTHER COMBINATIONS;A02AX;Drug Class;0:0:0
PA164712374;ANTACIDS WITH ANTIFLATULENTS;A02AF;Drug Class;0:0:0
PA164712375;ANTACIDS WITH ANTISPASMODICS;A02AG;Drug Class;0:0:0
PA164712376;ANTACIDS WITH SODIUM BICARBONATE;A02AH;Drug Class;0:0:0
PA165958418;ANTAZOLINE;R01AC04, R06AX05;Drug;0:0:0
PA164712378;ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01A;Drug Class;4:4:0
PA164712379;ANTHELMINTICS;P02;Drug Class;0:2:0
PA164712380;ANTHRAX VACCINES;J07AC;Drug Class;0:0:0
PA164712381;ANTI-ACNE PREPARATIONS;D10;Drug Class;28:91:0
PA164712382;ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE;D10B;Drug Class;0:0:0
PA164712383;ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10A;Drug Class;28:91:0
PA164712390;ANTIADRENAL PREPARATIONS;H02C;Drug Class;0:0:0
PA164712391;ANTIADRENERGIC AGENTS, CENTRALLY ACTING;C02A;Drug Class;2:6:0
PA164712392;ANTIADRENERGIC AGENTS, GANGLION-BLOCKING;C02B;Drug Class;0:0:0
PA164712393;ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING;C02C;Drug Class;6:52:0
PA164712394;ANTIALLERGIC AGENTS, EXCL. CORTICOSTEROIDS;A07EB, R01AC, R03BC;Drug Class;1:1:0
PA164712384;ANTI-ANDROGENS;L02BB;Drug Class;0:0:0
PA164712397;ANTIANDROGENS;G03H;Drug Class;0:2:0
PA164712398;ANTIANDROGENS AND ESTROGENS;G03HB;Drug Class;0:0:0
PA164712399;ANTIANDROGENS, PLAIN;G03HA;Drug Class;0:0:0
PA164712400;ANTIANEMIC PREPARATIONS;B03;Drug Class;7:24:0
PA164712402;ANTIARRHYTHMICS, CLASS IA;C01BA;Drug Class;3:11:0
PA452249;ANTIARRHYTHMICS, CLASS I AND III;C01B;Drug Class;18:76:0
PA164712403;ANTIARRHYTHMICS, CLASS IB;C01BB;Drug Class;5:9:0
PA164712404;ANTIARRHYTHMICS, CLASS IC;C01BC;Drug Class;6:25:0
PA164712401;ANTIARRHYTHMICS, CLASS III;C01BD;Drug Class;4:17:0
PA164712405;ANTIBACTERIALS FOR SYSTEMIC USE;J01;Drug Class;59:436:0
PA164712415;ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS;D06C;Drug Class;0:0:0
PA164712414;ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06;Drug Class;9:67:0
PA164712417;ANTIBIOTICS AND CORTICOSTEROIDS;G01BA;Drug Class;0:0:0
PA164712416;ANTIBIOTICS FOR TOPICAL USE;D06A;Drug Class;7:59:0
PA164712418;ANTICESTODALS;P02D;Drug Class;0:0:0
PA164712419;ANTICHOLINERGIC AGENTS;N04A;Drug Class;0:3:0
PA164712423;ANTICHOLINESTERASES;N06DA, N07AA;Drug Class;14:137:0
PA164712424;ANTICORTICOSTEROIDS;H02CA;Drug Class;0:0:0
PA164712385;ANTI-DEMENTIA DRUGS;N06D;Drug Class;15:137:0
PA164712425;ANTIDEPRESSANTS IN COMBINATION WITH PSYCHOLEPTICS;N06CA;Drug Class;15:71:0
PA164712426;ANTIDIARRHEAL MICROORGANISMS;A07F, A07FA;Drug Class;0:0:0
PA164712428;ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE;A07;Drug Class;42:268:0
PA164712429;ANTIDOTES;V03AB;Drug Class;99:331:0
PA164712431;ANTIEMETICS AND ANTINAUSEANTS;A04, A04A;Drug Class;17:83:0
PA143485705;ANTIEPILEPTICS;N03, N03A;Drug Class;197:1388:0
PA164712386;ANTI-ESTROGENS;L02BA;Drug Class;21:262:0
PA164712433;ANTIFIBRINOLYTICS;B02A;Drug Class;0:0:0
PA164712434;ANTIFUNGALS FOR DERMATOLOGICAL USE;D01;Drug Class;0:31:0
PA164712435;ANTIFUNGALS FOR SYSTEMIC USE;D01B, D01BA;Drug Class;0:4:0
PA164712436;ANTIFUNGALS FOR TOPICAL USE;D01A;Drug Class;0:31:0
PA10393;ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01E;Drug Class;13:37:0
PA164712387;ANTI-GONADOTROPIN-RELEASING HORMONES;H01CC;Drug Class;0:0:0
PA164712438;ANTIGONADOTROPINS AND SIMILAR AGENTS;G03XA;Drug Class;0:0:0
PA164712440;ANTIGOUT PREPARATIONS;M04, M04A;Drug Class;48:217:0
PA164712441;ANTIGROWTH HORMONES;H01CB;Drug Class;0:0:0
PA164750168;ANTIHEMOPHILIC FACTOR;;Drug;0:0:0
PA164712442;ANTIHEMORRHAGICS;B02;Drug Class;0:1:0
PA164712443;ANTIHIDROTICS;D11AA;Drug Class;0:0:0
PA164712444;ANTIHISTAMINES FOR SYSTEMIC USE;D04AA, R06, R06A;Drug Class;4:25:0
PA164712447;ANTIINFECTIVES;B05CA, S01A, S02A, S02AA, S03A, S03AA;Drug Class;20:110:0
PA164712453;ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS;G01A;Drug Class;54:147:0
PA164712455;ANTIINFECTIVES AND ANTISEPTICS FOR LOCAL ORAL TREATMENT;A01AB;Drug Class;3:9:0
PA164712457;ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS;G01B;Drug Class;0:0:0
PA164712454;ANTIINFECTIVES FOR SYSTEMIC USE;J;Drug Class;373:2753:0
PA164712456;ANTIINFECTIVES FOR TREATMENT OF ACNE;D10AF;Drug Class;5:14:0
PA164712458;ANTIINFLAMMATORY AGENTS;S01B, V10A;Drug Class;36:177:0
PA164712460;ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01C;Drug Class;18:74:0
PA164712463;ANTIINFLAMMATORY AGENTS, NON-STEROIDS AND ANTIINFECTIVES IN COMBINATION;S01CC;Drug Class;0:0:0
PA164712461;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01;Drug Class;36:204:0
PA10384;ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS;M01A;Drug Class;41:232:1
PA164712466;ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION;M01B;Drug Class;0:0:0
PA164712467;ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION WITH CORTICOSTEROIDS;M01BA;Drug Class;0:0:0
PA164712464;ANTIINFLAMMATORY PREPARATIONS, NON-STEROIDS FOR TOPICAL USE;M02AA;Drug Class;22:136:0
PA164712465;ANTIINFLAMMATORY PRODUCTS FOR VAGINAL ADMINISTRATION;G02CC;Drug Class;9:43:0
PA164712468;ANTIMALARIALS;P01B;Drug Class;11:97:0
PA452622;ANTIMETABOLITES;L01B;Drug Class;661:3534:0
PA164712469;ANTIMIGRAINE PREPARATIONS;N02C;Drug Class;9:23:0
PA164712470;ANTIMONY COMPOUNDS;P01CB;Drug Class;0:0:0
PA448452;ANTIMONY POTASSIUM TARTRATE;;Drug;0:0:0
PA164712471;ANTIMYCOBACTERIALS;J04;Drug Class;71:676:0
PA164712473;ANTIMYCOTICS FOR SYSTEMIC USE;J02, J02A;Drug Class;4:197:0
PA164712474;ANTINEMATODAL AGENTS;P02C;Drug Class;0:1:0
PA164712475;ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L;Drug Class;2096:10963:0
PA164712476;ANTINEOVASCULARISATION AGENTS;S01LA;Drug Class;8:80:0
PA164712478;ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS;A08, A08A;Drug Class;1:2:0
PA164712479;ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS;P;Drug Class;17:101:0
PA164712388;ANTI-PARATHYROID AGENTS;H05B;Drug Class;0:1:0
PA164712389;ANTI-PARKINSON DRUGS;N04;Drug Class;12:46:0
PA164712480;ANTIPROGESTOGENS;G03XB;Drug Class;0:0:0
PA164712482;ANTIPROPULSIVES;A07D, A07DA;Drug Class;0:4:0
PA164712483;ANTIPROTOZOALS;P01;Drug Class;12:86:0
PA164712484;ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.;D04, D04A;Drug Class;0:11:0
PA164712486;ANTIPSORIATICS;D05;Drug Class;1:8:0
PA164712487;ANTIPSORIATICS FOR SYSTEMIC USE;D05B;Drug Class;1:4:0
PA164712488;ANTIPSORIATICS FOR TOPICAL USE;D05A;Drug Class;1:6:0
PA448453;ANTIPYRINE;N02BB01, S02DA03;Drug;0:0:0
PA164712489;ANTISEPTICS;R02AA;Drug Class;0:0:0
PA164712492;ANTISEPTICS AND CORTICOSTEROIDS;G01BD;Drug Class;0:0:0
PA164712491;ANTISEPTICS AND DISINFECTANTS;D08, D08A;Drug Class;93:317:0
PA164712493;ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS;A03E;Drug Class;0:0:0
PA164712494;ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03D;Drug Class;0:0:0
PA164712496;ANTISPASMODICS IN COMBINATION WITH OTHER DRUGS;A03ED;Drug Class;0:0:0
PA164712495;ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03C;Drug Class;0:0:0
PA164712497;ANTISPASMODICS, PSYCHOLEPTICS AND ANALGESICS IN COMBINATION;A03EA;Drug Class;0:0:0
PA452200;ANTITHROMBOTIC AGENTS;B01, B01A;Drug Class;278:2975:0
PA164712500;ANTITREMATODALS;P02B;Drug Class;0:1:0
PA164712501;ANTIVARICOSE THERAPY;C05B;Drug Class;1:1:0
PA164712502;ANTIVERTIGO PREPARATIONS;N07C, N07CA;Drug Class;0:0:0
PA452174;ANTIVIRALS;D06BB, S01AD;Drug Class;3:8:0
PA164712504;ANTIVIRALS FOR SYSTEMIC USE;J05;Drug Class;241:1500:0
PA164712506;ANTRACEN DERIVATIVES;D05AC;Drug Class;0:0:0
PA164784000;ANTRAFENINE;;Drug;0:0:0
PA164712507;ANXIOLYTICS;N05B;Drug Class;11:53:0
PA166316721;APATINIB;;Drug;0:3:1
PA166209601;APL-9;;Drug;0:0:0
PA164781163;APOMORPHINE;G04BE07, N04BC07;Drug;0:0:0
PA164712508;APPETITE STIMULANTS;A15;Drug Class;0:0:0
PA166183406;APPLE JUICE;;Drug;0:0:1
PA164748866;APRACLONIDINE;S01EA03;Drug;0:0:0
PA166220442;APREMILAST;;Drug;0:10:0
PA164747039;APREPITANT;A04AD12;Drug;0:3:1
PA164764496;APRINDINE;C01BB04;Drug;0:0:0
PA164754809;APROBARBITAL;N05CA05;Drug;0:0:0
PA448472;APROTININ;B02AB01;Drug;0:0:0
PA165958370;ARBEKACIN;J01GB12;Drug;0:0:0
PA164747979;ARBUTAMINE;C01CA22;Drug;0:0:0
PA164746540;ARCITUMOMAB;;Drug;0:0:0
PA164754878;ARDEPARIN;;Drug;0:0:0
PA164745516;ARGATROBAN;B01AE03;Drug;0:0:0
PA166400062;ARIMOCLOMOL;N07XX17;Drug;0:0:0
PA10026;ARIPIPRAZOLE;N05AX12;Drug;11:104:1
PA166161216;ARIPIPRAZOLE LAUROXIL;N05AX;Prodrug;0:0:1
PA164712509;ARSENIC COMPOUNDS;G01AB, P01AR, P01CD;Drug Class;0:3:0
PA452638;ARSENITE;;Drug;0:0:0
PA165260403;ARTEETHER;P01BE04;Drug;0:0:1
PA165111696;ARTEMISININ;P01BE01;Drug;0:1:1
PA143485261;ARTEMISININ AND DERIVATIVES;P01BE;Drug Class;1:4:0
PA164712512;ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON;C02D;Drug Class;4:34:0
PA166182731;ARTICAINE;N01BB08;Drug;0:0:0
PA166182783;ARTICAINE / EPINEPHRINE;N01BB58;Drug;0:0:0
PA451998;ARYLHYDRAZINES;;Drug Class;0:0:0
PA164712513;ARYLOXYACETIC ACID DERIVATIVES;C03CC;Drug Class;0:0:0
PA164712515;ASCORBIC ACID (VITAMIN C), COMBINATIONS;A11GB;Drug Class;0:0:0
PA164712514;ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS;A11G;Drug Class;0:0:0
PA164712516;ASCORBIC ACID (VITAMIN C), PLAIN;A11GA;Drug Class;0:0:0
PA448493;ASPARTAME;;Drug;0:0:0
PA448497;ASPIRIN;A01AD05, B01AC06, N02BA01;Drug;79:314:1
PA166205381;ASTEGOLIMAB;;Drug;0:0:0
PA448498;ASTEMIZOLE;R06AX11;Drug;0:0:0
PA166128168;ASUNAPREVIR;;Drug;0:1:0
PA166200301;AT-001;;Drug;0:0:0
PA166354161;ATABECESTAT;;Drug;0:0:0
PA10251;ATAZANAVIR;J05AE08, J05AR15;Drug;17:95:1
PA166182674;ATAZANAVIR / COBICISTAT;;Drug;0:0:0
PA166182624;ATAZANAVIR / RITONAVIR;J05AR23;Drug;1:12:0
PA166320882;ATOGEPANT;N02CD07;Drug;0:0:1
PA134688071;ATOMOXETINE;N06BA09;Drug;6:40:1
PA448500;ATORVASTATIN;C10AA05;Drug;54:286:1
PA448502;ATOVAQUONE;P01AX06;Drug;0:1:0
PA164776840;ATRACURIUM;M03AC04;Drug;0:0:0
PA166312781;ATRELEUTON;;Drug;0:0:0
PA448505;ATROPINE;A03BA01, S01FA01;Drug;0:0:0
PA164781017;ATTAPULGITE;A07BC04;Drug;0:0:0
PA166341541;ATULIFLAPON;;Drug;0:0:0
PA166307381;AUMOLERTINIB;L01EB11;Drug;0:0:0
PA448510;AURANOFIN;M01CB03;Drug;0:0:0
PA166344302;AVACOPAN;L04AA59, L04AJ05;Drug;0:0:1
PA166182681;AVANAFIL;;Drug;0:0:0
PA166179849;AVATROMBOPAG;B02BX08;Drug;0:8:1
PA166169875;AVELUMAB;L01FF04;Drug;0:5:0
PA164712517;AVERMECTINES;P02CF;Drug Class;0:0:0
PA166324841;AVIBACTAM;;Drug;0:0:0
PA166211861;AXATILIMAB;;Drug;0:0:0
PA451996;AZACITIDINE;L01BC07;Drug;0:6:0
PA166049192;AZAPROPAZONE;;Drug;0:0:0
PA164712518;AZASPIRODECANEDIONE DERIVATIVES;N05BE;Drug Class;0:1:0
PA164747157;AZATADINE;R06AX09;Drug;0:0:0
PA448515;AZATHIOPRINE;L04AX01;Drug;21:210:1
PA164754850;AZELAIC ACID;D10AX03;Drug;0:0:0
PA448517;AZELASTINE;R01AC03, R06AX19, S01GX07;Drug;0:0:0
PA166329921;AZELNIDIPINE;;Drug;0:0:0
PA165958414;AZIDOCILLIN;J01CE04;Drug;0:0:0
PA448519;AZITHROMYCIN;J01FA10, S01AA26;Drug;0:5:1
PA164749135;AZLOCILLIN;J01CA09;Drug;0:0:0
PA448523;AZTREONAM;J01DF01;Drug;0:0:0
PA164745461;BACAMPICILLIN;J01CA06;Drug;0:1:0
PA448531;BACITRACIN;D06AX05, J01XX10, R02AB04;Drug;0:0:0
PA448533;BACLOFEN;M03BX01;Drug;0:0:0
PA164712519;BACTERIAL AND VIRAL VACCINES, COMBINED;J07C, J07CA;Drug Class;0:0:0
PA164712520;BACTERIAL VACCINES;J07A;Drug Class;0:0:0
PA166327081;BALOVAPTAN;;Drug;0:0:0
PA448536;BALSALAZIDE;A07EC04;Drug;0:0:0
PA164743113;BAMBUTEROL;R03CC12;Drug;0:0:0
PA166226401;BAMLANIVIMAB;;Drug;0:0:0
PA166185162;BAMOCAFTOR;;Drug;0:0:0
PA164738432;BARASERTIB;;Drug;0:0:0
PA448538;BARBITAL;N05CA04;Drug;0:0:0
PA164712523;BARBITURATES, COMBINATIONS;N05CB;Drug Class;0:0:0
PA164712522;BARBITURATES IN COMBINATION WITH OTHER DRUGS;N01AG;Drug Class;0:0:0
PA10827;BARBITURATES, PLAIN;N01AF, N03AA, N05CA;Drug Class;6:36:0
PA166197621;BARICITINIB;;Drug;0:0:0
PA448540;BARIUM SULFATE;;Drug;0:0:0
PA164712524;BARIUM SULFATE CONTAINING X-RAY CONTRAST MEDIA;V08BA;Drug Class;0:0:0
PA164747126;BASILIXIMAB;L04AC02;Drug;0:0:0
PA166327502;BAXDROSTAT;;Drug;0:0:0
PA166220606;BAZEDOXIFENE;;Drug;0:0:0
PA166305841;BCR-ABL TYROSINE KINASE INHIBITORS;L01EA;Drug Class;0:0:0
PA166332521;BEBT-109;;Drug;0:0:0
PA164749511;BECAPLERMIN;A01AD08, D03AX06;Drug;0:0:0
PA448547;BECLOMETHASONE;A07EA07, D07AC15, R01AD01, R03BA01;Drug;0:3:0
PA166342921;BECLOMETHASONE DIPROPIONATE;;Prodrug;0:0:0
PA166182604;BEDAQUILINE;;Drug;0:0:0
PA166351681;BEFOTERTINIB;;Drug;0:0:0
PA166334941;BELANTAMAB MAFODOTIN;L01FX15;Drug;0:0:0
PA166114904;BELIMUMAB;L04AA26;Drug;0:1:0
PA165971474;BELINOSTAT;L01XH04;Drug;0:7:1
PA164712526;BELLADONNA ALKALOIDS, SEMISYNTHETIC, QUATERNARY AMMONIUM COMPOUNDS;A03BB;Drug Class;0:0:0
PA164712527;BELLADONNA ALKALOIDS, TERTIARY AMINES;A03BA;Drug Class;0:0:0
PA164712528;BELLADONNA AND DERIVATIVES IN COMBINATION WITH ANALGESICS;A03DB;Drug Class;0:0:0
PA164712529;BELLADONNA AND DERIVATIVES IN COMBINATION WITH PSYCHOLEPTICS;A03CB;Drug Class;0:0:0
PA164712525;BELLADONNA AND DERIVATIVES, PLAIN;A03B;Drug Class;0:0:0
PA166395741;BELUMOSUDIL;L04AA48;Drug;0:0:0
PA166268761;BELZUTIFAN;L01XX74;Drug;0:2:0
PA166208581;BEMNIFOSBUVIR;;Drug;0:0:0
PA166352981;BEMPEDOIC ACID;C10AX15;Drug;0:0:0
PA166353821;BEMPEDOIC ACID / EZETIMIBE;C10BA10;Drug;0:0:0
PA448563;BENDROFLUMETHIAZIDE;C03AA01;Drug;0:0:0
PA166355021;BENMELSTOBART;;Drug;0:0:0
PA166049178;BENOXAPROFEN;M01AE06;Drug;0:0:0
PA165360203;BENSERAZIDE;;Drug;0:0:0
PA164750572;BENTIROMIDE;V04CK03;Drug;0:0:0
PA164748098;BENTOQUATAM;;Drug;0:0:0
PA448571;BENZALDEHYDE;;Drug;0:0:0
PA164712530;BENZAMIDES;N05AL;Drug Class;7:26:0
PA134852920;BENZBROMARONE;M04AB03;Drug;0:2:1
PA451991;BENZENE;;Drug;0:1:0
PA164712531;BENZIMIDAZOLE DERIVATIVES;P02CA;Drug Class;0:0:0
PA166228321;BENZNIDAZOLE;;Drug;0:0:0
PA448576;BENZOCAINE;C05AD03, D04AB04, N01BA05, R02AD01;Drug;0:0:0
PA164712532;BENZODIAZEPINE RELATED DRUGS;N05CF;Drug Class;0:0:0
PA448578;BENZOIC ACID;;Drug;0:0:0
PA164712533;BENZOMORPHAN DERIVATIVES;N02AD;Drug Class;0:0:0
PA164745459;BENZONATATE;R05DB01;Drug;0:0:0
PA164712534;BENZOTHIAZEPINE DERIVATIVES;C08DB;Drug Class;1:13:0
PA166287643;BENZOYLECGONINE;;Drug, Metabolite;0:0:1
PA166182627;BENZOYL PEROXIDE;;Drug;0:0:0
PA448586;BENZPHETAMINE;;Drug;0:0:0
PA164749018;BENZQUINAMIDE;;Drug;0:0:0
PA164776841;BENZTHIAZIDE;;Drug;0:0:0
PA448591;BENZTROPINE;N04AC01;Drug;0:0:0
PA134687812;BENZYDAMINE;A01AD02, G02CC03, M01AX07, M02AA05, R02AX03;Drug;0:0:0
PA448594;BENZYL ALCOHOL;;Drug;0:0:0
PA164748881;BENZYL BENZOATE;P03AX01;Drug;0:0:0
PA164754810;BENZYLPENICILLOYL POLYLYSINE;;Drug;0:0:0
PA164781356;BEPOTASTINE;;Drug;0:0:0
PA164754755;BEPRIDIL;C08EA02;Drug;0:1:0
PA166334921;BERMEKIMAB;L01FX11;Drug;0:0:0
PA166123556;BERYLLIUM;;Drug;0:0:0
PA164712536;BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES;C07F;Drug Class;0:0:0
PA164712537;BETA BLOCKING AGENTS AND OTHER DIURETICS;C07C;Drug Class;0:0:0
PA164712538;BETA BLOCKING AGENTS AND THIAZIDES;C07B;Drug Class;0:0:0
PA164712539;BETA BLOCKING AGENTS AND VASODILATORS;C07E;Drug Class;0:0:0
PA164712541;BETA BLOCKING AGENTS, NON-SELECTIVE;C07AA;Drug Class;7:32:1
PA164712542;BETA BLOCKING AGENTS, NON-SELECTIVE, AND OTHER ANTIHYPERTENSIVES;C07FA;Drug Class;0:0:0
PA164712543;BETA BLOCKING AGENTS, NON-SELECTIVE, AND OTHER DIURETICS;C07CA;Drug Class;0:0:0
PA164712544;BETA BLOCKING AGENTS, NON-SELECTIVE, AND THIAZIDES;C07BA;Drug Class;0:0:0
PA164712545;BETA BLOCKING AGENTS, NON-SELECTIVE, AND VASODILATORS;C07EA;Drug Class;0:0:0
PA164712546;BETA BLOCKING AGENTS, NON-SELECTIVE, THIAZIDES AND OTHER DIURETICS;C07DA;Drug Class;0:0:0
PA164712548;BETA BLOCKING AGENTS, SELECTIVE, AND OTHER ANTIHYPERTENSIVES;C07FB;Drug Class;0:0:0
PA164712549;BETA BLOCKING AGENTS, SELECTIVE, AND OTHER DIURETICS;C07CB;Drug Class;0:0:0
PA164712550;BETA BLOCKING AGENTS, SELECTIVE, AND THIAZIDES;C07BB;Drug Class;0:0:0
PA164712551;BETA BLOCKING AGENTS, SELECTIVE, AND VASODILATORS;C07EB;Drug Class;0:0:0
PA164712552;BETA BLOCKING AGENTS, SELECTIVE, THIAZIDES AND OTHER DIURETICS;C07DB;Drug Class;0:0:0
PA164712540;BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS;C07D;Drug Class;0:0:0
PA448601;BETA CAROTENE;A11CA02, D02BB01;Drug;0:0:0
PA166320721;BETA-EUDESMOL;;Drug;0:0:0
PA165958372;BETAHISTINE;N07CA01;Drug;0:0:0
PA448603;BETAINE;A16AA06;Drug;0:0:0
PA452154;BETA-LACTAM ANTIBACTERIALS, PENICILLINS;J01C;Drug Class;10:68:0
PA164712554;BETA-LACTAMASE INHIBITORS;J01CG;Drug Class;0:0:0
PA164712555;BETA-LACTAMASE RESISTANT PENICILLINS;J01CF;Drug Class;4:20:0
PA164712556;BETA-LACTAMASE SENSITIVE PENICILLINS;J01CE;Drug Class;2:4:0
PA164754818;BETAMETHASONE;A07EA04, C05AA05, D07AC01, D07XC01, H02AB01, R01AD06, R03BA04, S01BA06, S01CB04, S02BA07, S03BA03;Drug;0:0:0
PA448611;BETAXOLOL;C07AB05, S01ED02;Drug;0:0:0
PA164784036;BETAZOLE;V04CG02;Drug;0:0:0
PA448613;BETHANECHOL;N07AB02;Drug;0:0:0
PA164743235;BETHANIDINE;C02CC01;Drug;0:0:0
PA166342402;BETRIXABAN;B01AF04;Drug;0:0:0
PA164743236;BEVANTOLOL;C07AB06;Drug;0:1:0
PA164752250;BEXAROTENE;L01XX25;Drug;0:0:0
PA162364313;BEZAFIBRATE;C10AB02;Drug;0:4:0
PA164746255;BICALUTAMIDE;L02BB03;Drug;0:0:0
PA166335661;BICTEGRAVIR;;Drug;0:0:0
PA166335681;BICTEGRAVIR / EMTRICITABINE / TENOFOVIR ALAFENAMIDE;J05AR20;Drug;0:0:0
PA164746464;BIFONAZOLE;D01AC10;Drug;0:0:0
PA164712557;BIGUANIDES;A10BA, P01BB;Drug Class;29:144:0
PA164712559;BIGUANIDES AND AMIDINES;D08AC;Drug Class;0:0:0
PA166338421;BILASTINE;R06AX29, S01GX13;Drug;0:0:0
PA448617;BILE ACID PREPARATIONS;A05A, A05AA, C10AC;Drug Class;0:0:0
PA164712560;BILE AND LIVER THERAPY;A05;Drug Class;0:0:0
PA164748867;BIMATOPROST;S01EE03;Drug;0:0:0
PA164712561;BIOFLAVONOIDS;C05CA;Drug Class;0:0:0
PA448625;BIOTIN;A11HA05;Drug;0:0:0
PA448626;BIPERIDEN;N04AA02;Drug;0:0:0
PA164924560;BIRICODAR;;Drug;0:0:0
PA146096021;BISANTRENE;;Drug;0:3:0
PA164712562;BISMUTH PREPARATIONS;A07BB;Drug Class;0:0:0
PA164774805;BISMUTH SUBSALICYLATE;;Drug;0:0:0
PA166184057;BISOPROLOL FUMARATE / PERINDOPRIL ARGININE;C09BX02;Drug;0:0:0
PA164712564;BISPHOSPHONATES, COMBINATIONS;M05BB;Drug Class;0:0:0
PA164712565;BISQUATERNARY AMMONIUM COMPOUNDS;C02BC;Drug Class;0:0:0
PA10032;BIVALIRUDIN;B01AE06;Drug;0:0:0
PA166319041;BLONANSERIN;;Drug;0:3:0
PA164712566;BLOOD AND BLOOD FORMING ORGANS;B;Drug Class;283:2922:0
PA164712567;BLOOD AND RELATED PRODUCTS;B05A;Drug Class;0:0:0
PA164712570;BLOOD COAGULATION FACTORS;B02BD;Drug Class;0:0:0
PA164712568;BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS;A10B;Drug Class;75:508:0
PA164712569;BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05;Drug Class;1:5:0
PA164712571;BLOOD SUBSTITUTES AND PLASMA PROTEIN FRACTIONS;B05AA;Drug Class;0:0:0
PA164712572;BLOOD TESTS, AUXILIARY PRODUCTS;V07AD;Drug Class;0:0:0
PA164712573;BLOOD TRANSFUSION, AUXILIARY PRODUCTS;V07AC;Drug Class;0:0:0
PA166122526;BNP-32;;Drug;0:0:0
PA164712574;BONE MORPHOGENETIC PROTEINS;M05BC;Drug Class;0:0:0
PA165958425;BOPINDOLOL;C07AA17;Drug;0:0:0
PA164712575;BORIC ACID PRODUCTS;D08AD;Drug Class;0:0:0
PA10034;BOSENTAN;C02KX01;Drug;0:13:0
PA164747061;BOTULINUM TOXIN TYPE B;;Drug;0:0:0
PA166305861;B-RAF SERINE-THREONINE KINASE (BRAF) INHIBITORS;L01EC;Drug Class;0:5:0
PA166415721;BRENSOCATIB;;Drug;0:0:0
PA165948903;BRENTUXIMAB VEDOTIN;L01FX05;Drug;0:0:0
PA448662;BRETYLIUM;;Drug;0:0:0
PA166160053;BREXPIPRAZOLE;N05AX16;Drug;0:6:1
PA448665;BRIMONIDINE;D11AX21, S01EA05;Drug;0:0:1
PA166324482;BRINCIDOFOVIR;J05AB17;Drug;0:1:0
PA164744929;BRINZOLAMIDE;S01EC04;Drug;0:0:0
PA164924492;BRIVANIB;;Drug;0:0:1
PA166184058;BRIVUDINE;;Drug;0:0:0
PA166411581;BRODALUMAB;L04AC12;Drug;0:0:0
PA10035;BROMAZEPAM;N05BA08;Drug;0:0:1
PA448670;BROMFENAC;S01BC11;Drug;0:0:0
PA448671;BROMOCRIPTINE;G02CB01, N04BC01;Drug;0:0:0
PA164760854;BROMODIPHENHYDRAMINE;R06AA01;Drug;0:0:0
PA448675;BROMPHENIRAMINE;R06AB01;Drug;0:0:0
PA166119001;BROSTALLICIN;;Drug;0:1:0
PA166175777;BROTIZOLAM;;Drug;0:0:0
PA164712576;BRUCELLOSIS VACCINES;J07AD;Drug Class;0:0:0
PA166305921;BRUTON'S TYROSINE KINASE (BTK) INHIBITORS;L01EL;Drug Class;0:6:0
PA166123566;BUCILLAMINE;;Drug;0:2:0
PA164748223;BUCLIZINE;R06AE01;Drug;0:0:0
PA166300481;BULEVIRTIDE;J05AX28;Drug;0:0:0
PA164712577;BULK PRODUCERS;A06AC;Drug Class;0:0:0
PA135057240;BUPIVACAINE;N01BB01;Drug;0:0:0
PA165958426;BUPRANOLOL;C07AA19;Drug;0:0:0
PA448687;BUPROPION;N06AX12;Drug;34:112:1
PA10253;BUSERELIN;;Drug;0:0:0
PA448689;BUSPIRONE;N05BE01;Drug;0:1:0
PA164743463;BUTABARBITAL;;Drug;0:0:0
PA448695;BUTALBITAL;;Drug;0:0:0
PA164745478;BUTENAFINE;D01AE23;Drug;0:0:0
PA164748035;BUTETHAL;N05CA03;Drug;0:0:0
PA164781353;BUTOCONAZOLE;G01AF15;Drug;0:0:0
PA448704;BUTYLATED HYDROXYTOLUENE;;Drug;0:0:0
PA164712578;BUTYLPYRAZOLIDINES;M01AA;Drug Class;0:1:0
PA164712579;BUTYROPHENONE DERIVATIVES;N05AD;Drug Class;11:58:0
PA165958401;CABAZITAXEL;L01CD04;Drug;0:11:0
PA448708;CABERGOLINE;G02CB03, N04BC06;Drug;0:0:0
PA166251361;CABOTEGRAVIR;J05AJ04;Drug;0:0:0
PA165906891;CABOZANTINIB;L01EX07;Drug;0:3:1
PA164745614;CALCIDIOL;A11CC06;Drug, Metabolite, Biological Intermediate;0:0:0
PA164712580;CALCINEURIN INHIBITORS;L04AD;Drug Class;108:1258:0
PA448714;CALCIPOTRIOL;D05AX02;Drug;0:0:0
PA164712581;CALCITONIN PREPARATIONS;H05BA;Drug Class;0:0:0
PA448717;CALCITRIOL;A11CC04, D05AX03;Drug, Metabolite, Biological Intermediate;0:4:0
PA164746897;CALCIUM ACETATE;;Drug;0:0:0
PA448726;CALCIUM CARBONATE;;Drug;0:0:0
PA164712584;CALCIUM CHANNEL BLOCKERS AND DIURETICS;C08G, C08GA;Drug Class;0:0:0
PA448729;CALCIUM CHLORIDE;A12AA07, B05XA07, G04BA03;Drug;0:0:0
PA164712588;CALCIUM, COMBINATIONS WITH OTHER DRUGS;A12AX;Drug Class;0:0:0
PA164712587;CALCIUM COMPOUNDS;A02AC;Drug Class;0:0:0
PA164746233;CALCIUM GLUCEPTATE;A12AA10;Drug;0:0:0
PA448735;CALCIUM GLUCONATE;;Drug;0:0:0
PA164712585;CALCIUM HOMEOSTASIS;H05;Drug Class;0:1:0
PA448744;CALCIUM PANTOTHENATE;;Drug;0:0:0
PA10373;CALCIUM PHOSPHATE;;Drug;0:0:0
PA166197181;CAMOSTAT MESILATE;;Drug;0:0:0
PA153590860;CAMPTOTHECIN;;Drug;0:0:0
PA166362702;CAMRELIZUMAB;;Drug;0:0:0
PA166368021;CANAGLIFLOZIN;A10BK02;Drug;0:0:0
PA165958358;CANAKINUMAB;;Drug;0:7:0
PA166182234;CANDESARTAN CILEXETIL;;Prodrug;0:0:1
PA164754911;CANDICIDIN;G01AA04;Drug;0:0:0
PA164764517;CANDOXATRIL;;Drug;0:0:0
PA134687925;CANERTINIB;;Drug;0:0:0
PA131889722;CANFOSFAMIDE;;Drug;0:0:0
PA166175791;CANNABIDIOL;;Drug;0:5:1
PA164712589;CAPILLARY STABILIZING AGENTS;C05C;Drug Class;0:0:0
PA164746226;CAPREOMYCIN;J04AB30;Drug;0:0:0
PA164745489;CAPROMAB;;Drug;0:0:0
PA448776;CAPSAICIN;M02AB01, N01BX04;Drug;0:0:0
PA164712590;CAPSAICIN AND SIMILAR AGENTS;M02AB;Drug Class;0:0:0
PA448784;CARBACHOL;N07AB01, S01EB02;Drug;0:0:0
PA164712591;CARBAMATES;N05BC;Drug Class;0:0:0
PA164712592;CARBAMIC ACID ESTERS;M03BA;Drug Class;1:2:0
PA164712593;CARBAMIDE PRODUCTS;D02AE;Drug Class;0:0:0
PA164712594;CARBAPENEMS;J01DH;Drug Class;0:0:0
PA166184059;CARBASALATE CALCIUM;;Drug;0:0:0
PA448788;CARBENICILLIN;J01CA03;Drug;0:0:0
PA164743086;CARBETOCIN;H01BB03;Drug;0:0:0
PA448794;CARBIDOPA;;Drug;0:0:1
PA164746898;CARBINOXAMINE;R06AA08;Drug;0:0:0
PA448797;CARBOHYDRATES;V06DC;Drug Class;0:0:0
PA164712595;CARBOHYDRATES/PROTEINS/MINERALS/VITAMINS, COMBINATIONS;V06DA;Drug Class;0:0:0
PA448801;CARBON DIOXIDE;;Drug;0:0:0
PA10410;CARBONIC ANHYDRASE INHIBITORS;S01EC;Drug Class;3:15:0
PA164754883;CARBOPROST TROMETHAMINE;G02AD04;Drug;0:0:0
PA164712596;CARBOXAMIDE DERIVATIVES;N03AF;Drug Class;72:431:0
PA164712597;CARDIAC GLYCOSIDES;C01A;Drug Class;7:39:0
PA164712598;CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01C;Drug Class;5:20:0
PA164712599;CARDIAC THERAPY;C01;Drug Class;42:222:0
PA164712600;CARDIOVASCULAR SYSTEM;C, V09G;Drug Class;559:2133:0
PA166346661;CARFENTANIL;;Drug;0:0:0
PA166165203;CARFILZOMIB;;Drug;0:4:0
PA165958402;CARGLUMIC ACID;A16AA05;Drug;0:0:0
PA164712602;CARIES PROPHYLACTIC AGENTS;A01AA;Drug Class;0:0:0
PA448810;CARMUSTINE;L01AD01;Drug;0:0:0
PA164750571;CARPHENAZINE;;Drug;0:0:0
PA164781361;CARPROFEN;;Drug;0:0:0
PA448814;CARRAGEENAN;;Drug;0:0:0
PA164768736;CARTEOLOL;C07AA15, S01ED05;Drug;0:0:0
PA166255843;CASIRIVIMAB;;Drug;0:0:0
PA166255844;CASIRIVIMAB / IMDEVIMAB;J06BD07;Drug;0:0:0
PA166129533;CASOPITANT;;Drug;0:1:0
PA164743013;CASPOFUNGIN;J02AX04;Drug;0:0:0
PA448827;CASTOR OIL;;Drug;0:0:0
PA452605;CATIONIC XENOBIOTICS;;Drug Class;0:0:0
PA166334861;CATUMAXOMAB;L01FX03;Drug;0:0:0
PA166305962;CD20 (CLUSTERS OF DIFFERENTIATION 20) INHIBITORS;L01FA;Drug Class;10:37:0
PA166305963;CD22 (CLUSTERS OF DIFFERENTIATION 22) INHIBITORS;L01FB;Drug Class;0:0:0
PA166305981;CD38 (CLUSTERS OF DIFFERENTIATION 38) INHIBITORS;L01FC;Drug Class;0:0:0
PA166325661;CEDIROGANT;;Drug;0:0:0
PA164776752;CEFACETRILE;J01DB10;Drug;0:0:0
PA164749137;CEFACLOR;J01DC04;Drug;0:5:0
PA448835;CEFADROXIL;J01DB05;Drug;0:0:0
PA448886;CEFALOTIN;J01DB03;Drug;0:0:0
PA448837;CEFAMANDOLE;J01DC03;Drug;0:0:0
PA448839;CEFAZOLIN;J01DB04;Drug;0:0:0
PA164768739;CEFDINIR;J01DD15;Drug;0:0:0
PA164747187;CEFDITOREN;J01DD16;Drug;0:0:0
PA164754876;CEFEPIME;J01DE01;Drug;0:0:0
PA166351301;CEFIDEROCOL;J01DI04;Drug;0:0:0
PA164768821;CEFIXIME;J01DD08;Drug;0:0:0
PA164750569;CEFMENOXIME;J01DD05;Drug;0:0:0
PA164746819;CEFMETAZOLE;J01DC09;Drug;0:0:0
PA164743021;CEFONICID;J01DC06;Drug;0:0:0
PA448849;CEFOPERAZONE;J01DD12;Drug;0:0:0
PA164746057;CEFORANIDE;J01DC11;Drug;0:0:0
PA164784033;CEFOTETAN;J01DC05;Drug;0:0:0
PA164749298;CEFOTIAM;J01DC07;Drug;0:0:0
PA448856;CEFOXITIN;J01DC01;Drug;0:0:0
PA164748136;CEFPIRAMIDE;J01DD11;Drug;0:0:0
PA164746385;CEFPODOXIME;J01DD13;Drug;0:0:0
PA164746342;CEFPROZIL;J01DC10;Drug;0:0:0
PA448890;CEFRADINE;J01DB09;Drug;0:0:0
PA448861;CEFTAZIDIME;J01DD02;Drug;0:0:0
PA166324821;CEFTAZIDIME-AVIBACTAM;;Drug;0:0:0
PA164744555;CEFTIBUTEN;J01DD14;Drug;0:0:0
PA164748758;CEFTIZOXIME;J01DD07;Drug;0:0:0
PA448868;CEFUROXIME;J01DC02, S01AA27;Drug;0:0:0
PA448871;CELECOXIB;L01XX33, M01AH01;Drug;6:44:2
PA164924561;CELIPROLOL;C07AB08;Drug;0:4:0
PA448873;CELLULOSE;;Drug;0:0:0
PA166220421;CENICRIVIROC;;Drug;0:0:0
PA164712604;CENTRALLY ACTING ANTIOBESITY PRODUCTS;A08AA;Drug Class;1:2:0
PA164712605;CENTRALLY ACTING SYMPATHOMIMETICS;N06BA;Drug Class;82:289:0
PA164712603;CENTRAL NERVOUS SYSTEM;V09A;Drug Class;0:0:0
PA164781027;CEPHALOGLYCIN;;Drug;0:0:0
PA164749340;CEPHAPIRIN;J01DB08;Drug;0:0:0
PA166220607;CEPHARANTHINE;;Drug;0:0:0
PA166169879;CERLIPONASE ALFA;A16AB17;Drug;0:0:0
PA164764551;CERULENIN;;Drug;0:0:0
PA164774919;CERULETIDE;V04CC04;Drug;0:0:0
PA448905;CETIRIZINE;R06AE07;Drug;0:0:0
PA164764506;CETRORELIX;H01CC02;Drug;0:0:0
PA164754754;CEVIMELINE;N07AX03;Drug;0:0:0
PA448918;CHARCOAL PREPARATIONS;A07BA;Drug Class;0:0:0
PA164712606;CHEMICALS AND REAGENTS FOR ANALYSIS;V07AZ;Drug Class;0:0:0
PA164712607;CHEMOTHERAPEUTICS FOR TOPICAL USE;D06B;Drug Class;2:8:0
PA165958403;CHENODEOXYCHOLIC ACID;A05AA01;Drug;0:0:0
PA166359802;CHIGLITAZAR;;Drug;0:0:0
PA164748134;CHLOPHEDIANOL;R05DB10;Drug;0:0:0
PA448925;CHLORAL HYDRATE;N05CC01;Drug;0:0:0
PA448932;CHLORDIAZEPOXIDE;N05BA02;Drug;0:0:0
PA164776863;CHLORHEXIDINE;A01AB03, B05CA02, D08AC02, D09AA12, R02AA05, S01AX09, S02AA09, S03AA04;Drug;0:0:0
PA164712608;CHLORINE CONTAINING PRODUCTS;P03AB;Drug Class;0:0:0
PA164748977;CHLORMERODRIN;;Drug;0:0:0
PA448939;CHLORMEZANONE;M03BB02;Drug;0:0:0
PA448942;CHLOROPHYLL;;Drug;0:0:0
PA448946;CHLOROPROCAINE;N01BA04;Drug;0:0:0
PA165958419;CHLOROPYRAMINE;D04AA09, R06AC03;Drug;0:0:0
PA164768822;CHLOROTRIANISENE;G03CA06;Drug;0:0:0
PA164754879;CHLOROXINE;;Drug;0:0:0
PA164784022;CHLORPHENESIN;D01AE07;Drug;0:0:0
PA448960;CHLORPHENIRAMINE;R06AB04;Drug;0:0:0
PA166228322;CHLORPROGUANIL / DAPSONE;;Drug;0:0:0
PA448966;CHLORPROPAMIDE;A10BB02;Drug;0:0:0
PA164781400;CHLORPROTHIXENE;N05AF03;Drug;0:0:0
PA448971;CHLORZOXAZONE;M03BB03;Drug;0:0:0
PA164748138;CHOLECALCIFEROL;A11CC05;Drug, Biological Intermediate;0:0:0
PA164712609;CHOLERA VACCINES;J07AE;Drug Class;0:0:0
PA448974;CHOLESTYRAMINE;C10AC01;Drug;0:0:0
PA166160055;CHOLIC ACID;A05AA03;Drug;0:0:0
PA448976;CHOLINE;;Drug;0:0:0
PA164712610;CHOLINE DERIVATIVES;M03AB;Drug Class;58:88:0
PA164712611;CHOLINE ESTERS;N07AB;Drug Class;0:0:0
PA166182865;CHOP;;Drug;0:0:0
PA164783947;CHORIOGONADOTROPIN ALFA;G03GA08;Drug;0:0:0
PA448989;CHROMIUM;;Drug;0:0:0
PA448994;CHYMOTRYPSIN;;Drug;0:0:0
PA164712612;CICATRIZANTS;D03A;Drug Class;0:0:0
PA164781399;CICLESONIDE;R01AD13, R03BA08;Drug;0:0:0
PA164747060;CICLOPIROX;D01AE14, G01AX12;Drug;0:0:0
PA448998;CILASTATIN;;Drug;0:0:0
PA164748302;CILAZAPRIL;C09AA08;Drug;0:0:0
PA164924491;CILENGITIDE;;Drug;0:0:1
PA165948031;CILOMILAST;;Drug;0:0:0
PA449001;CIMETIDINE;A02BA01;Drug;0:1:0
PA164776671;CINACALCET;H05BX01;Drug;0:1:0
PA164743057;CINALUKAST;;Drug;0:0:0
PA165958427;CINITAPRIDE;;Drug;0:0:0
PA164749342;CINNARIZINE;N07CA02;Drug;0:0:0
PA164748034;CINOLAZEPAM;N05CD13;Drug;0:0:0
PA449007;CINOXACIN;J01MB06;Drug;0:0:0
PA449011;CISAPRIDE;A03FA02;Drug;0:4:0
PA164744925;CISATRACURIUM BESYLATE;;Drug;0:0:0
PA449015;CITALOPRAM;N06AB04;Drug;63:216:2
PA166344382;CITICOLINE;N06BX06;Drug, Biological Intermediate;0:0:0
PA449021;CITRIC ACID;A09AB04;Drug;0:0:0
PA449028;CLARITHROMYCIN;J01FA09;Drug;0:10:1
PA166199781;CLAZAKIZUMAB;;Drug;0:0:0
PA164776997;CLEMASTINE;D04AA14, R06AA04;Drug;0:0:0
PA164745640;CLENBUTEROL;R03AC14, R03CC13;Drug;0:0:0
PA166198261;CLEVUDINE;;Drug;0:0:0
PA164781044;CLIDINIUM;;Drug;0:0:0
PA10888;CLOBAZAM;N05BA09;Drug;4:16:1
PA164744375;CLOBETASOL;;Drug;0:0:0
PA164744013;CLOCORTOLONE;D07AB21;Drug;0:0:0
PA164754863;CLOFARABINE;L01BB06;Drug;0:0:0
PA164748759;CLOFAZIMINE;J04BA01;Drug;0:0:0
PA449045;CLOFIBRATE;C10AB01;Drug;0:0:0
PA449046;CLOMIFENE;G03GB02;Drug;0:0:0
PA449048;CLOMIPRAMINE;N06AA04;Drug;8:60:1
PA164771235;CLOMOCYCLINE;J01AA11;Drug;0:0:0
PA449050;CLONAZEPAM;N03AE01;Drug;0:1:1
PA449053;CLOPIDOGREL;B01AC04;Prodrug;51:919:2
PA164749297;CLORAZEPATE;;Drug;0:0:0
PA164752437;CLOTIAZEPAM;N05BA21;Drug;0:0:0
PA449057;CLOTRIMAZOLE;A01AB18, D01AC01, G01AF02;Drug;0:0:0
PA449059;CLOXACILLIN;J01CF02;Drug;0:0:0
PA166182867;CMF;;Drug;0:0:0
PA164744952;COAGULATION FACTOR IX;B02BD04;Drug;0:0:0
PA164748389;COAGULATION FACTOR VIIA;;Drug;0:0:0
PA166165092;COBICISTAT;V03AX03;Drug;0:0:0
PA449088;CODEINE;N02AA59, N02AA79, R05DA04;Prodrug;12:89:1
PA164712613;COD-LIVER OIL OINTMENTS;D03AA;Drug Class;0:0:0
PA449092;COLCHICINE;M04AC01;Drug;0:2:0
PA164712614;COLCHICINE DERIVATIVES;L01CC;Drug Class;0:0:0
PA449095;COLESEVELAM;C10AC04;Drug;0:0:0
PA449096;COLESTIPOL;C10AC02;Drug;0:0:0
PA164749509;COLISTIMETHATE;;Prodrug;0:0:0
PA164760862;COLISTIN;A07AA10, J01XB01;Drug;0:0:0
PA449107;COLLAGENASE;D03BA02, M09AB02;Drug;0:0:0
PA10420;COLONY STIMULATING FACTORS;L03AA;Drug Class;0:0:0
PA164712615;COLOURING AGENTS;S01JA;Drug Class;0:0:0
PA166230961;COMBINATION NICOTINE REPLACEMENT THERAPY;;Drug;0:1:0
PA164712618;COMBINATIONS AND COMPLEXES OF ALUMINIUM, CALCIUM AND MAGNESIUM COMPOUNDS;A02AD;Drug Class;0:0:0
PA164712619;COMBINATIONS FOR ERADICATION OF HELICOBACTER PYLORI;A02BD;Drug Class;0:0:0
PA164712620;COMBINATIONS OF ADRENERGICS;R03AH;Drug Class;0:0:0
PA164712616;COMBINATIONS OF ANTIBACTERIALS;J01R, J01RA;Drug Class;0:0:0
PA164712622;COMBINATIONS OF ANTIHISTAMINES;R06AK;Drug Class;0:0:0
PA164712617;COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02;C02N;Drug Class;0:0:0
PA164712623;COMBINATIONS OF ANTINEOPLASTIC AGENTS;L01XY;Drug Class;0:0:0
PA164712624;COMBINATIONS OF DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM;Drug Class;0:11:0
PA164712625;COMBINATIONS OF ORAL BLOOD GLUCOSE LOWERING DRUGS;A10BD;Drug Class;0:0:0
PA164712626;COMBINATIONS OF PENICILLINS, INCL. BETA-LACTAMASE INHIBITORS;J01CR;Drug Class;0:0:0
PA10492;COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVATIVES;J01EE;Drug Class;9:44:0
PA164712627;COMBINATIONS OF VITAMINS;A11JA;Drug Class;0:0:0
PA164742939;CONIVAPTAN;C03XA02;Drug;0:0:0
PA164712628;CONTACT LAXATIVES;A06AB;Drug Class;0:0:0
PA164712629;CONTRACEPTIVES FOR TOPICAL USE;G02B;Drug Class;0:0:0
PA164712630;CONTRAST MEDIA;V08;Drug Class;0:0:0
PA449114;COPPER;;Drug;0:0:0
PA449119;COPPER SULFATE;V03AB20;Drug;0:0:0
PA449122;CORN OIL;;Drug;0:0:0
PA164712631;CORTICOSTEROID DERIVATIVES;N02CB;Drug Class;0:0:0
PA164712634;CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION;S01CA, S02C, S02CA, S03C, S03CA;Drug Class;0:0:0
PA164712641;CORTICOSTEROIDS AND MYDRIATICS IN COMBINATION;S01BB;Drug Class;0:0:0
PA164712664;CORTICOSTEROIDS/ANTIINFECTIVES/MYDRIATICS IN COMBINATION;S01CB;Drug Class;18:74:0
PA164712647;CORTICOSTEROIDS, COMBINATIONS FOR TREATMENT OF ACNE;D10AA;Drug Class;15:53:0
PA164712643;CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS;D07C;Drug Class;0:0:0
PA164712644;CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS;D07B;Drug Class;0:0:0
PA164712645;CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS;D07;Drug Class;27:107:0
PA164712636;CORTICOSTEROIDS FOR SYSTEMIC USE;H02;Drug Class;35:145:0
PA164712637;CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS;H02B, H02BX;Drug Class;0:0:0
PA164712649;CORTICOSTEROIDS, MODERATELY POTENT, COMBINATIONS WITH ANTIBIOTICS;D07CB;Drug Class;0:0:0
PA164712650;CORTICOSTEROIDS, MODERATELY POTENT, COMBINATIONS WITH ANTISEPTICS;D07BB;Drug Class;0:0:0
PA164712648;CORTICOSTEROIDS, MODERATELY POTENT (GROUP II);D07AB;Drug Class;17:52:0
PA164712651;CORTICOSTEROIDS, MODERATELY POTENT, OTHER COMBINATIONS;D07XB;Drug Class;17:52:0
PA164712646;CORTICOSTEROIDS, OTHER COMBINATIONS;D07X;Drug Class;21:76:0
PA164712653;CORTICOSTEROIDS, POTENT, COMBINATIONS WITH ANTIBIOTICS;D07CC;Drug Class;0:0:0
PA164712654;CORTICOSTEROIDS, POTENT, COMBINATIONS WITH ANTISEPTICS;D07BC;Drug Class;0:0:0
PA164712652;CORTICOSTEROIDS, POTENT (GROUP III);D07AC;Drug Class;5:28:0
PA164712655;CORTICOSTEROIDS, POTENT, OTHER COMBINATIONS;D07XC;Drug Class;0:0:0
PA164712657;CORTICOSTEROIDS, VERY POTENT, COMBINATIONS WITH ANTIBIOTICS;D07CD;Drug Class;0:0:0
PA164712658;CORTICOSTEROIDS, VERY POTENT, COMBINATIONS WITH ANTISEPTICS;D07BD;Drug Class;0:0:0
PA164712656;CORTICOSTEROIDS, VERY POTENT (GROUP IV);D07AD;Drug Class;0:0:0
PA164712659;CORTICOSTEROIDS, VERY POTENT, OTHER COMBINATIONS;D07XD;Drug Class;0:0:0
PA164712661;CORTICOSTEROIDS, WEAK, COMBINATIONS WITH ANTIBIOTICS;D07CA;Drug Class;0:0:0
PA164712662;CORTICOSTEROIDS, WEAK, COMBINATIONS WITH ANTISEPTICS;D07BA;Drug Class;0:0:0
PA164712660;CORTICOSTEROIDS, WEAK (GROUP I);D07AA;Drug Class;5:27:0
PA164712663;CORTICOSTEROIDS, WEAK, OTHER COMBINATIONS;D07XA;Drug Class;4:24:0
PA449129;CORTICOTROPIN;H01AA01;Drug;0:0:0
PA449130;CORTISONE ACETATE;H02AB10, S01BA03;Drug;0:1:0
PA166400162;COSIBELIMAB;;Drug;0:0:0
PA164712665;COSMETICS;V07AT;Drug Class;0:0:0
PA164749052;COSYNTROPIN;H01AA02;Drug;0:0:0
PA164712666;COUGH AND COLD PREPARATIONS;R05;Drug Class;33:222:0
PA164712667;COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS;R05F;Drug Class;0:0:0
PA164712668;COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS;R05D;Drug Class;32:216:0
PA164712669;COXIBS;M01AH;Drug Class;7:51:0
PA165107062;CP-800,569;;Drug;0:0:0
PA165111677;CREMOPHOR EL;;Drug;0:0:0
PA166189801;CRIZANLIZUMAB-TMCA;B06AX01;Drug;0:0:0
PA449138;CROMOGLICATE;A07EB01, D11AH03, R01AC01, R03BC01, S01GX01;Drug;0:0:0
PA164745460;CROTAMITON;;Drug;0:0:0
PA164749510;CRYPTENAMINE;;Drug;0:0:0
PA164712670;CURARE ALKALOIDS;M03AA;Drug Class;0:0:0
PA164743456;CYCLACILLIN;;Drug;0:0:0
PA164748026;CYCLANDELATE;C04AX01;Drug;0:0:0
PA164712671;CYCLIC AMINES;J05AC;Drug Class;0:0:0
PA166305882;CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS;L01EF;Drug Class;0:11:0
PA164742937;CYCLIZINE;R06AE03;Drug;0:0:0
PA449160;CYCLOBENZAPRINE;M03BX08;Drug;0:0:0
PA165107357;CYCLOGUANIL;;Drug, Metabolite;0:3:0
PA164743019;CYCLOPENTOLATE;S01FA04;Drug;0:0:0
PA164764600;CYCLOSERINE;J04AB01;Drug;0:0:0
PA449168;CYCLOTHIAZIDE;C03AA09;Drug;0:0:0
PA164749387;CYCRIMINE;;Drug;0:0:0
PA164749366;CYPROHEPTADINE;R06AX02;Drug;0:0:0
PA10049;CYPROTERONE;;Drug;0:0:0
PA164712672;CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01D;Drug Class;169:639:0
PA165958369;DABIGATRAN ETEXILATE;B01AE07;Prodrug;0:0:1
PA164764446;DACLIZUMAB;L04AC01;Drug;0:0:0
PA151917012;DACTINOMYCIN;L01DA01;Drug;0:12:0
PA166210781;DACTOLISIB;;Drug;0:0:0
PA166209982;DALBAVANCIN;;Drug;0:0:0
PA164746234;DALFOPRISTIN;;Drug;0:0:0
PA166346321;DALPICICLIB;;Drug;0:0:0
PA165958404;DALTEPARIN;;Drug;0:0:0
PA166248921;DANAPAROID;B01AB09;Drug;0:0:0
PA164749056;DANAZOL;G03XA01;Drug;0:0:0
PA166119201;DANIQUIDONE;;Drug;0:0:0
PA449208;DANTROLENE;M03CA01;Drug;0:0:0
PA164712673;DANTROLENE AND DERIVATIVES;M03CA;Drug Class;0:0:0
PA166416242;DANUGLIPRON;;Drug;0:0:0
PA166104278;DAPAGLIFLOZIN;;Drug;0:0:0
PA164749109;DAPIPRAZOLE;S01EX02;Drug;0:0:0
PA166280581;DAPRODUSTAT;;Drug;0:0:0
PA449211;DAPSONE;D10AX05, J04BA02;Drug;8:24:0
PA165884699;DARAPLADIB;;Drug;0:7:0
PA166334883;DARATUMUMAB;L01FC01;Drug;0:0:0
PA164743138;DARBEPOETIN ALFA;B03XA02;Drug;0:0:0
PA164774901;DARIFENACIN;G04BD10;Drug;0:0:0
PA163522472;DARUNAVIR;J05AE10;Drug;0:2:0
PA166182623;DARUNAVIR / RITONAVIR;J05AR26;Drug;0:0:0
PA166163411;DASABUVIR;J05AP09;Drug;0:0:0
PA166160002;DASABUVIR / OMBITASVIR / PARITAPREVIR / RITONAVIR;J05AP52;Drug;0:0:0
PA166396081;DATOPOTAMAB DERUXTECAN;;Drug;0:0:0
PA449212;DAUNORUBICIN;L01DB02;Drug;16:122:0
PA166122486;DB-289;;Drug;0:0:0
PA452616;DEBRISOQUINE;C02CC04;Drug;2:39:0
PA164747980;DECAMETHONIUM;;Drug;0:0:0
PA164749631;DECITABINE;L01BC08;Drug;0:0:0
PA164712674;DECONGESTANTS AND ANTIALLERGICS;S01G;Drug Class;2:7:0
PA164712675;DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01A;Drug Class;31:113:0
PA164746490;DEFEROXAMINE;V03AC01;Drug;0:0:0
PA164749105;DEFIBROTIDE;B01AX01;Drug;0:0:0
PA165958373;DEGARELIX;L02BX02;Drug;0:0:0
PA166412461;DELAFLOXACIN;J01MA23;Drug;0:0:0
PA166324861;DELAMANID;J04AK06;Drug;0:0:0
PA449223;DELAVIRDINE;J05AG02;Drug;0:0:0
PA166363781;DELPAZOLID;;Drug;0:0:0
PA164745610;DEMECARIUM BROMIDE;S01EB04;Drug;0:0:0
PA164745513;DEMECLOCYCLINE;D06AA01, J01AA01;Drug;0:0:0
PA164750594;DENILEUKIN DIFTITOX;L01XX29;Drug;0:0:0
PA166048634;DENOSUMAB;;Drug;0:0:0
PA166328041;DEOXYSCHISANDRIN;;Drug;0:0:0
PA164712676;DERMATOLOGICALS;D;Drug Class;229:1632:0
PA166354901;DERSIMELAGON;;Drug;0:0:0
PA164742966;DESERPIDINE;C02AA05;Drug;0:0:0
PA164749136;DESFLURANE;N01AB07;Drug;47:18:1
PA449233;DESIPRAMINE;N06AA01;Drug, Metabolite;5:27:2
PA164747478;DESLANOSIDE;C01AA07;Drug;0:0:0
PA165817936;DESMETHYLASTEMIZOLE;;Drug;0:0:0
PA134687941;DESMETHYLCITALOPRAM;;Drug;0:7:0
PA449238;DESOGESTREL;G03AC09;Drug;0:0:0
PA164776996;DESONIDE;D07AB08, S01BA11;Drug;0:0:0
PA164746011;DESOXIMETASONE;D07AC03, D07XC02;Drug;0:0:0
PA449245;DESOXYCORTICOSTERONE PIVALATE;;Drug;0:0:0
PA164712677;DETOXIFYING AGENTS FOR ANTINEOPLASTIC TREATMENT;V03AF;Drug Class;2:28:0
PA166400021;DEURUXOLITINIB;;Drug;0:0:0
PA166169881;DEUTETRABENAZINE;N07XX16;Drug;0:0:0
PA166362501;DEUTIVACAFTOR;;Drug;0:0:0
PA164746251;DEXBROMPHENIRAMINE;R06AB06;Drug;0:0:0
PA164747936;DEXFENFLURAMINE;A08AA04;Drug;0:0:0
PA166049174;DEXIBUPROFEN;;Drug;0:0:0
PA166049175;DEXKETOPROFEN;;Drug;0:0:0
PA166110257;DEXLANSOPRAZOLE;A02BC06;Drug;1:4:1
PA10054;DEXMETHYLPHENIDATE;N06BA11;Drug;0:0:0
PA449261;DEXTRAN;;Drug;0:0:0
PA449273;DEXTROMETHORPHAN;R05DA09;Drug;7:105:1
PA166278341;DEXTROMETHORPHAN HYDROBROMIDE / BUPROPION HYDROCHLORIDE;N06AX62, N07XX59;Drug;0:0:0
PA166175998;DEXTROMETHORPHAN / QUINIDINE;C01BA51, N07XX59;Drug;0:0:0
PA164752444;DEXTROTHYROXINE;C10AX01;Drug;0:0:0
PA164746059;DEZOCINE;N02AX03;Drug;0:0:0
PA166348404;DIACETYL DAPSONE;;Prodrug;0:0:0
PA164712678;DIAGNOSTIC AGENTS;S01J, V04;Drug Class;5:28:0
PA164712680;DIAGNOSTIC RADIOPHARMACEUTICALS;V09;Drug Class;0:0:0
PA164712681;DIAMINOPYRIMIDINES;P01BD;Drug Class;2:7:0
PA449281;DIATRIZOATE;V08AA01;Drug;0:0:0
PA164712682;DIAZEPINES, OXAZEPINES AND THIAZEPINES;N05AH;Drug Class;142:594:0
PA449285;DIAZOXIDE;C02DA01, V03AH01;Drug;0:0:0
PA166292901;DIBEKACIN;J01GB09;Drug;0:0:0
PA164712683;DIBENZO-BICYCLO-OCTADIENE DERIVATIVES;N05BD;Drug Class;0:0:0
PA449286;DIBUCAINE;C05AD04, D04AB02, N01BB06, S01HA06, S02DA04;Drug;0:0:0
PA164712684;DICHLOROACETAMIDE DERIVATIVES;P01AC;Drug Class;0:0:0
PA165947835;DICHLOROACETIC ACID;;Drug, Metabolite;0:6:1
PA164745512;DICHLORPHENAMIDE;S01EC02;Drug;0:0:0
PA449298;DICUMAROL;B01AA01;Drug;0:0:0
PA164744928;DICYCLOMINE;A03AA07;Drug;0:0:0
PA164745534;DIENESTROL;G03CB01, G03CC02;Drug;0:0:0
PA164712685;DIET FORMULATIONS FOR TREATMENT OF OBESITY;V06A;Drug Class;0:0:0
PA164748883;DIETHYLCARBAMAZINE;P02CB02;Drug;0:0:0
PA164778098;DIETHYLPROPION;A08AA03;Drug;0:0:0
PA449307;DIETHYLSTILBESTROL;G03CB02, G03CC05, L02AA01;Drug;0:0:0
PA134653756;DIFLOMOTECAN;;Drug;0:1:0
PA164749408;DIFLORASONE;D07AC10;Drug;0:0:0
PA449313;DIFLUNISAL;N02BA11;Drug;0:0:0
PA165958405;DIFLUPREDNATE;D07AC19;Drug;0:0:0
PA164712687;DIGESTIVES, INCL. ENZYMES;A09, A09A;Drug Class;0:0:0
PA452244;DIGITALIS GLYCOSIDES;C01AA;Drug Class;7:39:0
PA449316;DIGITOXIN;C01AA04;Drug;0:0:0
PA164769030;DIGOXIN IMMUNE FAB;;Drug;0:0:0
PA164752819;DIHYDROERGOTOXINE;;Drug;0:0:0
PA166301762;DIHYDROQUINIDINE;;Drug, Metabolite;0:0:0
PA164744345;DIHYDROTACHYSTEROL;A11CC02;Drug;0:0:0
PA164746763;DIHYDROXYALUMINIUM;;Drug;0:0:0
PA152530737;DILAZEP;C01DX10;Drug;0:0:0
PA165958413;DILOXANIDE;P01AC01;Drug;0:0:0
PA449338;DIMENHYDRINATE;;Drug;0:0:0
PA165958420;DIMETHINDENE;D04AA13, R06AB03;Drug;0:0:0
PA449342;DIMETHYL SULFOXIDE;G04BX13, M02AX03;Drug;0:0:0
PA164781385;DINOPROST TROMETHAMINE;;Drug;0:0:0
PA166160060;DINUTUXIMAB;L01FX06;Drug;0:0:0
PA164748388;DIPHEMANIL METHYLSULFATE;;Drug;0:0:0
PA449349;DIPHENHYDRAMINE;D04AA32, R06AA02;Drug;0:7:0
PA164746037;DIPHENIDOL;;Drug;0:0:0
PA164746539;DIPHENOXYLATE;A07DA01;Drug;0:0:0
PA164712690;DIPHENYLBUTYLPIPERIDINE DERIVATIVES;N05AG;Drug Class;0:4:0
PA164712691;DIPHENYLMETHANE DERIVATIVES;N05BB;Drug Class;0:1:0
PA164712692;DIPHENYLPROPYLAMINE DERIVATIVES;N02AC;Drug Class;0:6:0
PA164746377;DIPHENYLPYRALINE;R06AA07;Drug;0:0:0
PA164712693;DIPHTHERIA VACCINES;J07AF;Drug Class;0:0:0
PA449364;DIPIVEFRIN;;Drug;0:0:0
PA449367;DIPYRIDAMOLE;B01AC07;Drug;0:0:0
PA166342382;DIRECT FACTOR XA INHIBITORS;B01AF;Drug Class;7:70:0
PA164712694;DIRECT THROMBIN INHIBITORS;B01AE;Drug Class;0:0:0
PA449368;DIRITHROMYCIN;J01FA13;Drug;0:0:0
PA166335022;DIROXIMEL FUMARATE;L04AX09;Prodrug;0:0:0
PA164712695;DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03E;Drug Class;50:120:0
PA166110254;DIVICINE;;Drug;0:0:0
PA164749211;DOCOSANOL;D06BB11;Drug;0:0:0
PA451988;DODECANE-TRIMETHYLAMINE;;Drug;0:0:0
PA449389;DOFETILIDE;C01BD04;Drug;0:6:0
PA166184505;DOLUTEGRAVIR / ABACAVIR / LAMIVUDINE;J05AR13;Drug;0:0:0
PA134711056;DOMPERIDONE;A03FA03;Drug;0:0:0
PA164712696;DOPA AND DOPA DERIVATIVES;N04BA;Drug Class;6:24:0
PA449396;DOPAMINE;C01CA04;Drug, Biological Intermediate;0:0:3
PA164712698;DOPAMINERGIC AGENTS;N04B;Drug Class;12:44:0
PA166399661;DORDAVIPRONE;;Drug;0:0:0
PA10318;DORNASE ALFA;;Drug;0:0:0
PA164748765;DORZOLAMIDE;S01EC03;Drug;0:0:0
PA166131608;DOVITINIB;;Drug;0:0:0
PA164744927;DOXACURIUM;M03AC07;Drug;0:0:0
PA164784026;DOXAPRAM;R07AB01;Drug;0:0:0
PA449407;DOXAZOSIN;C02CA04;Drug;0:5:0
PA449409;DOXEPIN;N06AA12;Drug;3:23:1
PA449412;DOXORUBICIN;L01DB01;Drug;77:294:3
PA449415;DOXYCYCLINE;A01AB22, J01AA02;Drug;0:1:0
PA449419;DOXYLAMINE;R06AA09;Drug;0:0:0
PA165291460;DPCPX;;Drug;0:0:0
PA164760855;DROMOSTANOLONE;;Drug;0:0:0
PA449421;DRONABINOL;A04AD10;Drug;0:1:0
PA153619853;DRONEDARONE;C01BD07;Drug;0:2:0
PA449422;DROPERIDOL;N05AD08;Drug;0:0:0
PA164749409;DROSPIRENONE;;Drug;0:0:0
PA165290928;DROSPIRENONE / ETHINYL ESTRADIOL;G03AA12;Drug;0:0:0
PA165958398;DROTAVERINE;A03AD02;Drug;0:0:0
PA131548935;DROTRECOGIN ALFA;;Drug;0:1:0
PA166049182;DROXICAM;;Drug;0:0:0
PA164748386;DROXIDOPA;;Drug;0:0:0
PA164712712;DRUGS ACTING ON SEROTONIN RECEPTORS;A03AE;Drug Class;0:0:0
PA164712699;DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05B;Drug Class;10:37:0
PA164712700;DRUGS FOR ACID RELATED DISORDERS;A02;Drug Class;19:444:0
PA164712701;DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION;A05C;Drug Class;0:0:0
PA164712713;DRUGS FOR EMBOLISATION;V03AM;Drug Class;0:0:0
PA164712702;DRUGS FOR FUNCTIONAL BOWEL DISORDERS;A03A;Drug Class;0:0:0
PA164712703;DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03;Drug Class;0:12:0
PA164712704;DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03;Drug Class;53:155:0
PA164712705;DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02B;Drug Class;19:444:0
PA164712706;DRUGS FOR TREATMENT OF BONE DISEASES;M05;Drug Class;10:37:0
PA164712714;DRUGS FOR TREATMENT OF HYPERCALCEMIA;V03AG;Drug Class;0:0:0
PA164712715;DRUGS FOR TREATMENT OF HYPERKALEMIA AND HYPERPHOSPHATEMIA;V03AE;Drug Class;0:0:0
PA164712716;DRUGS FOR TREATMENT OF HYPOGLYCEMIA;V03AH;Drug Class;0:0:0
PA164712707;DRUGS FOR TREATMENT OF LEPRA;J04B, J04BA;Drug Class;8:24:0
PA164712708;DRUGS FOR TREATMENT OF TUBERCULOSIS;J04A;Drug Class;78:800:0
PA164712709;DRUGS USED IN ADDICTIVE DISORDERS;N07B;Drug Class;326:1339:0
PA164712710;DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04C;Drug Class;0:9:0
PA164712719;DRUGS USED IN ERECTILE DYSFUNCTION;G04BE;Drug Class;6:9:0
PA164712721;DRUGS USED IN OPIOID DEPENDENCE;N07BC;Drug Class;167:788:0
PA451455;D-SORBITOL;;Drug;0:0:0
PA166354062;DT-678;;Drug, Metabolite;0:1:0
PA166285081;DULAGLUTIDE;A10BJ05;Drug;0:9:0
PA166327002;DUPILUMAB;D11AH05;Drug;0:0:0
PA164749300;DUTASTERIDE;G04CB02;Drug;0:0:0
PA166182761;DUVELISIB;L01EM04;Drug;0:0:0
PA451938;D-XYLITOL;;Drug;0:0:0
PA164748037;DYCLONINE;N01BX02, R02AD04;Drug;0:0:0
PA164745443;DYDROGESTERONE;G03DB01;Drug;0:0:0
PA164748027;DYPHYLLINE;R03DA01;Drug;0:0:0
PA166094735;E 7010;;Drug;0:0:0
PA166304861;EBASTINE;R06AX22;Drug;0:3:0
PA161660841;EBSELEN;;Drug;0:0:0
PA165958350;ECABET;;Drug;0:0:0
PA166222861;ECALLANTIDE;;Drug, Biological Intermediate;0:0:0
PA131550706;ECHINACEA;;Drug;0:0:0
PA164743139;ECHOTHIOPHATE IODIDE;;Drug;0:0:0
PA164746010;ECONAZOLE;D01AC03, G01AF05;Drug;0:0:0
PA164712722;ECTOPARASITICIDES, INCL. SCABICIDES;P03A;Drug Class;5:13:0
PA164712723;ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS;P03;Drug Class;5:13:0
PA449439;EDETIC ACID;;Drug;0:0:0
PA166128806;EDOXABAN;B01AF03;Drug;0:18:1
PA166334842;EDRECOLOMAB;L01FX01;Drug;0:0:0
PA449437;EDROPHONIUM;;Drug;0:0:0
PA164748817;EFALIZUMAB;L04AA21;Drug;0:0:0
PA449441;EFAVIRENZ;J05AG03;Drug;33:478:2
PA166176033;EFAVIRENZ / EMTRICITABINE / TENOFOVIR DISOPROXIL;;Drug;0:0:0
PA166268781;EFGARTIGIMOD ALFA;L04AA58;Drug;0:0:0
PA166205401;EFMARODOCOKIN;;Drug;0:0:0
PA166305965;EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR) INHIBITORS;L01FE;Drug Class;21:126:0
PA166206962;EIDD-2801;;Prodrug;0:0:0
PA164924562;ELACRIDAR;;Drug;0:0:0
PA166182348;ELAGOLIX;H01CC03;Drug;0:0:0
PA166163436;ELBASVIR;J05AP10;Drug;0:0:0
PA166163438;ELBASVIR / GRAZOPREVIR;J05AP54;Drug;0:3:0
PA10068;ELECTROLYTES;;Drug;0:0:0
PA164712724;ELECTROLYTE SOLUTIONS;B05XA;Drug Class;0:0:0
PA164712725;ELECTROLYTES WITH CARBOHYDRATES;A07C;Drug Class;0:0:0
PA134687947;ELETRIPTAN;N02CC06;Drug;0:7:1
PA166185161;ELEXACAFTOR;R07AX;Drug;0:7:2
PA166334882;ELOTUZUMAB;L01FX08;Drug;0:0:0
PA166328801;ELRANATAMAB;;Drug;0:0:0
PA165981594;ELTROMBOPAG;B02BX05;Drug;0:4:0
PA165291498;ELVITEGRAVIR;;Drug;0:0:0
PA166182675;ELVITEGRAVIR / COBICISTAT / EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE;;Drug;0:0:0
PA166182763;EMAPALUMAB;L04AA39;Drug;0:0:0
PA164751802;EMEDASTINE;S01GX06;Drug;0:0:0
PA164712727;EMOLLIENTS AND PROTECTIVES;D02, D02A;Drug Class;0:0:0
PA166163327;EMPAGLIFLOZIN;;Drug;0:5:0
PA10069;EMTRICITABINE;J05AF09;Drug;0:1:0
PA166308961;EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE;;Prodrug;0:0:0
PA166305001;EMVODODSTAT;;Drug;0:0:0
PA449459;ENCAINIDE;C01BC08;Drug;0:0:0
PA164712728;ENCEPHALITIS VACCINES;J07BA;Drug Class;0:0:0
PA164712729;ENDOCRINE THERAPY;L02;Drug Class;71:527:0
PA164712730;ENEMAS;A06AG;Drug Class;0:0:0
PA449461;ENFLURANE;N01AB04;Drug;47:14:1
PA166190121;ENFORTUMAB VEDOTIN;L01FX13;Drug;0:0:0
PA164744517;ENFUVIRTIDE;J05AX07;Drug;0:0:0
PA449462;ENOXACIN;J01MA04;Drug;0:0:0
PA449463;ENOXAPARIN;B01AB05;Drug;0:0:0
PA164768794;ENOXIMONE;C01CE03;Drug;0:0:0
PA164749350;ENPROFYLLINE;;Drug;0:0:0
PA166364001;ENSITRELVIR;J05AE16;Drug;0:0:0
PA164784025;ENTECAVIR;J05AF10;Drug;0:0:0
PA162370429;ENTOLIMOD;;Drug;0:0:0
PA166123406;ENZALUTAMIDE;L02BB04;Drug;0:0:0
PA164712731;ENZYME AND ACID PREPARATIONS, COMBINATIONS;A09AC;Drug Class;0:0:0
PA164712732;ENZYME INHIBITORS;L02BG;Drug Class;50:265:1
PA164712733;ENZYME PREPARATIONS;A09AA;Drug Class;0:0:0
PA164777031;EPHEDRA;;Drug;0:0:0
PA166305842;EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS;L01EB;Drug Class;27:257:0
PA164764489;EPINASTINE;R06AX24, S01GX10;Drug;0:0:0
PA449470;EPINEPHRINE;A01AD01, B02BC09, C01CA24, R01AA14, R03AA01, S01EA01;Drug;0:0:2
PA452611;EPIPODOPHYLLOTOXIN;;Drug;0:0:0
PA164749044;EPLERENONE;C03DA04;Drug;0:0:2
PA164712740;EPOXIDES;L01AG;Drug Class;0:0:0
PA449481;EPROSARTAN;C09CA02;Drug;0:0:0
PA449483;EPTIFIBATIDE;B01AC16;Drug;0:0:1
PA166320922;EPTINEZUMAB;N02CD05;Drug;0:0:1
PA166238941;EQUILENIN SULFATE;;Drug;0:0:0
PA166238861;EQUILIN SULFATE;;Drug;0:0:0
PA449484;ERGOCALCIFEROL;A11CC01;Drug;0:0:1
PA164752439;ERGOLOID MESYLATE;C04AE01;Drug;0:0:0
PA449487;ERGONOVINE;G02AB03;Drug;0:0:0
PA164712744;ERGOT ALKALOIDS AND OXYTOCIN INCL. ANALOGUES, IN COMBINATION;G02AC;Drug Class;0:0:0
PA164747651;ERGOTAMINE;N02CA02;Drug;0:0:0
PA166182723;ERIBULIN;L01XX41;Drug;0:0:0
PA164777032;ERTAPENEM;J01DH03;Drug;0:0:0
PA166269521;ERTUGLIFLOZIN;A10BK04;Drug;0:0:0
PA165291442;ERTUMAXOMAB;;Drug;0:0:0
PA164746528;ERYTHRITYL TETRANITRATE;C01DA13;Drug;0:0:0
PA166176008;ERYTHROMYCIN ETHYLSUCCINATE / SULFISOXAZOLE ACETYL;;Drug;0:0:0
PA10072;ERYTHROPOIETIN;B03XA01;Drug;0:5:0
PA10074;ESCITALOPRAM;N06AB10;Drug;27:202:1
PA166364961;ESKETAMINE;;Drug;0:0:0
PA165947475;ESLICARBAZEPINE ACETATE;;Prodrug;0:6:1
PA449500;ESMOLOL;C07AB09;Drug;0:0:0
PA166184493;ESOMEPRAZOLE / NAPROXEN;;Drug;0:0:0
PA449502;ESTAZOLAM;N05CD04;Drug;0:0:0
PA164712745;ESTERS OF AMINOBENZOIC ACID;N01BA;Drug Class;0:0:0
PA164712746;ESTERS OF BENZOIC ACID;N01BC;Drug Class;23:76:0
PA166190221;ESTRADIOL / PROGESTERONE;G03AA;Drug;0:0:0
PA166278261;ESTRADIOL VALERATE;G03C;Drug;0:0:0
PA449507;ESTRAMUSTINE;L01XX11;Drug;0:0:0
PA164712747;ESTREN DERIVATIVES;A14AB, G03DC;Drug Class;0:0:0
PA164769104;ESTRIOL;G03CA04, G03CC06;Drug;0:0:0
PA449509;ESTROGENS;G03C, L02AA;Drug Class;5:35:0
PA164712749;ESTROGENS, COMBINATIONS WITH OTHER DRUGS;G03CC;Drug Class;0:1:0
PA449512;ESTRONE;G03CA07, G03CC04;Drug, Biological Intermediate;0:1:1
PA165958342;ESTROPIPATE;;Drug;0:0:0
PA162630444;ESZOPICLONE;N05CF04;Drug;0:0:0
PA449515;ETANERCEPT;L04AB01;Drug;15:99:0
PA166255861;ETESEVIMAB;;Drug;0:0:0
PA449518;ETHACRYNIC ACID;C03CC01;Drug;0:0:0
PA164746758;ETHANOLAMINE OLEATE;C05BB01;Drug;0:0:0
PA164746383;ETHCHLORVYNOL;N05CM08;Drug;0:0:0
PA449525;ETHER;;Drug;0:0:0
PA164712750;ETHERS;N01AA;Drug Class;0:0:0
PA164712751;ETHERS CHEMICALLY CLOSE TO ANTIHISTAMINES;N04AB;Drug Class;0:0:0
PA164712753;ETHERS, CHEMICALLY CLOSE TO ANTIHISTAMINES;M03BC;Drug Class;0:0:0
PA164712752;ETHERS OF TROPINE OR TROPINE DERIVATIVES;N04AC;Drug Class;0:0:0
PA164745394;ETHINAMATE;;Drug;0:0:0
PA449527;ETHINYL ESTRADIOL;G03CA01, L02AA03;Drug;0:0:0
PA165290929;ETHINYL ESTRADIOL / NORELGESTROMIN;G03AA13;Drug;0:0:0
PA164768833;ETHIODIZED OIL;;Drug;0:0:0
PA164768738;ETHIONAMIDE;J04AD03;Drug;0:0:0
PA449531;ETHOPROPAZINE;N04AA05;Drug;0:0:0
PA164768735;ETHOTOIN;N03AB01;Drug;0:0:0
PA164754743;ETHOXZOLAMIDE;;Drug;0:0:0
PA164712754;ETHYLENE IMINES;L01AC;Drug Class;2:3:0
PA164749157;ETHYNODIOL DIACETATE;G03DC06;Drug;0:0:0
PA449550;ETODOLAC;M01AB08;Drug;0:0:0
PA164743987;ETOMIDATE;N01AX07;Drug;0:0:0
PA164771231;ETONOGESTREL;G03AC08;Drug;0:3:0
PA164776853;ETORICOXIB;M01AH05;Drug;0:0:0
PA166328841;ETRASIMOD;L04AE05;Drug;0:0:0
PA449554;ETRETINATE;D05BB01;Drug;0:0:0
PA166341581;EUGENOL;;Drug;0:0:0
PA166177894;EVACETRAPIB;;Drug;0:1:0
PA166222281;EVINACUMAB;C10AX17;Drug;0:0:1
PA165860788;EVODIAMINE;;Drug;0:1:0
PA166160027;EVOLOCUMAB;C10AX13;Drug;0:0:1
PA164749238;EXENATIDE;A10BJ01;Drug;0:10:0
PA164712755;EXPECTORANTS;R05CA;Drug Class;0:0:0
PA164712756;EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05C;Drug Class;1:6:0
PA10816;EZETIMIBE;C10AX09;Drug;0:5:0
PA166184498;EZETIMIBE / ROSUVASTATIN;C10BA06;Drug;0:0:0
PA166184495;EZETIMIBE / SIMVASTATIN;C10BA02;Drug;0:0:0
PA449585;FAMCICLOVIR;J05AB09, S01AD07;Drug;0:0:0
PA166362701;FAMITINIB;;Drug;0:0:0
PA449586;FAMOTIDINE;A02BA03;Drug;0:12:0
PA166123389;FAMPRIDINE;N07XX07;Drug;0:0:0
PA152207466;FARNESYLTRANSFERASE INHIBITORS;;Drug Class;0:0:0
PA165946121;FASUDIL;C04AX32;Drug;0:0:0
PA164712757;FAT/CARBOHYDRATES/PROTEINS/MINERALS/VITAMINS, COMBINATIONS;V06DB;Drug Class;0:0:0
PA164712758;FATTY ACID DERIVATIVES;N03AG;Drug Class;24:127:0
PA166196742;FAVIPIRAVIR;;Drug;0:0:0
PA166227662;FEBUXOSTAT 67M-4;;Drug;0:0:1
PA166280361;FEDRATINIB;L01EJ02;Drug;0:0:0
PA449590;FELBAMATE;N03AX10;Drug;0:0:0
PA166049177;FELBINAC;;Drug;0:0:0
PA449591;FELODIPINE;C08CA02;Drug;0:5:0
PA164744374;FELYPRESSIN;;Drug;0:0:0
PA164712759;FENAMATES;M01AG;Drug Class;0:0:0
PA166049176;FENBUFEN;;Drug;0:0:0
PA164747055;FENCAMFAMINE;N06BA06;Drug;0:0:0
PA449592;FENFLURAMINE;A08AA02;Drug;0:0:0
PA166248881;FENOFIBRATE / SIMVASTATIN;C10BA04;Drug;0:0:0
PA164784034;FENOLDOPAM;C01CA19;Drug;0:0:0
PA449597;FENOPROFEN;M01AE04;Drug;0:0:0
PA10079;FENOTEROL;G02CA03, R03AC04, R03CC04;Drug;0:9:2
PA449599;FENTANYL;N01AH01, N02AB03;Drug;48:251:1
PA449617;FERROUS SULFATE;;Drug;0:0:0
PA166182922;FEVIPIPRANT;;Drug;0:0:0
PA166321121;FEZOLINETANT;G02CX06;Drug;0:0:0
PA166123367;FIBOFLAPON;;Drug;0:2:0
PA164712760;FIBRATES;C10AB;Drug Class;17:55:0
PA164712761;FIBRINOGEN;B02BB;Drug Class;0:0:0
PA166305961;FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) TYROSINE KINASE INHIBITORS;L01EN;Drug Class;0:0:0
PA449626;FILGRASTIM;L03AA02;Drug;0:0:0
PA449627;FINASTERIDE;D11AX10, G04CB01;Drug;0:0:0
PA166264521;FINGOLIMOD;;Drug;0:0:0
PA166049194;FIROCOXIB;;Drug;0:0:0
PA166352541;FIRSOCOSTAT;;Drug;0:0:0
PA164712762;FIRST-GENERATION CEPHALOSPORINS;J01DB;Drug Class;1:1:0
PA452627;FLAVOPIRIDOL;;Drug;0:0:0
PA164781386;FLAVOXATE;G04BD02;Drug;0:0:0
PA449646;FLECAINIDE;C01BC04;Drug;4:15:0
PA164774762;FLEROXACIN;J01MA08;Drug;0:0:0
PA166153431;FLIBANSERIN;G02CX02;Drug;0:0:0
PA164781042;FLUCLOXACILLIN;J01CF05;Drug;2:17:0
PA449653;FLUCONAZOLE;D01AC15, J02AC01;Drug;0:17:0
PA449654;FLUCYTOSINE;D01AE21, J02AX01;Drug;0:0:0
PA164745609;FLUDIAZEPAM;N05BA17;Drug;0:0:0
PA164743961;FLUDROCORTISONE;H02AA02;Drug;0:0:0
PA166049190;FLUFENAMIC ACID;;Drug;0:0:0
PA449659;FLUMAZENIL;V03AB25;Drug;0:0:0
PA164749388;FLUMETHASONE PIVALATE;;Drug;0:0:0
PA164776636;FLUNARIZINE;N07CA03;Drug;0:0:0
PA164781320;FLUNITRAZEPAM;N05CD03;Drug;0:0:1
PA166049179;FLUNOXAPROFEN;;Drug;0:0:0
PA164754912;FLUOCINOLONE ACETONIDE;C05AA10, D07AC04, S01BA15, S02BA08;Drug;0:0:0
PA449664;FLUOCINONIDE;C05AA11, D07AC08;Drug;0:0:0
PA164746009;FLUORESCEIN;S01JA01;Drug;0:0:0
PA164781355;FLUOROMETHOLONE;C05AA06, D07AB06, D07XB04, D10AA01, S01BA07, S01CB05;Drug;0:0:0
PA452613;FLUOROQUINOLONES;J01MA;Drug Class;1:10:0
PA128406956;FLUOROURACIL;L01BC02, L01BC52;Drug;197:1024:2
PA166183787;FLUOROURACIL / SALICYLIC ACID;L01BC52;Drug;0:0:0
PA166176027;FLUOXETINE / OLANZAPINE;;Drug;0:0:0
PA164744518;FLUOXYMESTERONE;G03BA01;Drug;0:0:0
PA10268;FLUPENTHIXOL;N05AF01;Drug;0:3:0
PA449676;FLUPHENAZINE;N05AB02;Drug;0:0:0
PA164750513;FLURANDRENOLIDE;D07AC07;Drug;0:0:0
PA449681;FLURAZEPAM;N05CD01;Drug;0:0:1
PA449683;FLURBIPROFEN;M01AE09, M02AA19, R02AX01, S01BC04;Drug;2:8:1
PA162565878;FLUSPIRILENE;N05AG01;Drug;0:0:0
PA449685;FLUTAMIDE;L02BB01;Drug;0:0:0
PA166182582;FLUTICASONE;;Drug;0:1:0
PA449688;FLUVASTATIN;C10AA04;Drug;20:68:1
PA449690;FLUVOXAMINE;N06AB08;Drug;13:87:3
PA166182863;FOLFIRI;;Drug;4:64:0
PA150481187;FOLIC ACID ANALOGUES;L01BA;Drug Class;188:1006:0
PA164712763;FOLIC ACID AND DERIVATIVES;B03BB;Drug Class;6:23:0
PA449697;FOMEPIZOLE;V03AB34;Drug;0:0:0
PA164746297;FONDAPARINUX SODIUM;;Drug;0:0:0
PA164776845;FORASARTAN;;Drug;0:0:0
PA166185382;FORETINIB;;Drug;0:0:0
PA449703;FORMALDEHYDE;;Drug, Biological Intermediate;0:0:1
PA449705;FORMIC ACID;;Drug;0:0:0
PA134687907;FORMOTEROL;R03AC13;Drug;0:3:2
PA146096022;FORSKOLIN;;Drug;0:3:0
PA10084;FOSAMPRENAVIR;J05AE07;Drug;0:0:0
PA166182625;FOSAMPRENAVIR / RITONAVIR;;Drug;0:0:0
PA165958390;FOSAPREPITANT;;Drug;0:0:1
PA449706;FOSCARNET;J05AD01;Drug;0:0:0
PA164748039;FOSFOMYCIN;J01XX01;Drug;0:0:0
PA449710;FOSINOPRIL;C09AA09;Drug;0:0:0
PA164746820;FOSPHENYTOIN;N03AB05;Prodrug;0:0:1
PA165958389;FOSPROPOFOL;;Drug;0:0:0
PA164712764;FOURTH-GENERATION CEPHALOSPORINS;J01DE;Drug Class;0:0:0
PA164743181;FRAMYCETIN;D09AA01, R01AX08, S01AA07;Drug;0:0:0
PA164754891;FROVATRIPTAN;N02CC07;Drug;0:7:1
PA449716;FRUCTOSE;V06DC02;Drug, Biological Intermediate;0:0:1
PA166328842;FRUQUINTINIB;L01EK04;Drug;0:0:0
PA452614;FURAFYLLINE;;Drug;0:0:1
PA164746760;FURAZOLIDONE;G01AX06;Drug;0:0:0
PA166329761;FURMONERTINIB;;Drug;0:0:1
PA164749648;FUSIDIC ACID;D06AX01, D09AA02, J01XC01, S01AA13;Drug;0:0:0
PA164745426;GADOBENATE DIMEGLUMINE;V08CA08;Drug;0:0:0
PA165958377;GADOBUTROL;V08CA09;Drug;0:0:0
PA164784027;GADODIAMIDE;V08CA03;Drug;0:0:0
PA165958378;GADOFOSVESET TRISODIUM;V08CA11;Drug;0:0:0
PA164748760;GADOPENTETATE DIMEGLUMINE;;Drug;0:0:0
PA164746463;GADOTERIDOL;V08CA04;Drug;0:0:0
PA164743703;GADOVERSETAMIDE;V08CA06;Drug;0:0:0
PA165985534;GADOXETIC ACID;;Drug;0:0:0
PA449725;GALACTOSE;;Drug;0:0:0
PA166197481;GALIDESIVIR;;Drug;0:0:0
PA164745088;GALLAMINE TRIETHIODIDE;;Drug;0:0:0
PA164781198;GALLIUM NITRATE;;Drug;0:0:0
PA164746235;GALSULFASE;A16AB08;Drug;0:0:0
PA164743249;GAMMA-HOMOLINOLENIC ACID;;Drug;0:0:0
PA10819;GAMMA HYDROXYBUTYRIC ACID;;Drug;0:0:0
PA166328062;GAMMA SCHIZANDRIN;;Drug;0:0:0
PA166354221;GANAPLACIDE;;Drug;0:0:0
PA449733;GANCICLOVIR;J05AB06, S01AD09;Drug;0:1:1
PA164712765;GANGLIOSIDES AND GANGLIOSIDE DERIVATIVES;N07XA;Drug Class;0:0:0
PA449737;GARLIC OIL;;Drug;0:0:0
PA449738;GATIFLOXACIN;J01MA16, S01AE06;Drug;0:0:0
PA166415181;GEDATOLISIB;;Drug;0:0:0
PA166336741;GEFAPIXANT;R05DB29;Drug;0:0:0
PA449741;GELATIN AGENTS;;Drug;0:0:0
PA166122506;GEMCITABINE TRIPHOSPHATE DITRIETHYLAMINE;;Drug;0:0:0
PA449750;GEMFIBROZIL;C10AB04;Drug;0:0:0
PA10088;GEMIFLOXACIN;J01MA15;Drug;0:0:0
PA166368181;GEMIGLIPTIN;A10BH06;Drug;0:0:0
PA164712766;GENERAL NUTRIENTS;V06;Drug Class;0:0:0
PA165109660;GENISTEIN;;Drug;0:0:0
PA164712767;GENITO URINARY SYSTEM AND SEX HORMONES;G;Drug Class;90:320:0
PA449753;GENTAMICIN;D06AX07, J01GB03, S01AA11, S02AA14, S03AA06;Drug;4:41:1
PA449755;GENTIAN VIOLET;;Drug;0:0:0
PA165958397;GESTODENE;;Drug;0:0:0
PA166190061;GIMERACIL;;Drug;0:0:0
PA449758;GINKGO BILOBA;N06DX02;Drug;0:0:0
PA166118565;GINKGO BILOBA EXTRACT;;Drug;0:0:0
PA164781150;GINSENG;;Drug;0:0:0
PA166190681;GIVOSIRAN;A16AX16;Drug;0:0:0
PA166327122;GLASDEGIB;L01XJ03;Drug;0:0:0
PA166337141;GLECAPREVIR;;Drug;0:0:0
PA166337121;GLECAPREVIR / PIBRENTASVIR;J05AP57;Drug;0:0:0
PA164744895;GLIQUIDONE;A10BB08;Drug;0:10:0
PA164743233;GLISOXEPIDE;A10BB11;Drug;0:0:0
PA166350081;GLP-1 RECEPTOR AGONISTS;A10BJ;Drug Class;0:35:1
PA164779052;GLUCAGON RECOMBINANT;H04AA01;Drug;0:0:0
PA449770;GLUCONIC ACID;;Drug, Biological Intermediate;0:0:0
PA164747613;GLUCOSAMINE;M01AX05;Drug;0:0:0
PA449773;GLUCOSE;;Drug, Biological Intermediate;0:5:1
PA449777;GLUTARALDEHYDE;;Drug;0:0:0
PA164749505;GLUTETHIMIDE;N05CE01;Drug;0:0:0
PA449783;GLYCERIN;;Drug;0:0:0
PA449789;GLYCINE;B05CX03;Drug, Biological Intermediate;0:0:2
PA164748839;GLYCODIAZINE;A10BC01;Drug;0:0:0
PA164712768;GLYCOGENOLYTIC HORMONES;H04A, H04AA;Drug Class;0:0:0
PA164712770;GLYCOPEPTIDE ANTIBACTERIALS;J01XA;Drug Class;2:45:0
PA164754882;GLYCOPYRROLATE;A03AB02, R03BB06;Drug;0:0:0
PA140222783;GLYCYL-SARCOSINE;;Drug;0:0:0
PA449798;GOLD PREPARATIONS;M01CB;Drug Class;0:0:0
PA166316702;GOLIMUMAB;L04AB06;Drug;0:1:0
PA449801;GONADORELIN;H01CA01, V04CM01;Drug;0:0:0
PA164712771;GONADOTROPIN RELEASING HORMONE ANALOGUES;L02AE;Drug Class;0:2:0
PA164712772;GONADOTROPIN-RELEASING HORMONES;H01CA;Drug Class;0:0:0
PA164712773;GONADOTROPINS;G03GA;Drug Class;2:4:0
PA164712774;GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03G;Drug Class;2:4:0
PA164747674;GOSERELIN;L02AE03;Drug;0:1:0
PA449808;GRAMICIDIN D;R02AB30;Drug;0:0:0
PA130620649;GRANULOCYTE COLONY-STIMULATING FACTOR;;Drug, Biological Intermediate;0:0:0
PA151958355;GRAPEFRUIT JUICE;;Drug;0:0:1
PA166163437;GRAZOPREVIR;J05AP11;Drug;0:3:0
PA449812;GREPAFLOXACIN;J01MA11;Drug;0:0:0
PA449814;GRISEOFULVIN;D01AA08, D01BA01;Drug;0:0:0
PA165291499;GS-9350;;Drug;0:0:0
PA449818;GUAIFENESIN;R05CA03;Drug;0:0:0
PA164774903;GUANABENZ;;Drug;0:0:0
PA164745308;GUANADREL SULFATE;;Drug;0:0:0
PA449823;GUANETHIDINE;C02CC02, S01EX01;Drug;0:0:0
PA449825;GUANFACINE;C02AC02;Drug;0:0:0
PA164781028;GUANIDINE;;Drug;0:0:0
PA164712775;GUANIDINE DERIVATIVES;C02CC, C02DG;Drug Class;6:44:0
PA164712777;GUANIDINE DERIVATIVES AND DIURETICS;C02LF;Drug Class;0:0:0
PA166347521;GUMARONTINIB;;Drug;0:0:0
PA134687923;GW2016;;Drug;0:0:0
PA164712778;GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01;Drug Class;54:147:0
PA164712779;H2-RECEPTOR ANTAGONISTS;A02BA;Drug Class;0:26:0
PA10240;HAEMOPHILUS B CONJUGATE VACCINE (PRP-D-DIPHTHERIA TOXOID CONJUGATE);;Drug;0:0:0
PA164746526;HALAZEPAM;N05BA13;Drug;0:0:0
PA164768832;HALOBETASOL PROPIONATE;D07AC21;Drug;0:0:0
PA449839;HALOFANTRINE;P01BX01;Drug;0:0:0
PA164712782;HALOGENATED HYDROCARBONS;N01AB;Drug Class;248:173:0
PA449841;HALOPERIDOL;N05AD01;Drug;10:64:1
PA164768737;HALOPROGIN;D01AE11;Drug;0:0:0
PA449845;HALOTHANE;N01AB01;Drug;47:61:1
PA449848;HELIUM;;Drug;0:0:0
PA449849;HEMIN;;Drug;0:0:0
PA164712783;HEMODIALYTICS AND HEMOFILTRATES;B05Z;Drug Class;0:0:0
PA164712784;HEMODIALYTICS, CONCENTRATES;B05ZA;Drug Class;0:0:0
PA164712785;HEMOFILTRATES;B05ZB;Drug Class;0:0:0
PA10339;HEMOPHILUS INFLUENZAE B VACCINES;J07AG;Drug Class;0:0:0
PA164712786;HEPARIN GROUP;B01AB;Drug Class;1:1:0
PA164712787;HEPARINS OR HEPARINOIDS FOR TOPICAL USE;C05BA;Drug Class;1:1:0
PA164712788;HEPATIC AND RETICULO ENDOTHELIAL SYSTEM;V09D;Drug Class;0:0:0
PA164783812;HEPTABARBITAL;N05CA11;Drug;0:0:0
PA166305964;HER2 (HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2) INHIBITORS;L01FD;Drug Class;10:58:0
PA164742902;HESPERETIN;;Drug;0:0:0
PA449867;HESPERIDIN;;Drug;0:0:0
PA164746559;HETACILLIN;J01CA18;Drug;0:0:0
PA449871;HEXACHLOROPHENE;D08AE01;Drug;0:0:0
PA164743020;HEXAFLURONIUM BROMIDE;M03AC05;Drug;0:0:0
PA449875;HEXOBARBITAL;N01AF02, N05CA16;Drug;0:0:0
PA449877;HEXOCYCLIUM;;Drug;0:0:0
PA142899133;HEXOPRENALINE;R03AC06, R03CC05;Drug;0:0:0
PA164746489;HEXYLCAINE;;Drug;0:0:0
PA164712790;HIGH-CEILING DIURETICS;C03C;Drug Class;17:41:0
PA164712791;HIGH-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS;C03EB;Drug Class;0:0:0
PA449880;HISTAMINE PHOSPHATE;V04CG03;Drug;0:0:0
PA164712780;HMG COA REDUCTASE INHIBITORS IN COMBINATION WITH OTHER LIPID MODIFYING AGENTS;C10BA;Drug Class;0:0:0
PA164749405;HOMATROPINE METHYLBROMIDE;;Drug;0:0:0
PA452637;HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03A;Drug Class;8:36:0
PA164712792;HORMONE ANTAGONISTS AND RELATED AGENTS;L02B;Drug Class;73:550:0
PA164712793;HORMONES AND RELATED AGENTS;L02A;Drug Class;0:2:0
PA166222881;HUMAN C1 ESTERASE INHIBITOR;B06AC01;Drug;0:0:0
PA166305884;HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) TYROSINE KINASE INHIBITORS;L01EH;Drug Class;2:11:0
PA165958431;HYALURONAN;D03AX05, M09AX01, R01AX09, S01KA01;Drug;0:0:0
PA164745713;HYALURONIDASE;B06AA03;Drug;0:0:0
PA10387;HYDANTOIN DERIVATIVES;N03AB;Drug Class;46:371:0
PA164712794;HYDRAZIDES;J04AC;Drug Class;23:218:0
PA164712795;HYDRAZINOPHTHALAZINE DERIVATIVES;C02DB;Drug Class;3:33:0
PA164712796;HYDRAZINOPHTHALAZINE DERIVATIVES AND DIURETICS;C02LG;Drug Class;0:0:0
PA449900;HYDROCODONE;R05DA03;Drug;7:18:1
PA165290925;HYDROCODONE / ACETOMINOPHEN;N02AJ22;Drug;0:0:0
PA164745515;HYDROCORTAMATE;;Drug;0:0:0
PA449905;HYDROCORTISONE;A01AC03, A07EA02, C05AA01, D07AA02, D07XA01, H02AB09, S01BA02, S01CB03, S02BA01;Drug;0:4:0
PA164752557;HYDROFLUMETHIAZIDE;C03AA02;Drug;0:0:0
PA449917;HYDROGEN PEROXIDE;;Drug;0:0:0
PA166220665;HYDROMORPHOL N-OXIDE;;Drug, Metabolite;0:0:1
PA449918;HYDROMORPHONE;N02AA03;Drug, Metabolite;0:16:1
PA133888889;HYDROQUINIDINE;;Drug;0:0:0
PA449924;HYDROQUINONE;;Drug;0:0:0
PA164768689;HYDROXOCOBALAMIN;B03BA03, V03AB33;Drug;0:0:0
PA166228341;HYDROXYCOBALAMIN;;Drug;0:0:0
PA449932;HYDROXYPROGESTERONE;G03DA03;Drug, Metabolite, Biological Intermediate;0:0:0
PA164746492;HYDROXYPROPYL CELLULOSE;;Drug;0:0:0
PA164712797;HYDROXYQUINOLINE DERIVATIVES;P01AA;Drug Class;0:0:0
PA164745514;HYDROXYSTILBAMIDINE ISETHIONATE;;Drug;0:0:0
PA140222718;HYDROXYTRYPTAMINE;;Drug;0:0:0
PA449943;HYDROXYZINE;N05BB01;Drug;0:1:0
PA166242401;HYGROMYCIN B;;Drug;0:1:0
PA166222902;HYMECROMONE;;Drug;0:0:0
PA164776844;HYOSCYAMINE;A03BA03;Drug;0:0:0
PA165985514;HYPERFORIN;;Drug;0:0:0
PA164712798;HYPERTONIC SOLUTIONS;B05DB;Drug Class;0:0:0
PA164712799;HYPNOTICS AND SEDATIVES;N05C;Drug Class;12:61:0
PA164712800;HYPNOTICS AND SEDATIVES IN COMBINATION, EXCL. BARBITURATES;N05CX;Drug Class;0:0:0
PA164712801;HYPOTHALAMIC HORMONES;H01C;Drug Class;0:0:0
PA10270;IBANDRONATE;M05BA06;Drug;0:1:0
PA166331561;IBOGAINE;;Drug;0:1:0
PA164781375;IBRITUMOMAB;V10XX02;Drug;0:0:0
PA166121346;IBRUTINIB;L01EL01;Drug;0:4:0
PA165958351;IBUDILAST;R03DC04;Drug;0:0:0
PA166049187;IBUFENAC;;Drug;0:0:0
PA449957;IBUPROFEN;C01EB16, G02CC01, M01AE01, M02AA13;Drug;8:46:2
PA449958;IBUTILIDE;C01BD05;Drug;0:2:0
PA164749185;ICATIBANT;B06AC02;Drug;0:0:0
PA164743096;ICODEXTRIN;;Drug;0:0:0
PA164746077;ICOSAPENT;;Drug;0:0:0
PA166306061;IDARUCIZUMAB;V03AB37;Drug;0:0:1
PA164781019;IDOXURIDINE;D06BB01, J05AB02, S01AD01;Drug;0:0:0
PA153627678;IDRAPARINUX;;Drug;0:0:0
PA164749134;IDURSULFASE;A16AB09;Drug;0:0:0
PA449964;IFOSFAMIDE;L01AA06;Drug;0:5:1
PA166178387;IGURATIMOD;;Drug;0:4:0
PA165947499;ILAPRAZOLE;;Drug;0:0:0
PA164746843;ILOPROST;B01AC11;Drug;0:0:0
PA166255842;IMDEVIMAB;J06BD07;Drug;0:0:0
PA164712804;IMIDAZOLE AND TRIAZOLE DERIVATIVES;D01AC;Drug Class;0:29:0
PA164712807;IMIDAZOLE DERIVATIVES;A07AC, G01AF, J01XD, J02AB;Drug Class;1:16:0
PA164712809;IMIDAZOLE DERIVATIVES AND CORTICOSTEROIDS;G01BF;Drug Class;0:0:0
PA164712810;IMIDAZOLINE DERIVATIVES;C04AB;Drug Class;0:0:0
PA164712811;IMIDAZOLINE RECEPTOR AGONISTS;C02AC;Drug Class;2:6:0
PA164712812;IMIDAZOLINE RECEPTOR AGONISTS IN COMBINATION WITH DIURETICS;C02LC;Drug Class;0:0:0
PA164712813;IMIDAZOTHIAZOLE DERIVATIVES;P02CE;Drug Class;0:1:0
PA164742934;IMIGLUCERASE;A16AB02;Drug;0:0:0
PA449968;IMIPENEM;;Drug;0:0:0
PA449969;IMIPRAMINE;N06AA02;Drug;4:36:1
PA164754884;IMMUNE GLOBULIN;;Drug;0:0:0
PA164712814;IMMUNE SERA;J06A, J06AA;Drug Class;0:0:0
PA164712815;IMMUNE SERA AND IMMUNOGLOBULINS;J06;Drug Class;0:0:0
PA164712817;IMMUNOGLOBULINS;J06B;Drug Class;0:3:0
PA164712818;IMMUNOGLOBULINS, NORMAL HUMAN;J06BA;Drug Class;0:0:0
PA164712819;IMMUNOSTIMULANTS;L03, L03A;Drug Class;105:565:0
PA164712821;IMMUNOSUPPRESSANTS;L04, L04A;Drug Class;418:2955:0
PA166268802;INCLISIRAN;C10AX16;Drug;0:0:1
PA164712823;INCONTINENCE EQUIPMENT;V07AN;Drug Class;0:0:0
PA449975;INDAPAMIDE;C03BA11;Drug;0:1:0
PA164754881;INDECAINIDE;;Drug;0:0:0
PA164712824;INDIFFERENT PREPARATIONS;S02DC;Drug Class;0:0:0
PA164712825;INDIUM (111IN) COMPOUNDS;V09HB, V09IB;Drug Class;0:0:0
PA449981;INDOCYANINE GREEN;;Drug;0:0:0
PA164712827;INDOLE DERIVATIVES;N05AE;Drug Class;3:24:0
PA166224921;INEBILIZUMAB;L04AA47;Drug;0:0:0
PA164712828;INFANT FORMULAS;V06C;Drug Class;0:0:0
PA164712829;INFLAMMATION AND INFECTION DETECTION;V09H;Drug Class;0:0:0
PA165291474;INIPARIB;;Drug;0:0:0
PA166182756;INOTERSEN;N07XX15;Drug;0:0:0
PA166177510;INOTUZUMAB OZOGAMICIN;L01FB01;Drug;0:0:0
PA164712831;INSECTICIDES AND REPELLENTS;P03B;Drug Class;0:0:0
PA164784029;INSULIN-ASPART;A10AB05, A10AD05;Drug;0:0:0
PA164746470;INSULIN-DETEMIR;A10AE05;Drug;0:0:0
PA449992;INSULIN GLARGINE;A10AE04;Drug;0:0:0
PA164760859;INSULIN-GLULISINE;A10AB06;Drug;0:0:0
PA164747059;INSULIN-LISPRO;;Drug;0:0:0
PA164745627;INSULIN LYSPRO RECOMBINANT;A10AB04, A10AC04, A10AD04;Drug;0:0:0
PA166175761;INSULIN PEGLISPRO;;Drug;0:0:0
PA164781053;INSULIN, PORCINE;;Drug;0:0:0
PA164712832;INSULINS AND ANALOGUES;A10A;Drug Class;0:1:0
PA164712833;INSULINS AND ANALOGUES FOR INHALATION;A10AF;Drug Class;0:0:0
PA164712834;INSULINS AND ANALOGUES FOR INJECTION, FAST-ACTING;A10AB;Drug Class;0:0:0
PA164712835;INSULINS AND ANALOGUES FOR INJECTION, INTERMEDIATE-ACTING;A10AC;Drug Class;0:0:0
PA164712836;INSULINS AND ANALOGUES FOR INJECTION, INTERMEDIATE-ACTING COMBINED WITH FAST-ACTING;A10AD;Drug Class;0:0:0
PA164712837;INSULINS AND ANALOGUES FOR INJECTION, LONG-ACTING;A10AE;Drug Class;0:0:0
PA164749376;INTERFERON ALFACON-1;L03AB09;Drug;0:0:0
PA164746538;INTERFERON ALFA-N1;L03AB06;Drug;0:4:0
PA164746228;INTERFERON ALFA-N3;;Drug;0:0:0
PA164746386;INTERFERON GAMMA-1B;;Drug;0:0:0
PA451999;INTERFERONS;L03AB;Drug Class;109:564:0
PA164712838;INTERLEUKIN INHIBITORS;L04AC;Drug Class;7:35:0
PA164712839;INTERLEUKINS;L03AC;Drug Class;0:0:0
PA164712840;INTERMEDIATE-ACTING SULFONAMIDES;J01EC;Drug Class;2:13:0
PA164712841;INTESTINAL ADSORBENTS;A07B;Drug Class;0:0:0
PA164712842;INTESTINAL ANTIINFECTIVES;A07A;Drug Class;15:140:0
PA164712843;INTESTINAL ANTIINFLAMMATORY AGENTS;A07E;Drug Class;27:124:0
PA164712844;INTRAUTERINE CONTRACEPTIVES;G02BA;Drug Class;0:0:0
PA164712845;INTRAVAGINAL CONTRACEPTIVES;G02BB;Drug Class;0:0:0
PA450043;INULIN;;Drug;0:0:0
PA10116;IOBENGUANE (131I);;Drug;0:0:0
PA450049;IODINE;;Drug;0:0:0
PA164712846;IODINE (123I) COMPOUNDS;V09AB;Drug Class;0:0:0
PA164712847;IODINE (125I) COMPOUNDS;V09GB;Drug Class;0:0:0
PA164712848;IODINE (131I) COMPOUNDS;V09XA, V10XA;Drug Class;0:12:0
PA164712851;IODINE PRODUCTS;D08AG;Drug Class;0:0:0
PA164712850;IODINE THERAPY;H03C, H03CA;Drug Class;0:0:0
PA164745532;IODIPAMIDE;V08AC04;Drug;0:0:0
PA164783998;IODIXANOL;V08AB09;Drug;0:0:0
PA450061;IOHEXOL;V08AB02;Drug;0:0:0
PA164743143;IOPHENDYLATE;;Drug;0:0:0
PA450082;IPRATROPIUM;R01AX03, R03BB01;Drug;0:0:0
PA165949694;IPTAKALIM;;Drug;0:0:0
PA450085;IRINOTECAN;L01XX19;Prodrug;54:432:2
PA450087;IRON;;Drug;0:2:0
PA164712854;IRON BIVALENT, ORAL PREPARATIONS;B03AA;Drug Class;0:0:0
PA164712855;IRON CHELATING AGENTS;V03AC;Drug Class;19:40:0
PA164764618;IRON DEXTRAN;;Drug;0:0:0
PA164712856;IRON IN COMBINATION WITH FOLIC ACID;B03AD;Drug Class;0:0:0
PA164712857;IRON IN OTHER COMBINATIONS;B03AE;Drug Class;0:0:0
PA164712853;IRON PREPARATIONS;B03A;Drug Class;0:0:0
PA164712858;IRON TRIVALENT, ORAL PREPARATIONS;B03AB;Drug Class;0:0:0
PA164712859;IRON TRIVALENT, PARENTERAL PREPARATIONS;B03AC;Drug Class;0:0:0
PA164712860;IRRIGATING SOLUTIONS;B05C;Drug Class;1:5:0
PA166224941;ISATUXIMAB;L01FC02;Drug;0:0:0
PA166356301;ISAVUCONAZOLE;J02AC05;Drug;0:0:0
PA166400261;ISLATRAVIR;;Drug;0:0:0
PA450101;ISOCARBOXAZID;N06AF01;Drug;0:0:0
PA450103;ISOETHARINE;R03AC07, R03CC06;Drug;0:0:0
PA450106;ISOFLURANE;N01AB06;Drug;47:32:1
PA164748933;ISOFLUROPHATE;;Drug;0:0:0
PA165958379;ISOMETHEPTENE;A03AX10;Drug;0:0:0
PA450112;ISONIAZID;J04AC01;Drug;23:234:2
PA166176022;ISONIAZID / PYRAZINAMIDE / RIFAMPIN;J04AM05;Drug;0:21:0
PA164781398;ISOPROPAMIDE;A03AB09;Drug;0:0:0
PA450117;ISOPROPYL ALCOHOL;;Drug;0:0:0
PA450126;ISOSORBIDE MONONITRATE;C01DA14;Drug;0:0:0
PA165958421;ISOTHIPENDYL;D04AA22, R06AD09;Drug;0:0:0
PA164712861;ISOTONIC SOLUTIONS;B05DA;Drug Class;0:0:0
PA450128;ISOTRETINOIN;D10AD04, D10BA01;Drug;0:0:0
PA166049183;ISOXICAM;;Drug;0:0:0
PA166185381;ISPINESIB MESYLATE;;Drug;0:0:0
PA450131;ISRADIPINE;C08CA03;Drug;0:0:0
PA166299901;ITACITINIB;;Drug;0:0:0
PA450132;ITRACONAZOLE;J02AC02;Drug;0:1:0
PA166123415;IVABRADINE;C01EB17;Drug;0:0:0
PA166308201;IVARMACITINIB;;Drug;0:0:0
PA450133;IVERMECTIN;D11AX22, P02CF01;Drug;0:0:0
PA164712802;I.V. SOLUTION ADDITIVES;B05X;Drug Class;0:0:0
PA164712803;I.V. SOLUTIONS;B05B;Drug Class;0:0:0
PA165110439;IXABEPILONE;L01DC04;Drug;0:0:0
PA166300321;IXEKIZUMAB;L04AC13;Drug;0:0:0
PA166305885;JANUS-ASSOCIATED KINASE (JAK) INHIBITORS;L01EJ;Drug Class;0:0:0
PA166346421;JBPOS0101;;Drug;0:0:0
PA164749133;JOSAMYCIN;J01FA07;Drug;0:0:0
PA450137;KANAMYCIN;A07AA08, J01GB04, S01AA24;Drug;4:16:1
PA10457;KAOLIN;A07BC02;Drug;0:0:0
PA164749385;KETAZOLAM;N05BA10;Drug;0:0:0
PA166211241;KETOBEMIDONE;;Drug;0:2:0
PA450146;KETOCONAZOLE;D01AC08, G01AF11, J02AB02;Drug;0:14:1
PA450152;KETOTIFEN;R06AX17, S01GX08;Drug;0:0:0
PA164749508;KUNECATECHINS;D06BB12;Drug;0:0:0
PA140222784;KYOTORPHIN;;Drug;0:0:0
PA164743150;LABETALOL;C07AG01;Drug;0:7:1
PA166187141;LACIDIPINE;C08CA09;Drug;0:3:0
PA450161;LACTOSE;;Drug;0:0:0
PA164748762;LACTULOSE;A06AD11;Drug;0:0:0
PA166110255;LAFUTIDINE;;Drug;0:2:0
PA448055;L-ALANINE;;Drug;0:0:0
PA166184501;LAMIVUDINE / ABACAVIR;J05AR02;Drug;0:0:0
PA164924564;LANIQUIDAR;;Drug;0:0:0
PA450180;LANSOPRAZOLE;A02BC03;Drug;4:90:1
PA10305;LANTHANUM CARBONATE;;Drug;0:0:0
PA448478;L-ARGININE;;Drug;0:0:0
PA164776670;LARONIDASE;A16AB05;Drug;0:0:0
PA166129564;LAROPIPRANT;;Drug;0:1:0
PA166325721;LASMIDITAN;N02CC08;Drug;0:0:1
PA164776968;L-ASPARAGINE;;Drug;0:3:0
PA448494;L-ASPARTIC ACID;;Drug;0:0:0
PA164743144;LATAMOXEF;J01DD06;Drug;0:0:0
PA166153449;LATONDUINE A;;Drug;0:1:0
PA164712862;LAXATIVES;A06, A06A;Drug Class;0:0:0
PA450154;L-CARNITINE;;Drug;0:0:0
PA164747225;L-CITRULLINE;;Drug;0:0:0
PA449173;L-CYSTEINE;;Drug;0:0:0
PA449176;L-CYSTINE;;Drug;0:0:0
PA450191;LECITHIN;;Drug;0:0:0
PA166163427;LEDIPASVIR / SOFOSBUVIR;J05AP51;Drug;0:2:0
PA166325461;LEFAMULIN;J01XX12;Drug;0:0:0
PA166340543;LENABASUM;;Drug;0:0:0
PA166319281;LENACAPAVIR;J05AX31;Drug;0:0:0
PA166313326;LENIOLISIB;;Drug;0:0:0
PA166211881;LENZILUMAB;;Drug;0:0:0
PA450195;LEPIRUDIN;B01AE02;Drug;0:0:0
PA164769058;LERCANIDIPINE;C08CA13;Drug;0:0:0
PA166211921;LERONLIMAB;;Drug;0:0:0
PA166160006;LESINURAD;M04AB05;Drug;0:0:0
PA164712863;LEUKOTRIENE RECEPTOR ANTAGONISTS;R03DC;Drug Class;16:26:0
PA450203;LEUPROLIDE;L02AE02;Drug;0:1:0
PA166400081;LEVACETYLLEUCINE;;Drug;0:0:0
PA164749284;LEVALLORPHAN;;Drug;0:0:0
PA450205;LEVAMISOLE;P02CE01;Drug;0:1:0
PA164747027;LEVOBUNOLOL;S01ED03;Drug;0:0:0
PA164754741;LEVOBUPIVACAINE;N01BB10;Drug;0:0:0
PA164742988;LEVOCABASTINE;R01AC02, S01GX02;Drug;0:0:0
PA450214;LEVOFLOXACIN;J01MA12, S01AE05;Drug;0:9:0
PA166129561;LEVOMEFOLIC ACID;;Drug, Biological Intermediate;0:2:2
PA134687942;LEVOMEPROMAZINE;;Drug;0:2:0
PA166227621;LEVOMETHADONE;N07BC05;Drug;0:0:0
PA450215;LEVOMETHADYL ACETATE;N07BC03;Drug;0:0:0
PA166182150;LEVOMILNACIPRAN;;Drug;0:0:0
PA165958380;LEVONORDEFRIN;;Drug;0:0:0
PA450218;LEVONORGESTREL;G03AC03, G03AD01;Drug;0:9:0
PA164744368;LEVORPHANOL;;Drug;0:0:0
PA164749138;LEVOSIMENDAN;C01CX08;Drug;0:0:0
PA450221;LEVOTHYROXINE;H03AA01;Drug;0:8:0
PA449776;L-GLUTAMIC ACID;;Drug;0:0:0
PA10090;L-GLUTAMINE;A16AA03;Drug;0:0:0
PA449882;L-HISTIDINE;;Drug;0:0:0
PA450226;LIDOCAINE;C01BB01, C05AD01, D04AB01, N01BB02, R02AD02, S01HA07, S02DA01;Drug;0:3:1
PA166182735;LIDOCAINE AND TETRACAINE;N01BA53, N01BB52;Drug;0:0:0
PA166176018;LIDOCAINE / PRILOCAINE;;Drug;0:0:0
PA165818137;LIDOFLAZINE;;Drug;0:0:0
PA166318541;LIMERTINIB;;Drug;0:0:0
PA166368161;LINAGLIPTIN;A10BH05;Drug;0:0:0
PA164749212;LINCOMYCIN;J01FF02;Drug;0:0:0
PA164712864;LINCOSAMIDES;J01FF;Drug Class;2:2:0
PA164754914;LINDANE;P03AB02;Drug;0:0:0
PA450233;LINEZOLID;J01XX08;Drug;0:0:0
PA164748036;LIOTRIX;;Drug;0:0:0
PA450239;LIPASE;;Drug;0:0:0
PA164712865;LIPID MODIFYING AGENTS;C10;Drug Class;220:925:0
PA164712866;LIPID MODIFYING AGENTS, COMBINATIONS;C10B;Drug Class;0:0:0
PA164712867;LIPID MODIFYING AGENTS, PLAIN;C10A;Drug Class;220:925:0
PA164776929;LIPOIC ACID;A16AX01;Drug;0:0:0
PA164712868;LIQUID PLASTERS;D02AD;Drug Class;0:0:0
PA164748975;LISDEXAMFETAMINE;N06BA12;Drug;0:1:0
PA164750430;L-ISOLEUCINE;;Drug;0:0:0
PA164749019;LISURIDE;G02CB02, N02CA07;Drug;0:0:0
PA450249;LIVER EXTRACT;;Drug;0:0:0
PA164712871;LIVER THERAPY;A05BA;Drug Class;0:0:0
PA164712870;LIVER THERAPY, LIPOTROPICS;A05B;Drug Class;0:0:0
PA166347561;LIXISENATIDE;A10BJ03;Drug;0:0:0
PA450197;L-LEUCINE;;Drug;0:0:0
PA450280;L-LYSINE;;Drug;0:0:0
PA450453;L-METHYLDOPA;;Drug;0:0:0
PA164712872;LOCAL ANESTHETICS;C05AD, D04AB, N01, N01A, N01B, R02AD, S01H, S01HA;Drug Class;342:616:0
PA164712873;LOCAL HEMOSTATICS;B02BC;Drug Class;0:0:0
PA164744510;LOFEXIDINE;N07BC04;Drug;0:0:0
PA164749165;LOMEFLOXACIN;J01MA07, S01AE04;Drug;0:0:0
PA137867605;LOMEGUATRIB;;Drug;0:0:0
PA166114922;LOMITAPIDE;C10AX12;Drug;0:0:1
PA164749407;LOMUSTINE;L01AD02;Drug;0:0:0
PA164712874;LONG-ACTING SULFONAMIDES;J01ED;Drug Class;1:2:0
PA450262;LOPERAMIDE;A07DA03;Drug;0:4:0
PA166182605;LOPINAVIR / RITONAVIR;J05AR10;Drug;0:0:0
PA164754806;LORACARBEF;J01DC08;Drug;0:0:0
PA450266;LORATADINE;R06AX13;Drug;0:0:0
PA166353881;LORCASERIN;A08AA11;Drug;0:0:0
PA136437519;LORENZO'S OIL;;Drug;0:0:0
PA164783814;L-ORNITHINE;;Drug, Biological Intermediate;0:0:0
PA165958395;LORNOXICAM;M01AC05;Drug;1:6:1
PA166169432;LOSIGAMONE;;Drug;0:0:0
PA164764569;LOTEPREDNOL ETABONATE;S01BA14;Drug;0:0:0
PA450272;LOVASTATIN;C10AA02;Drug;12:17:1
PA164712877;LOW-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS;C03EA;Drug Class;50:120:0
PA164712875;LOW-CEILING DIURETICS, EXCL. THIAZIDES;C03B;Drug Class;7:8:0
PA164712876;LOW-CEILING DIURETICS, THIAZIDES;C03A;Drug Class;52:122:0
PA164712878;LOW-ENERGY DIETS;V06AA;Drug Class;0:0:0
PA450273;LOXAPINE;N05AH01;Drug;0:0:0
PA451125;L-PROLINE;;Drug;0:0:0
PA451330;L-SERINE;;Drug, Biological Intermediate;0:0:2
PA451673;L-THREONINE;;Drug;0:0:0
PA451822;L-TYROSINE;;Drug, Biological Intermediate;0:0:1
PA164777012;LUBIPROSTONE;A06AX03;Drug;0:0:0
PA164748783;LUCANTHONE;;Drug;0:0:0
PA166131607;LUCITANIB;;Drug;0:0:0
PA166235281;LUMASIRAN;A16AX18;Drug;0:0:0
PA164769031;LUMIRACOXIB;M01AH06;Drug;0:3:0
PA164712879;LUNG SURFACTANTS;R07AA;Drug Class;0:0:0
PA166117453;LURBINECTEDIN;L01XX69;Drug;0:0:0
PA166190001;LUSPATERCEPT;B03XA06;Drug;0:0:0
PA166182748;LUSUTROMBOPAG;B02BX07;Drug;0:0:0
PA164750539;LUTROPIN ALFA;G03GA07;Drug;0:0:0
PA451843;L-VALINE;;Drug;0:0:0
PA165816891;LY2140023;;Drug;0:0:0
PA164747190;LYMECYCLINE;J01AA04;Drug;0:0:0
PA166366902;LYSERGIC ACID DIETHYLAMIDE;;Drug;0:0:0
PA166261201;MACITENTAN;;Drug;0:5:0
PA164712882;MACROLIDES;J01FA;Drug Class;2:15:0
PA164712883;MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS;J01F;Drug Class;4:26:0
PA166114925;MAFENIDE;D06BA03;Drug;0:1:0
PA164712884;MAGNESIUM;A02AA, A12CC;Drug Class;0:0:0
PA450290;MAGNESIUM ACETATE;;Drug;0:0:0
PA450294;MAGNESIUM CHLORIDE;;Drug;0:0:0
PA164712885;MAGNESIUM COMPOUNDS;A02AA;Drug Class;0:0:0
PA450296;MAGNESIUM GLUCONATE;;Drug;0:0:0
PA166234822;MAGNESIUM HYDROXIDE;;Drug;0:0:0
PA450298;MAGNESIUM OXIDE;A02AA02, A06AD02, A12CC10;Drug;0:0:0
PA450302;MAGNESIUM SULFATE;A06AD04, A12CC02, B05XA05, D11AX05, V04CC02;Drug;0:0:0
PA166182547;MAGNESIUM TRISILICATE;;Drug;0:0:0
PA164712886;MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08C;Drug Class;0:0:0
PA164748092;MALATHION;P03AX03;Drug;0:0:0
PA166305883;MAMMALIAN TARGET OF RAPAMYCIN (MTOR) KINASE INHIBITORS;L01EG;Drug Class;26:84:0
PA450320;MANNITOL;A06AD16, B05BC01, B05CX04, R05CB16;Drug;0:0:0
PA164712880;MAO INHIBITORS;C02KC;Drug Class;0:0:0
PA164712881;MAO INHIBITORS AND DIURETICS;C02LL;Drug Class;0:0:0
PA166268803;MARALIXIBAT;A05AX04;Drug;0:0:0
PA166335461;MARIBAVIR;J05AX10;Drug;0:0:0
PA164748329;MARIMASTAT;;Drug;0:0:0
PA166185383;MASITINIB;;Drug;0:0:0
PA164746493;MASOPROCOL;L01XX10;Drug;0:0:0
PA166272922;MAVACAMTEN;C01EB24;Drug;0:1:0
PA166353004;MAVORIXAFOR;;Drug;0:0:0
PA166209301;MAVRILIMUMAB;;Drug;0:0:0
PA165291473;MAYTANSINE;;Drug;0:0:0
PA450326;MAZINDOL;A08AA05;Drug;0:0:0
PA164776669;MEBENDAZOLE;P02CA01;Drug;0:0:0
PA450334;MECAMYLAMINE;C02BB01;Drug;0:0:0
PA164774876;MECASERMIN;H01AC03;Drug;0:0:0
PA450336;MECHLORETHAMINE;L01AA05;Drug;0:0:0
PA450338;MECLIZINE;R06AE05;Drug;0:0:0
PA450341;MECLOFENAMIC ACID;M01AG04, M02AA18;Drug;0:0:0
PA164712888;MEDICAL GASES;V03AN;Drug Class;0:0:0
PA164712890;MEDICATED DRESSINGS;D09, D09A;Drug Class;0:0:0
PA164712891;MEDICATED DRESSINGS WITH ANTIINFECTIVES;D09AA;Drug Class;0:0:0
PA164712892;MEDICATED SHAMPOOS;D11AC;Drug Class;0:0:0
PA165290930;MEDROXYPROGESTERONE / CONJUGATED ESTROGENS;G03FA12, G03FB06;Drug;0:0:0
PA450346;MEDRYSONE;S01BA08;Drug;0:0:0
PA450347;MEFENAMIC ACID;M01AG01;Drug;0:0:0
PA450351;MEGESTROL;;Drug;0:0:0
PA162360980;MEGLITINIDES;;Drug Class;0:0:0
PA166127606;MELACINE(RIBI IMMUNOCHEM);;Drug;0:0:0
PA10136;MELARSOPROL;P01CD01;Drug;0:0:0
PA164752558;MELATONIN;N05CH01;Drug, Biological Intermediate;0:0:1
PA164712893;MELATONIN RECEPTOR AGONISTS;N05CH;Drug Class;0:1:0
PA450353;MELOXICAM;M01AC06;Drug;1:5:1
PA166301641;MELPERONE;;Drug;0:0:0
PA450358;MENADIONE;B02BA02;Drug;0:0:0
PA166123066;MENADIONE SODIUM BISULFITE;;Drug;0:1:0
PA164712894;MENINGOCOCCAL VACCINES;J07AH;Drug Class;0:0:0
PA164776605;MENTHOL;;Drug;0:0:0
PA164746250;MEPENZOLATE;A03AB12;Drug;0:0:0
PA166184711;MEPHEDRONE;;Drug;0:1:0
PA164745533;MEPHENTERMINE;C01CA11;Drug;0:0:0
PA164748741;MEPIVACAINE;N01BB03;Drug;0:0:0
PA166313323;MEPOLIZUMAB;R03DX09;Drug;0:0:0
PA450377;MEPROBAMATE;N05BC01;Drug;0:0:0
PA165958366;MEPYRAMINE;D04AA02, R06AC01;Drug;0:0:0
PA164748010;MEQUITAZINE;R06AD07;Drug;0:0:0
PA450379;MERCAPTOPURINE;L01BB02;Drug, Metabolite;41:387:1
PA164712895;MERCURIAL DIURETICS;C03BC;Drug Class;0:0:0
PA164712896;MERCURIAL PRODUCTS;D08AK;Drug Class;0:0:0
PA166210763;MERIMEPODIB;;Drug;0:0:0
PA164764445;MEROPENEM;J01DH02;Drug;0:0:0
PA450384;MESALAZINE;A07EC02;Drug;0:3:1
PA450385;MESNA;R05CB05, V03AF01;Drug;0:0:0
PA450386;MESORIDAZINE;N05AC03;Drug, Metabolite;0:0:0
PA450388;MESTRANOL;;Drug;0:0:0
PA166183788;METABUTETHAMINE;N01BA01;Drug;0:0:0
PA164748761;METARAMINOL;C01CA09;Drug;0:0:0
PA164747189;METAXALONE;;Drug;0:0:0
PA450398;METHACHOLINE CHLORIDE;;Drug;0:2:0
PA164750512;METHACYCLINE;J01AA05;Drug;0:0:0
PA450401;METHADONE;N07BC02;Drug;100:468:1
PA164746889;METHADYL ACETATE;;Drug;0:0:0
PA164712897;METHANOLQUINOLINES;P01BC;Drug Class;1:9:0
PA164747037;METHANTHELINE;A03AB07;Drug;0:0:0
PA164746525;METHARBITAL;N03AA30;Drug;0:0:0
PA450413;METHAZOLAMIDE;S01EC05;Drug;2:14:0
PA164743018;METHDILAZINE;R06AD04;Drug;0:0:0
PA450423;METHIONINE;V03AB26;Drug, Biological Intermediate;0:0:2
PA164749506;METHOCARBAMOL;M03BA03;Drug;0:0:0
PA164784030;METHOHEXITAL;N01AF01, N05CA15;Drug;0:0:0
PA450428;METHOTREXATE;L01BA01, L04AX03;Drug;175:1029:5
PA164743234;METHOTRIMEPRAZINE;N05AA02;Drug;0:0:0
PA450431;METHOXAMINE;C01CA10;Drug;0:0:1
PA450434;METHOXYFLURANE;N02BG09;Drug;47:1:1
PA166182621;METHOXYPHENAMINE;;Drug;0:0:0
PA164743145;METHSUXIMIDE;N03AD03;Drug;0:0:0
PA164748094;METHYCLOTHIAZIDE;C03AA08;Drug;0:0:0
PA164784028;METHYL AMINOLEVULINATE;L01XD03;Drug;0:0:0
PA165816878;METHYLCHOLANTHRENE;;Drug;0:0:0
PA164712898;METHYLDOPA;C02AB;Drug Class;0:3:0
PA164712899;METHYLDOPA AND DIURETICS IN COMBINATION;C02LB;Drug Class;0:0:0
PA166250241;METHYLENE DIACETATE;;Drug;0:0:0
PA450461;METHYLERGONOVINE;G02AB01;Drug;0:0:0
PA164712900;METHYLHYDRAZINES;L01XB;Drug Class;0:2:0
PA164784032;METHYLSCOPOLAMINE;;Drug;0:0:0
PA165958383;METHYLTESTOSTERONE;G03BA02, G03EK01;Drug;0:0:0
PA164746748;METHYPRYLON;N05CE02;Drug;0:0:0
PA164777034;METICILLIN;J01CF03;Drug;0:0:0
PA164748727;METIPRANOLOL;S01ED04;Drug;0:0:0
PA164783811;METIXENE;N04AA03;Drug;0:0:0
PA450475;METOCLOPRAMIDE;A03FA01;Drug;0:8:1
PA164749507;METOCURINE;M03AA04;Drug;0:0:0
PA164781022;METOLAZONE;C03BA08;Drug;0:0:0
PA450480;METOPROLOL;C07AB02;Drug;17:92:2
PA164742936;METRIZAMIDE;V08AB01;Drug;0:0:0
PA450486;METYRAPONE;V04CD01;Drug;0:0:0
PA450487;METYROSINE;C02KB01;Drug;0:0:1
PA164750540;MEZLOCILLIN;J01CA10;Drug;0:0:0
PA165290932;MI-63;;Drug;0:0:0
PA450492;MIBEFRADIL;C08CX01;Drug;0:0:0
PA164781026;MICAFUNGIN;J02AX05;Drug;0:0:0
PA450494;MICONAZOLE;A01AB09, A07AC01, D01AC02, G01AF04, J02AB01, S02AA13;Drug;0:0:0
PA164749381;MIDODRINE;C01CA17;Drug;0:0:0
PA450500;MIFEPRISTONE;G03XB01;Drug;0:0:0
PA164776726;MIGLITOL;A10BF02;Drug;0:0:0
PA10140;MIGLUSTAT;A16AX06;Drug;0:0:0
PA164712901;MILK SUBSTITUTES;V06DF;Drug Class;0:0:0
PA164749171;MILRINONE;C01CE02;Drug;0:0:0
PA166338801;MILTIRONE;;Drug;0:0:0
PA164752445;MIMOSINE;;Drug;0:0:0
PA164748351;MINAPRINE;N06AX07;Drug;0:0:0
PA164712903;MINERALOCORTICOIDS;H02AA;Drug Class;0:1:0
PA164712902;MINERAL SUPPLEMENTS;A12;Drug Class;0:0:0
PA450521;MINOXIDIL;C02DC01, D11AX01;Drug;0:0:0
PA166114927;MIPOMERSEN;C10AX11;Drug;0:0:0
PA166177513;MIRABEGRON;G04BD12;Drug;0:8:0
PA166049181;MIROPROFEN;;Drug;0:0:0
PA450522;MIRTAZAPINE;N06AX11;Drug;10:33:0
PA450523;MISOPROSTOL;A02BB01, G02AD06;Drug;0:2:0
PA166278021;MITAPIVAT;B06AX04;Drug;0:0:0
PA164748124;MITIGLINIDE;A10BX08;Drug;0:0:0
PA166358101;MITIPERSTAT;;Drug;0:0:0
PA166305881;MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS;L01EE;Drug Class;0:12:0
PA450524;MITOMYCIN;L01DC03;Drug;0:0:0
PA166415841;MITRAGYNINE;;Drug;0:0:0
PA450528;MIVACURIUM;M03AC10;Drug;0:5:0
PA165964366;MK-7246;;Drug;0:0:0
PA452615;MOCLOBEMIDE;N06AG02;Drug;0:1:0
PA164769059;MOEXIPRIL;C09AA13;Drug;0:0:0
PA166334901;MOGAMULIZUMAB;L01FX09;Drug;0:0:0
PA164746756;MOLINDONE;N05AE02;Drug;0:0:0
PA450536;MOLYBDENUM;;Drug;0:0:0
PA166334801;MOMELOTINIB;L01EJ04;Drug;0:0:1
PA450541;MOMETASONE;D07AC13, D07XC03, R01AD09, R03BA07;Drug;0:0:0
PA164712904;MONOAMINE OXIDASE A INHIBITORS;N06AG;Drug Class;0:1:0
PA164712905;MONOAMINE OXIDASE B INHIBITORS;N04BD;Drug Class;3:10:0
PA164712906;MONOAMINE OXIDASE INHIBITORS, NON-SELECTIVE;N06AF;Drug Class;0:12:0
PA164712907;MONOBACTAMS;J01DF;Drug Class;0:0:0
PA164764582;MONOBENZONE;D11AX13;Drug;0:0:0
PA164712908;MONOCLONAL ANTIBODIES;L01F, L01XC;Drug Class;70:386:0
PA164747738;MORICIZINE;C01BG01;Drug;0:0:0
PA164712909;MORPHINAN DERIVATIVES;N02AF;Drug Class;3:8:0
PA166118340;MOTESANIB;;Drug;0:0:1
PA166163260;MOVIPREP;A06AD15;Drug;0:0:0
PA166334922;MOXETUMOMAB PASUDOTOX;L01FB02;Drug;0:0:0
PA450555;MOXIFLOXACIN;J01MA14, S01AE07;Drug;0:3:0
PA140222720;MPP+;;Drug;0:0:0
PA164712910;MUCOLYTICS;R05CB;Drug Class;1:6:0
PA164712912;MULTIVITAMINS, COMBINATIONS;A11A;Drug Class;0:0:0
PA164712914;MULTIVITAMINS, OTHER COMBINATIONS;A11AB;Drug Class;0:0:0
PA164712913;MULTIVITAMINS, PLAIN;A11B, A11BA;Drug Class;0:2:0
PA164712911;MULTIVITAMINS WITH MINERALS;A11AA;Drug Class;0:0:0
PA164712916;MUMPS VACCINES;J07BE;Drug Class;0:0:0
PA164764568;MUPIROCIN;D06AX09, R01AX06;Drug;0:0:0
PA164743097;MUROMONAB;L04AA02;Drug;0:0:0
PA164712917;MUSCLE RELAXANTS;C05AE, M03;Drug Class;61:112:0
PA164712918;MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS;M03B;Drug Class;2:6:0
PA164712919;MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS;M03C;Drug Class;0:0:0
PA452389;MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS;M03A;Drug Class;58:93:0
PA164712921;MUSCULO-SKELETAL SYSTEM;M;Drug Class;157:567:0
PA165107990;MYCLOBUTANIL;;Drug;0:0:0
PA164712922;MYDRIATICS AND CYCLOPLEGICS;S01F;Drug Class;2:11:0
PA164746998;NABILONE;A04AD11;Drug;0:0:0
PA450572;NABUMETONE;M01AX01;Drug;0:0:0
PA164752287;N-ACETYL-D-GLUCOSAMINE;;Drug;0:0:0
PA448014;N-ACETYLETHANOLAMINE;;Drug, Biological Intermediate;0:0:0
PA450573;NADOLOL;C07AA12;Drug;0:0:0
PA10815;NADROPARIN;;Drug;0:0:0
PA166220602;NAFAMOSTAT;;Drug;0:0:0
PA164754805;NAFARELIN;H01CA02;Drug;0:0:0
PA450576;NAFCILLIN;J01CF06;Drug;0:0:0
PA164748617;NAFTIFINE;D01AE22;Drug;0:0:0
PA164745372;NALBUPHINE;N02AF02;Drug;0:0:0
PA166325183;NALDEMEDINE;A06AH05;Drug;0:0:0
PA164746384;NALIDIXIC ACID;J01MB02;Drug;0:2:0
PA166176241;NALMEFENE;;Drug;0:5:0
PA164746281;NANDROLONE;;Drug;0:0:0
PA165958423;NANDROLONE DECANOATE;;Drug;0:0:0
PA165958384;NAPHAZOLINE;R01AA08, R01AB02, S01GA01;Drug;0:0:0
PA154081779;NAPHTHOL;;Drug;0:0:0
PA450597;NARATRIPTAN;N02CC02;Drug;0:0:1
PA151958361;NARINGENIN;;Drug;0:0:0
PA151958360;NARINGIN;;Drug;0:0:0
PA164712923;NASAL DECONGESTANTS FOR SYSTEMIC USE;R01B;Drug Class;1:6:0
PA164712924;NASAL PREPARATIONS;R01;Drug Class;31:113:0
PA164747191;NATALIZUMAB;L04AA23;Drug;0:0:0
PA164744325;NATAMYCIN;A01AB10, A07AA03, D01AA02, G01AA02, S01AA10;Drug;0:0:0
PA450600;NATEGLINIDE;A10BX03;Drug;0:3:2
PA164712925;NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN;G03CA;Drug Class;5:35:0
PA164712926;NATURAL OPIUM ALKALOIDS;N02AA;Drug Class;75:470:0
PA166185384;NAVITOCLAX;;Drug;0:0:0
PA166344301;NAZARTINIB;;Drug;0:0:0
PA166334881;NECITUMUMAB;L01FE03;Drug;0:0:0
PA166328843;NEDOSIRAN;;Drug;0:0:0
PA164752425;NELARABINE;L01BB07;Drug;0:0:0
PA450608;NEOMYCIN;A01AB08, A07AA01, B05CA09, D06AX04, J01GB05, R02AB01, S01AA03, S02AA07, S03AA01;Drug;1:5:0
PA450611;NEOSTIGMINE;N07AA01, S01EB06;Drug;0:0:0
PA165958407;NEPAFENAC;S01BC10;Drug;0:0:0
PA165360204;NEPICASTAT;;Drug;0:0:0
PA164712927;NERVE DEPRESSANTS;V03AZ;Drug Class;93:317:0
PA164712928;NERVOUS SYSTEM;N;Drug Class;2009:7790:0
PA164781045;NESIRITIDE;C01DX19;Drug;0:0:0
PA164754913;NETILMICIN;J01GB07, S01AA23;Drug;0:0:0
PA164712929;NEURAMINIDASE INHIBITORS;J05AH;Drug Class;2:11:0
PA450616;NEVIRAPINE;J05AG01;Drug;66:208:1
PA129945760;NG-MONOMETHYL-L-ARGININE;;Drug;0:0:0
PA450617;NIACIN;C04AC01, C10AD02;Drug;0:4:0
PA450620;NICARDIPINE;C08CA04;Drug;0:2:0
PA164743014;NICERGOLINE;C04AE02;Drug;0:0:0
PA165958408;NICLOSAMIDE;P02DA01;Drug;0:0:0
PA166184081;NICORANDIL;C01DX16;Drug;0:0:0
PA164712930;NICOTINIC ACID AND DERIVATIVES;C04AC, C10AD;Drug Class;0:4:0
PA164746749;NIFLUMIC ACID;M01AX02, M02AA17;Drug;0:0:0
PA166228342;NIFURTIMOX;;Drug;0:0:0
PA450632;NILUTAMIDE;L02BB02;Drug;0:0:0
PA165958385;NILVADIPINE;C08CA10;Drug;0:0:0
PA137179528;NIMESULIDE;M01AX17, M02AA26;Drug;0:2:0
PA166324741;NINGETINIB;;Drug;0:0:0
PA166249521;NINTEDANIB;;Drug;0:1:0
PA166279883;NIRMATRELVIR;;Drug;0:0:0
PA166279921;NIRMATRELVIR / RITONAVIR;J05AE30;Drug;0:0:0
PA166328844;NIROGACESTAT;;Drug;0:0:0
PA450634;NISOLDIPINE;C08CA07;Drug;0:0:0
PA164754874;NITAZOXANIDE;P01AX11;Drug;0:0:0
PA164777037;NITISINONE;A16AX04;Drug;0:0:0
PA10242;NITRAZEPAM;N05CD02;Drug;0:0:0
PA450635;NITRIC OXIDE;R07AX01;Drug;0:1:0
PA450636;NITRILE;;Drug;0:0:0
PA164712932;NITROFERRICYANIDE DERIVATIVES;C02DD;Drug Class;1:1:0
PA164712933;NITROFURAN DERIVATIVES;D08AF, J01XE, P01CC;Drug Class;1:4:0
PA164754877;NITROFURAZONE;B05CA03, D08AF01, D09AA03, P01CC02, S01AX04, S02AA02;Drug;0:0:0
PA450643;NITROGEN;;Drug;0:0:0
PA164712936;NITROGEN MUSTARD ANALOGUES;L01AA;Drug Class;125:409:0
PA450644;NITROGLYCERIN;C01DA02, C05AE01;Drug;0:2:0
PA164712937;NITROIMIDAZOLE DERIVATIVES;P01AB, P01CA;Drug Class;1:2:0
PA164712939;NITROSOUREAS;L01AD;Drug Class;0:0:0
PA164754993;NITROXOLINE;J01XX07;Drug;0:0:0
PA166318601;NIVASOREXANT;;Drug;0:0:0
PA166277902;NIVOLUMAB / RELATLIMAB;L01XY03;Drug;0:0:0
PA164752234;NIZATIDINE;A02BA04;Drug;0:0:0
PA450570;N,N-DIMETHYLACETAMIDE;;Drug;0:0:0
PA166299581;N,N-DIMETHYLTRYPTAMINE;;Drug;0:0:0
PA150047156;NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;J05AG;Drug Class;99:652:0
PA450648;NONOXYNOL-9;;Drug;0:0:0
PA164712941;NON-SELECTIVE BETA-ADRENORECEPTOR AGONISTS;R03CB;Drug Class;1:2:0
PA164712940;NON-SELECTIVE CALCIUM CHANNEL BLOCKERS;C08E;Drug Class;0:1:0
PA10389;NON-SELECTIVE MONOAMINE REUPTAKE INHIBITORS;N06AA;Drug Class;47:314:0
PA164712942;NON-WATERSOLUBLE X-RAY CONTRAST MEDIA;V08AD;Drug Class;0:0:0
PA164953212;NORELGESTROMIN;G03A;Drug;0:0:0
PA450649;NOREPINEPHRINE;C01CA03;Drug, Biological Intermediate;0:1:1
PA450651;NORETHINDRONE;G03AC01, G03DC02;Drug;0:0:0
PA166397661;NORETHINDRONE ACETATE;;Drug;0:0:0
PA450654;NORFLOXACIN;J01MA06, S01AE02;Drug;0:0:0
PA164744346;NORGESTIMATE;;Drug;0:0:0
PA450656;NORGESTREL;;Drug;0:0:0
PA450657;NORTRIPTYLINE;N06AA10;Drug;9:84:1
PA165374638;NOSCAPINE;R05DA07;Drug;0:1:0
PA164768819;NOVOBIOCIN;;Drug;0:0:0
PA166159659;NPPB;;Drug;0:1:0
PA166049196;NS-398;;Drug;0:0:0
PA452628;NUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS;J05AB;Drug Class;49:369:0
PA166182882;NUSINERSEN;M09AX07;Drug;0:0:0
PA164712944;NUTRIENTS WITHOUT PHENYLALANINE;V06CA;Drug Class;0:0:0
PA450666;NYSTATIN;A07AA02, D01AA01, G01AA01;Drug;0:0:0
PA166413001;OBICETRAPIB;;Drug;0:0:0
PA166122586;OBINUTUZUMAB;L01FA03;Drug;0:0:0
PA134711724;OCHRATOXIN A;;Drug;0:0:0
PA450678;OCTREOTIDE;H01CB02;Drug;0:0:0
PA164712945;OCULAR VASCULAR DISORDER AGENTS;S01L;Drug Class;8:80:0
PA166268805;ODEVIXIBAT;A05AX05;Drug;0:0:0
PA165291493;OFATUMUMAB;L01FA02;Drug;0:0:0
PA450684;OFLOXACIN;J01MA01, S01AE01, S02AA16;Drug;0:0:0
PA166163434;OLARATUMAB;L01FX10;Drug;0:0:0
PA166321021;OLCEGEPANT;;Drug;0:0:1
PA166400181;OLEZARSEN;;Drug;0:0:0
PA166223601;OLICERIDINE;N02AX07;Drug;0:0:0
PA450698;OLOPATADINE;R01AC08, S01GX09;Drug;0:0:0
PA450700;OLSALAZINE;A07EC03;Drug;0:0:0
PA165374637;OLTIPRAZ;;Drug;0:0:0
PA166285901;OLVEREMBATINIB;;Drug;0:0:0
PA166114929;OMACETAXINE;L01XX40;Drug;0:1:0
PA166360321;OMADACYCLINE;J01AA15;Drug;0:0:0
PA164752253;OMALIZUMAB;R03DX05;Drug;0:0:0
PA166365281;OMAVELOXOLONE;N07XX25;Drug;0:0:0
PA166163409;OMBITASVIR;;Drug;0:0:0
PA166163408;OMBITASVIR / PARITAPREVIR / RITONAVIR;J05AP53;Drug;0:1:0
PA450702;OMEGA-3 POLYUNSATURATED FATTY ACIDS;C10AX06;Drug Class;0:1:0
PA450704;OMEPRAZOLE;A02BC01;Drug;5:182:1
PA166117241;ONARTUZUMAB;;Drug;0:0:0
PA166415761;ONRADIVIR;;Drug;0:0:0
PA164924563;ONTOGEN;;Drug;0:0:0
PA164712946;OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03;Drug Class;25:127:0
PA164712947;OPHTHALMOLOGICALS;S01;Drug Class;131:635:0
PA164712949;OPIOIDS IN COMBINATION WITH ANTISPASMODICS;N02AG;Drug Class;0:0:0
PA164712951;OPIUM DERIVATIVES AND EXPECTORANTS;R05FA;Drug Class;0:0:0
PA166197161;OPLUNOFUSP;;Drug;0:0:0
PA164747991;OPRELVEKIN;L03AC02;Drug;0:0:0
PA164712952;ORAL REHYDRATION SALT FORMULATIONS;A07CA;Drug Class;0:0:0
PA166183405;ORANGE JUICE;;Drug;0:0:1
PA130619705;ORBOFIBAN;;Drug;0:0:0
PA450390;ORCIPRENALINE;R03AB03, R03CB03;Drug;0:0:1
PA166416241;ORFORGLIPRON;;Drug;0:0:0
PA164712953;ORGANIC ACIDS;G01AD;Drug Class;0:2:0
PA10472;ORGANIC NITRATES;C01DA;Drug Class;1:3:0
PA164712954;ORGANOPHOSPHOROUS COMPOUNDS;P02BB;Drug Class;0:0:0
PA164712955;ORIPAVINE DERIVATIVES;N02AE;Drug Class;21:66:0
PA164776864;ORLISTAT;A08AB01;Drug;0:0:0
PA450715;ORPHENADRINE;;Drug;0:0:0
PA166337301;OSAVAMPATOR;;Drug;0:0:0
PA166327521;OSILODROSTAT;H02CA02;Drug;0:0:0
PA164712956;OSMOTICALLY ACTING LAXATIVES;A06AD;Drug Class;0:0:0
PA164743058;OSPA LIPOPROTEIN;;Drug;0:0:0
PA166182883;OSPEMIFENE;G03XC05;Drug;0:0:1
PA151958300;OTAMIXABAN;;Drug;0:0:0
PA164712957;OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09X;Drug Class;50:120:0
PA164712999;OTHER AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX;Drug Class;0:1:0
PA164713000;OTHER AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CX;Drug Class;0:0:0
PA164713001;OTHER AGENTS FOR LOCAL ORAL TREATMENT;A01AD;Drug Class;77:294:0
PA164713002;OTHER AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AX;Drug Class;0:0:0
PA164712958;OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;A16, A16A;Drug Class;21:23:0
PA164713003;OTHER ALKYLATING AGENTS;L01AX;Drug Class;3:17:0
PA164713004;OTHER AMINOGLYCOSIDES;J01GB;Drug Class;13:76:0
PA164712960;OTHER ANABOLIC AGENTS;A14B;Drug Class;0:0:0
PA164712961;OTHER ANALGESICS AND ANTIPYRETICS;N02B, N02BG;Drug Class;160:373:0
PA164713006;OTHER ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AX;Drug Class;0:0:0
PA164713007;OTHER ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE;D10BX;Drug Class;0:0:0
PA164713008;OTHER ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AX;Drug Class;8:24:0
PA164713011;OTHER ANTIALLERGICS;S01GX;Drug Class;1:1:0
PA164712962;OTHER ANTIANEMIC PREPARATIONS;B03X, B03XA;Drug Class;0:0:0
PA164712963;OTHER ANTIBACTERIALS;J01X, J01XX;Drug Class;5:53:0
PA164713014;OTHER ANTIBIOTICS FOR TOPICAL USE;D06AX;Drug Class;7:59:0
PA164713015;OTHER ANTICESTODALS;P02DX;Drug Class;0:0:0
PA164713009;OTHER ANTI-DEMENTIA DRUGS;N06DX;Drug Class;1:2:0
PA164713016;OTHER ANTIDEPRESSANTS;N06AX;Drug Class;167:418:0
PA164712964;OTHER ANTIDIARRHEALS;A07X, A07XA;Drug Class;0:0:0
PA164713018;OTHER ANTIEMETICS;A04AD;Drug Class;0:1:0
PA164713019;OTHER ANTIEPILEPTICS;N03AX;Drug Class;33:170:0
PA164713020;OTHER ANTIFUNGALS FOR TOPICAL USE;D01AE;Drug Class;0:2:0
PA164713021;OTHER ANTIGLAUCOMA PREPARATIONS;S01EX;Drug Class;0:0:0
PA164713022;OTHER ANTIGOUT PREPARATIONS;M04AX;Drug Class;1:2:0
PA164713023;OTHER ANTIHISTAMINES FOR SYSTEMIC USE;R06AX;Drug Class;4:17:0
PA164712965;OTHER ANTIHYPERTENSIVES;C02K, C02KX;Drug Class;0:13:0
PA164713025;OTHER ANTIHYPERTENSIVES AND DIURETICS;C02LX;Drug Class;0:0:0
PA164713026;OTHER ANTIINFECTIVES;S01AX;Drug Class;0:0:0
PA164713027;OTHER ANTIINFECTIVES AND ANTISEPTICS;G01AX;Drug Class;0:0:0
PA164713028;OTHER ANTIINFLAMMATORY AND ANTIRHEUMATIC AGENTS, NON-STEROIDS;M01AX;Drug Class;0:2:0
PA164713030;OTHER ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION WITH OTHER DRUGS;M01BX;Drug Class;0:0:0
PA164713029;OTHER ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AX;Drug Class;0:0:0
PA164713031;OTHER ANTIMALARIALS;P01BX;Drug Class;0:0:0
PA164713032;OTHER ANTIMIGRAINE PREPARATIONS;N02CX;Drug Class;2:6:0
PA164713033;OTHER ANTIMYCOTICS FOR SYSTEMIC USE;J02AX;Drug Class;0:0:0
PA164713034;OTHER ANTINEMATODALS;P02CX;Drug Class;0:0:0
PA164712966;OTHER ANTINEOPLASTIC AGENTS;L01X, L01XK, L01XX;Drug Class;416:1846:0
PA164713036;OTHER ANTIOBESITY DRUGS;A08AX;Drug Class;0:0:0
PA164713010;OTHER ANTI-PARATHYROID AGENTS;H05BX;Drug Class;0:1:0
PA164713037;OTHER ANTIPRURITICS;D04AX;Drug Class;0:0:0
PA164713038;OTHER ANTIPSORIATICS FOR SYSTEMIC USE;D05BX;Drug Class;0:0:0
PA164713039;OTHER ANTIPSORIATICS FOR TOPICAL USE;D05AX;Drug Class;0:4:0
PA164713040;OTHER ANTIPSYCHOTICS;N05AX;Drug Class;102:437:0
PA164713041;OTHER ANTISEPTICS AND DISINFECTANTS;D08AX;Drug Class;93:317:0
PA164713042;OTHER ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DC;Drug Class;0:0:0
PA164713043;OTHER ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CC;Drug Class;0:0:0
PA164713044;OTHER ANTITHROMBOTIC AGENTS;B01AX;Drug Class;0:0:0
PA164713045;OTHER ANTITHYROID PREPARATIONS;H03BX;Drug Class;0:0:0
PA164713046;OTHER ANTITREMATODAL AGENTS;P02BX;Drug Class;0:0:0
PA164713047;OTHER ANTIVIRALS;J05AX;Drug Class;4:12:0
PA164713048;OTHER ANXIOLYTICS;N05BX;Drug Class;0:0:0
PA164713049;OTHER BACTERIAL VACCINES;J07AX;Drug Class;0:0:0
PA452159;OTHER BETA-LACTAM ANTIBACTERIALS;J01D;Drug Class;4:16:0
PA164713050;OTHER BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS;A10BX;Drug Class;19:37:0
PA164713051;OTHER CAPILLARY STABILIZING AGENTS;C05CX;Drug Class;0:0:0
PA164713052;OTHER CARDIAC COMBINATION PRODUCTS;C01EX;Drug Class;0:0:0
PA164713053;OTHER CARDIAC GLYCOSIDES;C01AX;Drug Class;0:0:0
PA164712967;OTHER CARDIAC PREPARATIONS;C01E, C01EB;Drug Class;8:46:0
PA164713055;OTHER CARDIAC STIMULANTS;C01CX;Drug Class;0:0:0
PA164713056;OTHER CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GX;Drug Class;0:0:0
PA164713058;OTHER CENTRALLY ACTING AGENTS;M03BX;Drug Class;1:2:0
PA164713057;OTHER CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AX;Drug Class;0:0:0
PA164713059;OTHER CEPHALOSPORINS;J01DI;Drug Class;0:0:0
PA164713060;OTHER CHEMOTHERAPEUTICS;D06BX;Drug Class;1:2:0
PA164713061;OTHER CICATRIZANTS;D03AX;Drug Class;0:0:0
PA164713062;OTHER CLASS I ANTIARRHYTHMICS;C01BG;Drug Class;0:0:0
PA164712968;OTHER COLD COMBINATION PREPARATIONS;R05X;Drug Class;0:0:0
PA164713063;OTHER COMBINATIONS OF NUTRIENTS;V06DX;Drug Class;0:0:0
PA164713064;OTHER COUGH SUPPRESSANTS;R05DB;Drug Class;0:0:0
PA164713065;OTHER COUGH SUPPRESSANTS AND EXPECTORANTS;R05FB;Drug Class;0:0:0
PA164713066;OTHER CYTOTOXIC ANTIBIOTICS;L01DC;Drug Class;11:24:0
PA164712969;OTHER DERMATOLOGICAL PREPARATIONS;D11, D11A;Drug Class;87:1060:0
PA164713067;OTHER DERMATOLOGICALS;D11AX;Drug Class;6:47:0
PA164712971;OTHER DIAGNOSTIC AGENTS;V04C, V04CX;Drug Class;5:28:0
PA164712972;OTHER DIAGNOSTIC RADIOPHARMACEUTICALS;V09X;Drug Class;0:0:0
PA164713069;OTHER DIAGNOSTIC RADIOPHARMACEUTICALS FOR INFLAMMATION AND INFECTION DETECTION;V09HX;Drug Class;0:0:0
PA164713070;OTHER DIAGNOSTIC RADIOPHARMACEUTICALS FOR TUMOUR DETECTION;V09IX;Drug Class;0:0:0
PA164712973;OTHER DIURETICS;C03X;Drug Class;0:0:0
PA164713071;OTHER DOPAMINERGIC AGENTS;N04BX;Drug Class;1:7:0
PA164713072;OTHER DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BX;Drug Class;0:0:0
PA164712974;OTHER DRUGS FOR ACID RELATED DISORDERS;A02X;Drug Class;0:0:0
PA164713073;OTHER DRUGS FOR BILE THERAPY;A05AX;Drug Class;0:0:0
PA164712976;OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM;M09, M09A, M09AX;Drug Class;3:12:0
PA164713075;OTHER DRUGS FOR FUNCTIONAL BOWEL DISORDERS;A03AX;Drug Class;0:0:0
PA164712977;OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS;R03B, R03BX;Drug Class;12:40:0
PA164713077;OTHER DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX;Drug Class;0:0:0
PA164713078;OTHER DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AK;Drug Class;17:246:0
PA164713079;OTHER DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CX;Drug Class;0:0:0
PA164712978;OTHER DRUGS USED IN DIABETES;A10X;Drug Class;0:0:0
PA164713080;OTHER ECTOPARASITICIDES, INCL. SCABICIDES;P03AX;Drug Class;0:0:0
PA164713081;OTHER EMOLLIENTS AND PROTECTIVES;D02AX;Drug Class;0:0:0
PA164713082;OTHER ESTROGENS;G03CX;Drug Class;0:0:0
PA164712980;OTHER GYNECOLOGICALS;G02, G02C, G02CX;Drug Class;10:63:0
PA164712981;OTHER HEMATOLOGICAL AGENTS;B06, B06A;Drug Class;1:19:0
PA164713085;OTHER HEM PRODUCTS;B06AB;Drug Class;0:0:0
PA164713086;OTHER HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DX;Drug Class;0:0:0
PA164713087;OTHER HIGH-CEILING DIURETICS;C03CX;Drug Class;0:0:0
PA164713088;OTHER HORMONE ANTAGONISTS AND RELATED AGENTS;L02BX;Drug Class;0:0:0
PA164713089;OTHER HORMONES;L02AX;Drug Class;0:0:0
PA164713090;OTHER HYPNOTICS AND SEDATIVES;N05CM;Drug Class;5:34:0
PA164713092;OTHER IMMUNOGLOBULINS;J06BC;Drug Class;0:0:0
PA164713093;OTHER IMMUNOSTIMULANTS;L03AX;Drug Class;3:14:0
PA164713094;OTHER IMMUNOSUPPRESSANTS;L04AX;Drug Class;225:1211:0
PA164713095;OTHER INSECTICIDES AND REPELLENTS;P03BX;Drug Class;0:0:0
PA164713096;OTHER INTESTINAL ADSORBENTS;A07BC;Drug Class;0:0:0
PA164713097;OTHER INTESTINAL ANTIINFECTIVES;A07AX;Drug Class;0:0:0
PA164713098;OTHER IRRIGATING SOLUTIONS;B05CX;Drug Class;0:0:0
PA164713091;OTHER I.V. SOLUTION ADDITIVES;B05XX;Drug Class;0:0:0
PA164713099;OTHER LAXATIVES;A06AX;Drug Class;0:0:0
PA164713100;OTHER LIPID MODIFYING AGENTS;C10AX;Drug Class;0:1:0
PA164713101;OTHER LOCAL ANESTHETICS;N01BX;Drug Class;0:0:0
PA164713102;OTHER LOW-CEILING DIURETICS;C03BX;Drug Class;0:0:0
PA164713103;OTHER MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CX;Drug Class;0:0:0
PA164713104;OTHER MINERAL PRODUCTS;A12CX;Drug Class;0:0:0
PA164712983;OTHER MINERAL SUPPLEMENTS;A12C;Drug Class;0:0:0
PA164713105;OTHER MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS;M03AX;Drug Class;0:0:0
PA164713106;OTHER NASAL PREPARATIONS;R01AX;Drug Class;0:0:0
PA164712984;OTHER NERVOUS SYSTEM DRUGS;N07, N07X, N07XX;Drug Class;321:1311:0
PA164713108;OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS;C08EX;Drug Class;0:0:0
PA164713109;OTHER NON-THERAPEUTIC AUXILIARY PRODUCTS;V07AY;Drug Class;0:0:0
PA164712986;OTHER NUTRIENTS;V06D;Drug Class;0:0:0
PA164712987;OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03D;Drug Class;0:0:0
PA164713110;OTHER OPHTHALMOLOGICAL DIAGNOSTIC AGENTS;S01JX;Drug Class;0:0:0
PA164712988;OTHER OPHTHALMOLOGICALS;S01X, S01XA;Drug Class;31:163:0
PA164713112;OTHER OPIOIDS;N02AX;Drug Class;38:138:0
PA164712989;OTHER OTOLOGICALS;S02D;Drug Class;23:79:0
PA164713113;OTHER OXYTOCICS;G02AX;Drug Class;0:0:0
PA164713114;OTHER PARASYMPATHOMIMETICS;N07AX;Drug Class;0:1:0
PA164713115;OTHER PERIPHERAL VASODILATORS;C04AX;Drug Class;0:4:0
PA164712990;OTHER PLAIN VITAMIN PREPARATIONS;A11H, A11HA;Drug Class;0:2:0
PA164713117;OTHER PLANT ALKALOIDS AND NATURAL PRODUCTS;L01CX;Drug Class;0:5:0
PA164713118;OTHER POTASSIUM-SPARING AGENTS;C03DB;Drug Class;1:3:0
PA164713119;OTHER PSYCHOSTIMULANTS AND NOOTROPICS;N06BX;Drug Class;0:0:0
PA164713120;OTHER QUATERNARY AMMONIUM COMPOUNDS;M03AC;Drug Class;0:5:0
PA164713121;OTHER QUINOLONES;J01MB;Drug Class;0:2:0
PA164713122;OTHER RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CX;Drug Class;0:0:0
PA164713123;OTHER RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EX;Drug Class;0:0:0
PA164712991;OTHER RESPIRATORY SYSTEM PRODUCTS;R07, R07A, R07AX;Drug Class;59:186:0
PA164713125;OTHER SCLEROSING AGENTS;C05BX;Drug Class;0:0:0
PA164713126;OTHER SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CX;Drug Class;0:0:0
PA164712993;OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X;Drug Class;6:18:0
PA164713127;OTHER SPECIFIC ANTIRHEUMATIC AGENTS;M01CX;Drug Class;0:0:0
PA164713128;OTHER SURGICAL AIDS;S01KX;Drug Class;0:0:0
PA164712994;OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D, R03DX;Drug Class;17:31:0
PA164713130;OTHER SYSTEMIC HEMOSTATICS;B02BX;Drug Class;0:1:0
PA164713131;OTHER THERAPEUTIC PRODUCTS;V03AX;Drug Class;0:0:0
PA164712995;OTHER THERAPEUTIC RADIOPHARMACEUTICALS;V10X;Drug Class;0:0:0
PA164713132;OTHER TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AX;Drug Class;0:0:0
PA164713133;OTHER UROLOGICALS;G04BX;Drug Class;2:5:0
PA164712996;OTHER UROLOGICALS, INCL. ANTISPASMODICS;G04B;Drug Class;11:26:0
PA164712997;OTHER VACCINES;J07X;Drug Class;0:0:0
PA164713134;OTHER VASODILATORS USED IN CARDIAC DISEASES;C01DX;Drug Class;0:0:0
PA164713135;OTHER VIRAL VACCINES;J07BX;Drug Class;0:0:0
PA164712998;OTHER VITAMIN PRODUCTS, COMBINATIONS;A11J;Drug Class;0:0:0
PA164713136;OTOLOGICALS;S02;Drug Class;48:210:0
PA163522138;OUABAIN;C01AC01;Drug;0:0:0
PA164713137;OVULATION STIMULANTS, SYNTHETIC;G03GB;Drug Class;0:0:0
PA450725;OXACILLIN;J01CF04;Drug;0:0:0
PA166357383;OXALOACETATE;;Drug, Biological Intermediate;0:0:0
PA164748782;OXAMNIQUINE;P02BA02;Drug;0:0:0
PA164749395;OXANDROLONE;A14AA08;Drug;0:0:0
PA450730;OXAPROZIN;M01AE12;Drug;0:0:0
PA163522137;OXATOMIDE;;Drug;0:0:0
PA164713139;OXAZOLIDINE DERIVATIVES;N03AC;Drug Class;0:0:0
PA164713138;OXAZOL, THIAZINE, AND TRIAZINE DERIVATIVES;M03BB;Drug Class;0:0:0
PA450732;OXCARBAZEPINE;N03AF02;Drug;20:57:1
PA164713140;OXICAMS;M01AC;Drug Class;4:26:0
PA164754742;OXICONAZOLE;D01AC11, G01AF17;Drug;0:0:0
PA10284;OXPRENOLOL;C07AA02;Drug;0:1:0
PA164748137;OXTRIPHYLLINE;R03DA02;Drug;0:0:0
PA164742933;OXYBENZONE;;Drug;0:0:0
PA164764617;OXYBUPROCAINE;D04AB03, S01HA02;Drug;0:0:0
PA164746030;OXYBUTYNIN;G04BD04;Drug;0:0:0
PA450741;OXYCODONE;N02AA05;Drug;21:122:1
PA450744;OXYGEN;;Drug;0:0:0
PA164748840;OXYMETAZOLINE;R01AA05, R01AB07, S01GA04;Drug;0:0:0
PA166182885;OXYMETAZOLINE AND TETRACAINE;N01BA53;Drug;0:0:0
PA450750;OXYPHENBUTAZONE;M01AA03, M02AA04, S01BC02;Drug;0:0:0
PA164776910;OXYPHENCYCLIMINE;A03AA01;Drug;0:0:0
PA164752252;OXYPHENONIUM;A03AB03;Drug;0:0:0
PA450757;OXYTETRACYCLINE;D06AA03, G01AA07, J01AA06, S01AA04;Drug;0:0:0
PA164713141;OXYTOCICS;G02A;Drug Class;0:2:0
PA450760;OXYTOCIN;H01BB02;Drug;0:0:0
PA164713142;OXYTOCIN AND ANALOGUES;H01BB;Drug Class;0:0:0
PA166411141;OZANIMOD;L04AE02;Drug;0:0:0
PA165949675;PACTIMIBE;;Drug;0:0:0
PA164713143;PAIN PALLIATION (BONE SEEKING AGENTS);V10B;Drug Class;0:0:0
PA164744014;PALIFERMIN;V03AF08;Drug;0:0:0
PA164748781;PALIVIZUMAB;J06BB16;Drug;0:0:0
PA166115579;PAMAQUINE;;Drug;0:2:0
PA164713144;PANCREATIC HORMONES;H04;Drug Class;0:0:0
PA448428;PANCRELIPASE;;Drug;0:0:0
PA10238;PANCREOZYMIN (CHOLECYSTOKININ);;Drug;0:0:0
PA450771;PANCURONIUM;M03AC01;Drug;0:0:0
PA166161307;PANOBINOSTAT;;Drug;0:0:0
PA450774;PANTOPRAZOLE;A02BC02;Drug;3:40:1
PA450778;PAPAIN;;Drug;0:0:0
PA164745550;PAPAVERINE;A03AD01, G04BE02;Drug;0:0:0
PA164713145;PAPAVERINE AND DERIVATIVES;A03AD;Drug Class;0:0:0
PA164713146;PAPILLOMAVIRUS VACCINES;J07BM;Drug Class;0:0:0
PA166184497;PARACETAMOL, COMBINATIONS EXCL. PSYCHOLEPTICS (VICKS MEDINAIT SIRUP);N02BE51;Drug;0:0:0
PA450790;PARAFORMALDEHYDE;;Drug;0:0:0
PA164713147;PARAMAGNETIC CONTRAST MEDIA;V08CA;Drug Class;0:0:0
PA164748880;PARAMETHADIONE;N03AC01;Drug;0:0:0
PA164777035;PARAMETHASONE;H02AB05;Drug;0:0:0
PA166162420;PARAMETHOXYMETHAMPHETAMINE;;Drug;0:1:0
PA164713148;PARASYMPATHOMIMETICS;N07A, S01EB;Drug Class;1:2:0
PA164713150;PARATHYROID HORMONES AND ANALOGUES;H05A, H05AA;Drug Class;0:0:0
PA166049193;PARECOXIB;;Drug;0:0:0
PA450797;PARGYLINE;C02KC01;Drug;0:0:0
PA450798;PARICALCITOL;H05BX02;Drug;0:0:0
PA166163410;PARITAPREVIR;;Drug;0:0:0
PA164784023;PAROMOMYCIN;A07AA06;Drug;0:8:1
PA450801;PAROXETINE;N06AB05;Drug;48:247:2
PA166396061;PATRITUMAB DERUXTECAN;;Drug;0:0:0
PA164742856;PEFLOXACIN;J01MA03;Drug;0:0:0
PA450831;PEGADEMASE BOVINE;;Drug;0:0:0
PA164781387;PEGFILGRASTIM;L03AA13;Drug;0:0:0
PA164749390;PEGINTERFERON ALFA-2A;L03AB11, L03AB61;Drug;31:211:1
PA164784024;PEGINTERFERON ALFA-2B;L03AB10, L03AB60;Drug;41:289:1
PA166205561;PEGINTERFERON LAMBDA 1A;;Drug;0:0:0
PA166360201;PEGLOXENATIDE;;Drug;0:0:0
PA164749630;PEGVISOMANT;H01AX01;Drug;0:0:0
PA134687926;PELITINIB;;Drug;0:0:0
PA164781018;PEMIROLAST;;Drug;0:0:0
PA450836;PEMOLINE;N06BA05;Drug;0:0:0
PA164749474;PENBUTOLOL;C07AA23;Drug;0:1:0
PA450839;PENCICLOVIR;D06BB06, J05AB13;Drug;0:0:0
PA450840;PENICILLAMINE;M01CC01;Drug;0:0:0
PA164713152;PENICILLAMINE AND SIMILAR AGENTS;M01CC;Drug Class;0:0:0
PA164713153;PENICILLINS WITH EXTENDED SPECTRUM;J01CA;Drug Class;2:36:0
PA450849;PENTAGASTRIN;V04CG04;Drug;0:0:0
PA450850;PENTAMIDINE;;Drug;0:3:0
PA450851;PENTAMIDINE ISETHIONATE;;Drug;0:0:0
PA164744326;PENTAZOCINE;N02AD01;Drug;0:0:0
PA450859;PENTOBARBITAL;N05CA01;Drug;0:0:0
PA164777033;PENTOLINIUM;;Drug;0:0:0
PA164774806;PENTOSAN POLYSULFATE;;Drug;0:0:0
PA450863;PENTOSTATIN;L01XX08;Drug;0:0:0
PA450864;PENTOXIFYLLINE;C04AD03;Drug;0:0:0
PA450868;PEPSIN;;Drug;0:0:0
PA166230941;PERAMPANEL;;Drug;0:5:1
PA162565876;PERAZINE;;Drug;0:0:0
PA164713154;PERCHLORATES;H03BC;Drug Class;0:0:0
PA164781354;PERFLUTREN;;Drug;0:0:0
PA450873;PERGOLIDE;N04BC02;Drug;0:0:0
PA130150436;PERHEXILINE;C08EX02;Drug;0:0:0
PA165291471;PERIFOSINE;;Drug;0:0:0
PA164713157;PERIPHERALLY ACTING ANTIOBESITY PRODUCTS;A08AB;Drug Class;0:0:0
PA164713156;PERIPHERAL VASODILATORS;C04, C04A;Drug Class;0:8:0
PA164713158;PERITONEAL DIALYTICS;B05D;Drug Class;0:0:0
PA164743137;PERMETHRIN;P03AC04;Drug;0:0:0
PA165291546;PEROSPIRONE;;Drug;0:0:0
PA164713159;PEROXIDES;D10AE;Drug Class;0:0:0
PA128406983;PESTICIDES;;Drug Class;0:0:0
PA166321741;PEXIDARTINIB;L01EX15;Drug;0:0:0
PA152241908;PHA-665752;;Drug;0:0:0
PA164745309;PHENACEMIDE;N03AX07;Drug;0:0:0
PA450897;PHENACETIN;N02BE03;Drug;0:0:0
PA128406980;PHENCYCLIDINE;;Drug;0:0:0
PA450902;PHENDIMETRAZINE;;Drug;0:0:0
PA450903;PHENELZINE;N06AF03;Drug;0:0:0
PA1000;PHENFORMIN;A10BA01;Drug;0:0:0
PA164750491;PHENINDAMINE;R06AX04;Drug;0:0:0
PA164784031;PHENINDIONE;B01AA02;Drug;0:0:0
PA164744506;PHENIRAMINE;D04AA16, R06AB05;Drug;0:0:0
PA164747188;PHENMETRAZINE;;Drug;0:0:0
PA450913;PHENOL;C05BB05, D08AE03, N01BX03, R02AA19;Drug;0:0:0
PA164713161;PHENOL AND DERIVATIVES;D08AE;Drug Class;0:0:0
PA450918;PHENOLSULFONPHTHALEIN;;Drug;0:0:0
PA164713162;PHENOTHIAZINE DERIVATIVES;R06AD;Drug Class;0:1:0
PA10478;PHENOTHIAZINES WITH ALIPHATIC SIDE-CHAIN;N05AA, N05AB, N05AC;Drug Class;12:42:0
PA450919;PHENOXYBENZAMINE;C04AX02;Drug;0:4:0
PA450921;PHENPROCOUMON;B01AA04;Drug;12:81:1
PA164771230;PHENSUXIMIDE;N03AD02;Drug;0:0:0
PA164748099;PHENTERMINE;A08AA01;Drug;0:0:0
PA450926;PHENTOLAMINE;C04AB01, V03AB36;Drug;0:0:0
PA165950342;PHENYLACETIC ACID;;Drug;0:0:0
PA164713163;PHENYLALKYLAMINE DERIVATIVES;C08DA, C08EA;Drug Class;13:36:0
PA450932;PHENYLBUTAZONE;M01AA01, M02AA01;Drug;0:1:0
PA164713165;PHENYLPIPERIDINE DERIVATIVES;N02AB;Drug Class;49:245:0
PA164748965;PHENYLPROPANOLAMINE;R01BA01;Drug;0:0:0
PA450947;PHENYTOIN;N03AB02;Drug;36:302:2
PA10479;PHOSPHATES;;Drug;0:0:0
PA166305941;PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITORS;L01EM;Drug Class;0:0:0
PA164768860;PHOSPHATIDYLSERINE;;Drug;0:0:0
PA164713166;PHOSPHODIESTERASE INHIBITORS;C01CE;Drug Class;0:0:0
PA164713167;PHOSPHONIC ACID DERIVATIVES;J05AD;Drug Class;0:0:0
PA450953;PHOSPHORIC ACID;;Drug;0:0:0
PA450954;PHOSPHORUS;;Drug;0:0:0
PA450957;PHYSOSTIGMINE;S01EB05, V03AB19;Drug;0:0:0
PA166337161;PIBRENTASVIR;;Drug;0:0:0
PA164777007;PICROTOXIN;;Drug;0:0:0
PA450962;PILOCARPINE;N07AX01, S01EB01;Drug;0:1:0
PA166186035;PILSICAINIDE;;Drug;0:1:0
PA164783790;PIMECROLIMUS;D11AH02;Drug;0:0:0
PA450966;PINDOLOL;C07AA03;Drug;0:2:1
PA165958415;PIPAZETHATE;R05DB11;Drug;0:0:0
PA164764567;PIPECURONIUM;;Drug;0:0:0
PA450975;PIPERACILLIN;J01CA12;Drug;0:0:0
PA166228323;PIPERACILLIN-TAZOBACTAM;;Drug;0:0:0
PA166104279;PIPERAQUINE;;Drug;0:0:0
PA450977;PIPERAZINE;P02CB01;Drug;0:0:0
PA164713168;PIPERAZINE AND DERIVATIVES;P02CB;Drug Class;0:0:0
PA164713169;PIPERAZINE DERIVATIVES;R06AE;Drug Class;0:0:0
PA164713170;PIPERIDINEDIONE DERIVATIVES;N05CE;Drug Class;0:0:0
PA450980;PIPERONYL BUTOXIDE;;Drug;0:0:0
PA164747673;PIPOBROMAN;L01AX02;Drug;0:0:0
PA10158;PIPOTIAZINE;N05AC04;Drug;0:0:0
PA450983;PIRBUTEROL;R03AC08, R03CC07;Drug;0:0:0
PA10159;PIRENZEPINE;A02BX03;Drug;0:0:0
PA166249581;PIRFENIDONE;L04AX05;Drug;0:1:1
PA166212681;PIRITRAMIDE;N02AC03;Drug;0:6:0
PA450985;PIROXICAM;M01AC01, M02AA07, S01BC06;Drug;1:12:1
PA166328845;PIRTOBRUTINIB;L01EL05;Drug;0:0:0
PA142650384;PITAVASTATIN;C10AA08;Drug;4:25:1
PA166185163;PITOLISANT;N07XX11;Drug;0:0:0
PA164713171;PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01;Drug Class;4:4:0
PA164776912;PIVAMPICILLIN;J01CA02;Drug;0:0:0
PA164750167;PIVMECILLINAM;J01CA08;Drug;0:0:0
PA164713172;PLAGUE VACCINES;J07AK;Drug Class;0:0:0
PA164713173;PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS;L01C;Drug Class;171:677:0
PA164713174;PLASTERS;V07AA;Drug Class;0:0:0
PA164713175;PLATELET AGGREGATION INHIBITORS EXCL. HEPARIN;B01AC;Drug Class;151:1372:0
PA166228921;PLAZOMICIN;J01GB14;Drug;0:0:1
PA165958410;PLERIXAFOR;L03AX16;Drug;0:0:0
PA165958411;PLICAMYCIN;L01DC02;Drug;0:0:0
PA164713177;PNEUMOCOCCAL VACCINES;J07AL;Drug Class;0:0:0
PA450993;PODOFILOX;D06BB04;Drug;0:0:0
PA452642;PODOPHYLLOTOXIN DERIVATIVES;L01CB;Drug Class;16:34:0
PA10162;PODOPHYLLUM;;Drug;0:0:0
PA166313341;POLATUZUMAB VEDOTIN;L01FX14;Drug;0:0:0
PA450999;POLIOMYELITIS VACCINES;J07BF;Drug Class;0:0:0
PA451013;POLYETHYLENE GLYCOL;;Drug;0:0:0
PA451018;POLYETHYLENE GLYCOL 400;;Drug;0:0:0
PA451020;POLYETHYLENE GLYCOL 6000;;Drug;0:0:0
PA451023;POLYETHYLENE GLYCOL 8000;;Drug;0:0:0
PA451027;POLYMYXIN B SULFATE;A07AA05, J01XB02, S01AA18, S02AA11, S03AA03;Drug;0:0:0
PA164713178;POLYMYXINS;J01XB;Drug Class;0:0:0
PA451038;POLYSORBATE 80;;Drug;0:0:0
PA164749386;POLYSTYRENE SULFONATE;V03AE01;Drug;0:0:0
PA164748763;POLYTHIAZIDE;C03AA05;Drug;0:0:0
PA166411121;PONESIMOD;L04AE04;Drug;0:0:0
PA164752658;PORFIMER;;Drug;0:0:0
PA151958574;POSACONAZOLE;J02AC04;Drug;0:1:0
PA164713179;POSTERIOR PITUITARY LOBE HORMONES;H01B;Drug Class;0:0:0
PA451047;POTASSIUM;;Drug, Ion;0:0:0
PA451049;POTASSIUM ACETATE;;Drug;0:0:0
PA451055;POTASSIUM CHLORIDE;A12BA01, B05XA01;Drug;0:0:0
PA451057;POTASSIUM GLUCONATE;;Drug;0:0:0
PA451060;POTASSIUM IODIDE;R05CA02, S01XA04, V03AB21;Drug;0:0:0
PA166190081;POTASSIUM OXONATE;;Drug;0:0:0
PA451071;POTASSIUM PHOSPHATE, INCL. COMB. WITH OTHER POTASSIUM SALTS;;Drug;0:0:0
PA164713182;POTASSIUM-SPARING AGENTS;C03D;Drug Class;9:18:0
PA166326001;POZIOTINIB;;Drug;0:0:0
PA152241909;PP2;;Drug;0:0:0
PA164752820;PRACTOLOL;C07AB01;Drug;0:0:0
PA164744926;PRALIDOXIME;V03AB04;Drug;0:0:0
PA164781394;PRAMLINTIDE;A10BX05;Drug;0:0:0
PA134698661;PRANLUKAST;R03DC02;Drug;0:0:1
PA451089;PRAVASTATIN;C10AA03;Drug;36:177:2
PA164776668;PRAZEPAM;N05BA11;Drug;0:0:0
PA164764583;PRAZIQUANTEL;P02BA01;Drug;0:2:0
PA451093;PRAZOSIN;C02CA01;Drug;0:3:0
PA164749394;PREDNICARBATE;D07AC18;Drug;0:0:0
PA164713183;PREGNADIEN DERIVATIVES;G03DB;Drug Class;0:0:0
PA164713184;PREGNEN (4) DERIVATIVES;G03DA;Drug Class;1:3:0
PA166334121;PREGNENOLONE;;Drug, Biological Intermediate;0:0:0
PA165817938;PRENYLAMINE;C01DX02;Drug;0:0:0
PA165958355;PREOTACT;;Drug;0:0:0
PA164713186;PREPARATIONS CONTAINING SULFUR;D10AB;Drug Class;0:0:0
PA164713187;PREPARATIONS FOR BILIARY TRACT THERAPY;A05AB;Drug Class;0:0:0
PA164713185;PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03;Drug Class;0:0:0
PA164713188;PREPARATIONS INCREASING URIC ACID EXCRETION;M04AB;Drug Class;2:6:0
PA164713189;PREPARATIONS INHIBITING URIC ACID PRODUCTION;M04AA;Drug Class;45:207:0
PA164713190;PREPARATIONS WITH NO EFFECT ON URIC ACID METABOLISM;M04AC;Drug Class;0:2:0
PA164713191;PREPARATIONS WITH SALICYLIC ACID DERIVATIVES;M02AC;Drug Class;0:0:0
PA166115441;PRIDOPIDINE;;Drug;0:1:0
PA451101;PRILOCAINE;N01BB04;Drug;0:0:0
PA451105;PRIMIDONE;N03AA03;Drug;0:5:1
PA451106;PROBENECID;M04AB01;Drug;0:2:1
PA451107;PROBUCOL;C10AX02;Drug;0:0:0
PA451108;PROCAINAMIDE;C01BA02;Drug;0:2:0
PA451110;PROCAINE;C05AD05, N01BA02, S01HA05;Drug;0:0:0
PA451112;PROCARBAZINE;L01XB01;Drug;0:2:0
PA164748908;PROCATEROL;R03AC16, R03CC08;Drug;0:0:0
PA164784001;PROCYCLIDINE;N04AA04;Drug;0:0:0
PA164748742;PROFLAVINE;;Drug;0:0:0
PA164747990;PROGABIDE;N03AG05;Drug;0:0:0
PA164713192;PROGESTOGENS;G03AC, G03D, L02AB;Drug Class;1:10:0
PA164713195;PROGESTOGENS AND ESTROGENS, FIXED COMBINATIONS;G03FA;Drug Class;0:0:0
PA452359;PROGESTOGENS AND ESTROGENS IN COMBINATION;G03AA, G03AB, G03F;Drug Class;0:0:0
PA164713196;PROGESTOGENS AND ESTROGENS, SEQUENTIAL PREPARATIONS;G03FB;Drug Class;0:0:0
PA451124;PROGUANIL;P01BB01;Drug;0:9:0
PA164713197;PROLACTINE INHIBITORS;G02CB;Drug Class;0:0:0
PA166364761;PROLGOLIMAB;L01FF08;Drug;0:0:0
PA451126;PROMAZINE;N05AA03;Drug;0:0:0
PA451128;PROMETHAZINE;D04AA10, R06AD02;Drug;0:1:0
PA164746224;PROPANTHELINE;A03AB05;Drug;0:0:0
PA164776849;PROPARACAINE;S01HA04;Drug;0:0:0
PA164781043;PROPERICIAZINE;N05AC01;Drug;0:0:0
PA165107991;PROPICONAZOLE;;Drug;0:0:0
PA164778685;PROPIOMAZINE;N05CM06;Drug;0:0:0
PA451142;PROPOXYPHENE;N02AC04;Drug;0:0:0
PA164713199;PROPULSIVES;A03F, A03FA;Drug Class;2:14:0
PA165958387;PROPYLHEXEDRINE;;Drug;0:0:0
PA166220601;PROSCILLARIDIN;;Drug;0:0:0
PA164713200;PROSTAGLANDIN ANALOGUES;S01EE;Drug Class;4:8:0
PA449345;PROSTAGLANDIN E2;G02AD02;Drug, Biological Intermediate;0:0:0
PA449479;PROSTAGLANDIN I2;B01AC09;Drug, Biological Intermediate;0:0:0
PA452363;PROSTAGLANDINS;A02BB, C01EA, G02AD;Drug Class;0:2:0
PA10366;PROTAMINE;;Drug;0:0:0
PA164713201;PROTECTIVES AGAINST UV-RADIATION;D02B;Drug Class;0:0:0
PA164713202;PROTECTIVES AGAINST UV-RADIATION FOR SYSTEMIC USE;D02BB;Drug Class;0:0:0
PA164713203;PROTECTIVES AGAINST UV-RADIATION FOR TOPICAL USE;D02BA;Drug Class;0:0:0
PA164713205;PROTEINASE INHIBITORS;B02AB;Drug Class;0:0:0
PA164713204;PROTEIN KINASE INHIBITORS;L01E;Drug Class;59:418:0
PA451465;PROTEIN SUPPLEMENTS;V06B;Drug Class;0:0:0
PA164713206;PROTEOLYTIC ENZYMES;D03BA;Drug Class;0:0:0
PA164713207;PROTON PUMP INHIBITORS;A02BC;Drug Class;19:445:1
PA451168;PROTRIPTYLINE;N06AA11;Drug;0:0:0
PA451170;PSEUDOEPHEDRINE;R01BA02;Drug;0:0:0
PA166338881;PSILOCYBIN;;Prodrug;0:0:0
PA164713208;PSORALENS FOR SYSTEMIC USE;D05BA;Drug Class;1:2:0
PA164713209;PSORALENS FOR TOPICAL USE;D05AD;Drug Class;1:2:0
PA164713210;PSYCHOANALEPTICS;N06;Drug Class;522:2250:0
PA164713211;PSYCHOLEPTICS;N05;Drug Class;343:1411:0
PA164713212;PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION;N06C;Drug Class;15:71:0
PA164713214;PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS;N06B;Drug Class;91:406:0
PA164713213;PSYCHOSTIMULANTS IN COMBINATION WITH PSYCHOLEPTICS;N06CB;Drug Class;0:0:0
PA164713215;PURINE DERIVATIVES;C04AD;Drug Class;0:0:0
PA166318581;PYRANTEL;P02CC01;Drug;0:0:0
PA164713216;PYRAZOLONE DERIVATIVES;C03CD;Drug Class;0:0:0
PA164713218;PYRETHRINES;P03BA;Drug Class;0:0:0
PA164713219;PYRETHRINES, INCL. SYNTHETIC COMPOUNDS;P03AC;Drug Class;0:0:0
PA10481;PYRETHRINS AND PIPERONYL BUTOXIDE;;Drug;0:0:0
PA451185;PYRIDOSTIGMINE;N07AA02;Drug;0:0:0
PA164749166;PYRIDOXAL;;Drug;0:0:0
PA164749650;PYRIDOXAL PHOSPHATE;A11HA06;Drug;0:2:0
PA451897;PYRIDOXINE;;Drug;0:0:0
PA165817939;PYRILAMINE;;Drug;0:0:0
PA166248741;PYRIMETHAMINE / SULFADOXINE;;Drug;0:0:0
PA164713220;PYRIMIDINE ANALOGUES;L01BC;Drug Class;371:1896:1
PA164713221;PYRIMIDINE DERIVATIVES;C02DC;Drug Class;0:0:0
PA164778686;PYRUVIC ACID;;Drug;0:0:0
PA164713222;QUATERNARY AMMONIUM COMPOUNDS;D08AJ;Drug Class;0:0:0
PA164744373;QUAZEPAM;N05CD10;Drug;0:0:0
PA451201;QUETIAPINE;N05AH04;Drug;21:97:1
PA164745551;QUINACRINE;P01AX05;Drug;0:0:0
PA164749042;QUINESTROL;;Drug;0:0:0
PA164760863;QUINETHAZONE;C03BA02;Drug;0:0:0
PA164783957;QUINIDINE BARBITURATE;;Drug;0:0:0
PA451213;QUININE;P01BC01;Drug;0:1:0
PA164713223;QUININE AND DERIVATIVES;M09AA;Drug Class;0:0:0
PA164713224;QUINOLINE DERIVATIVES;D08AH, G01AC;Drug Class;0:0:0
PA164713226;QUINOLINE DERIVATIVES AND CORTICOSTEROIDS;G01BC;Drug Class;0:0:0
PA164713227;QUINOLINE DERIVATIVES AND RELATED SUBSTANCES;P02BA;Drug Class;0:1:0
PA164713228;QUINOLINES;M01CA;Drug Class;0:0:0
PA164713229;QUINOLONE ANTIBACTERIALS;J01M;Drug Class;1:21:0
PA164713230;QUINOLONE VASODILATORS;C01DB;Drug Class;0:0:0
PA164749647;QUINUPRISTIN;;Drug;0:0:0
PA451216;RABEPRAZOLE;A02BC04;Drug;3:86:1
PA10367;RABIES IMMUNOGLOBULIN;;Drug;0:0:0
PA451219;RABIES VACCINES;J07BG;Drug Class;0:0:0
PA164744896;RAMELTEON;N05CH02;Drug;0:0:0
PA166365201;RAMOSETRON;;Drug;0:0:0
PA451224;RANITIDINE;A02BA02;Drug;0:13:0
PA164746007;RANOLAZINE;C01EB18;Drug;0:0:0
PA164713231;RAUWOLFIA ALKALOIDS;C02AA;Drug Class;0:0:0
PA164713232;RAUWOLFIA ALKALOIDS AND DIURETICS IN COMBINATION;C02LA;Drug Class;0:0:0
PA166277861;RAVULIZUMAB;L04AA43;Drug;0:0:0
PA166220441;RAZUPROTAFIB;;Drug;0:0:0
PA166248841;(R)-CITALOPRAM;;Drug;0:0:0
PA144614921;REBOXETINE;N06AX18;Drug;0:0:0
PA164755085;REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;;Drug;0:0:0
PA166178280;REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;;Drug, Biological Intermediate;0:0:1
PA166277901;RELATLIMAB;;Drug;0:0:0
PA166397681;RELUGOLIX;L02BX04;Drug;0:0:0
PA166397682;RELUGOLIX / ESTRADIOL / NORETHINDRONE ACETATE;H01CC54;Drug;0:0:0
PA166197141;REMDESIVIR;J05AB16;Drug;0:0:1
PA164774779;REMIKIREN;C09XA01;Drug;0:0:0
PA166321761;REMIMAZOLAM;N05CD14;Drug;0:8:0
PA164749051;REMOXIPRIDE;N05AL04;Drug;0:0:0
PA164713233;RENAL SYSTEM;V09C;Drug Class;0:0:0
PA164713234;RENIN-INHIBITORS;C09XA;Drug Class;50:120:0
PA164768818;RESCINNAMINE;C02AA01;Drug;0:0:0
PA451236;RESERPINE;C02AA02;Drug;0:0:0
PA164713237;RESPIRATORY STIMULANTS;R07AB;Drug Class;0:0:0
PA164713235;RESPIRATORY SYSTEM;R, V09E;Drug Class;194:753:0
PA165291838;RESVERATROL;;Drug;0:0:0
PA164749341;RETAPAMULIN;D06AX13;Drug;0:0:0
PA166416261;RETATRUTIDE;;Drug;0:0:0
PA164743728;RETEPLASE;B01AD07;Drug;0:0:0
PA144997862;RETIGABINE;N03AX21;Drug;0:0:0
PA166177686;RETINAL;;Drug;0:0:0
PA164713238;RETINOIDS FOR TOPICAL USE IN ACNE;D10AD;Drug Class;0:0:0
PA164713239;RETINOIDS FOR TREATMENT OF ACNE;D10BA;Drug Class;0:0:0
PA164713240;RETINOIDS FOR TREATMENT OF PSORIASIS;D05BB;Drug Class;0:2:0
PA166301721;REZIVERTINIB;;Drug;0:0:0
PA451241;RIBAVIRIN;J05AB04;Drug;46:346:1
PA451242;RIBOFLAVIN;;Drug;0:0:1
PA166292902;RIBOSTAMYCIN;J01GB10;Drug;0:0:0
PA165291475;RIDAFOROLIMUS;L01EG03;Drug;0:0:0
PA164746413;RIDOGREL;;Drug;0:0:0
PA451249;RIFABUTIN;J04AB04;Drug;0:0:0
PA164783809;RIFAPENTINE;J04AB05;Drug;0:2:0
PA164752443;RIFAXIMIN;A07AA11, D06AX11;Drug;0:0:0
PA166256441;RILONACEPT;;Drug;0:1:0
PA451251;RILUZOLE;N07XX02;Drug;0:0:0
PA166335641;RILZABRUTINIB;;Drug;0:0:0
PA164748038;RIMANTADINE;J05AC02;Drug;0:0:0
PA164752251;RIMEXOLONE;H02AB12, S01BA13;Drug;0:0:0
PA152407999;RIMONABANT;A08AX01;Drug;0:0:0
PA166203981;RINTATOLIMOD;;Drug;0:0:0
PA166182682;RIOCIGUAT;;Drug;0:0:0
PA166270781;RIPRETINIB;;Drug;0:0:0
PA166363161;RISANKIZUMAB;L04AC18;Drug;0:0:0
PA166321401;RITLECITINIB;;Drug;0:0:0
PA165948052;ROFLUMILAST;;Drug;0:1:0
PA166396903;ROLAPITANT;A04AD14;Drug;0:0:0
PA153906323;ROLIPRAM;;Drug;0:0:0
PA164779049;ROLITETRACYCLINE;J01AA09;Drug;0:0:0
PA166161306;ROMIDEPSIN;;Drug;0:0:0
PA166301801;ROMOSOZUMAB;;Drug;0:0:0
PA164749035;ROPINIROLE;N04BC04;Drug;0:0:0
PA451271;ROPIVACAINE;N01BB09;Drug;0:0:0
PA164776843;ROSOXACIN;J01MB01;Drug;0:0:0
PA166129554;ROSTAFUROXIN;;Drug;0:0:0
PA134308647;ROSUVASTATIN;C10AA07;Drug;24:158:1
PA164713241;ROTA VIRUS DIARRHEA VACCINES;J07BH;Drug Class;0:0:0
PA166129566;ROTIGAPTIDE;;Drug;0:0:0
PA166165149;ROTIGOTINE;;Drug;0:0:0
PA165958352;ROTIGOTINE TRANSDERMAL PATCH;N04BC09;Drug;0:0:0
PA165958424;ROXATIDINE ACETATE;A02BA06;Drug;0:0:0
PA164750505;ROXITHROMYCIN;J01FA06;Drug;0:0:0
PA166313325;ROZANOLIXIZUMAB;;Drug;0:0:0
PA164713242;RUBELLA VACCINES;J07BJ;Drug Class;0:2:0
PA166131606;RUFINAMIDE;;Drug;0:0:0
PA165107052;RUPATADINE;;Drug;0:0:0
PA166340101;RUSFERTIDE;;Drug;0:0:0
PA166123386;RUXOLITINIB;L01EJ01;Drug;0:0:0
PA166176123;RYANODINE;;Drug;0:1:0
PA166398001;SACITUZUMAB TIRUMOTECAN;;Drug;0:0:0
PA164754994;S-ADENOSYLMETHIONINE;;Drug, Biological Intermediate;0:0:4
PA450300;SALICYLATE-MAGNESIUM;;Drug;0:0:0
PA451428;SALICYLATE-SODIUM;;Drug;0:0:0
PA451299;SALICYLIC ACID;D01AE12, S01BC08;Drug;0:0:1
PA164713243;SALICYLIC ACID AND DERIVATIVES;N02BA;Drug Class;77:294:0
PA164713244;SALICYLIC ACID DERIVATIVES;P02DA;Drug Class;0:0:0
PA164713245;SALICYLIC ACID PREPARATIONS;D02AF;Drug Class;0:0:0
PA448715;SALMON CALCITONIN;H05BA01;Drug;0:0:0
PA164745462;SALSALATE;N02BA06;Drug;0:0:0
PA164713246;SALT SOLUTIONS;B05CB;Drug Class;0:0:0
PA166415161;SAPITINIB;;Drug;0:0:0
PA164746338;SAPRISARTAN;;Drug;0:0:0
PA451305;SAQUINAVIR;J05AE01;Drug;0:2:0
PA166182626;SAQUINAVIR / RITONAVIR;;Drug;0:0:0
PA165958501;SARACATINIB;;Drug;0:0:0
PA164748631;SARGRAMOSTIM;L03AA09;Drug;0:0:0
PA166197221;SARILUMAB;L04AC14;Drug;0:8:0
PA166235323;SATRALIZUMAB;L04AC19;Drug;0:0:0
PA164745371;SATUMOMAB PENDETIDE;V09IB02;Drug;0:0:0
PA166306941;SAVOLITINIB;;Drug;0:0:0
PA165958362;SAXAGLIPTIN;A10BH03;Drug;0:2:0
PA166049195;SC-560;;Drug;0:0:0
PA166289002;SCHISANDRIN;;Drug;0:0:0
PA166289003;SCHISANDROL B;;Drug;0:0:0
PA166289021;SCHISANHENOL;;Drug;0:0:0
PA166289001;SCHISANTHERIN A;;Drug;0:0:0
PA164713247;SCILLA GLYCOSIDES;C01AB;Drug Class;0:0:0
PA164713248;SCLEROSING AGENTS FOR LOCAL INJECTION;C05BB;Drug Class;0:0:0
PA451308;SCOPOLAMINE;A04AD01, N05CM05, S01FA02;Drug;0:0:0
PA166170903;SCUTELLARIN;;Drug;0:0:0
PA164784035;SECOBARBITAL;N05CA06;Drug;0:0:0
PA164713250;SECONDARY AND TERTIARY AMINES;C02BB;Drug Class;0:0:0
PA164713249;SECOND-GENERATION CEPHALOSPORINS;J01DC;Drug Class;0:0:0
PA164760844;SECRETIN;V04CK01;Drug;0:0:0
PA166300301;SECUKINUMAB;L04AC10;Drug;0:0:0
PA166400041;SELADELPAR;A05AX07;Drug;0:0:0
PA164713251;SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS;C08D;Drug Class;14:48:0
PA164713252;SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08C;Drug Class;19:75:0
PA164713254;SELECTIVE ESTROGEN RECEPTOR MODULATORS;G03XC;Drug Class;6:18:0
PA164713255;SELECTIVE IMMUNOSUPPRESSANTS;L04AA;Drug Class;20:75:0
PA164713256;SELECTIVE SEROTONIN (5HT1) AGONISTS;N02CC;Drug Class;9:76:0
PA451319;SELENIUM;A12CE;Drug Class;0:0:0
PA164771240;SELENIUM SULFIDE;D01AE13;Drug;0:0:0
PA10489;SELENIUM SUPPLEMENTS;;Drug;0:0:0
PA166281602;SELEXIPAG;;Drug;0:2:0
PA166129529;SELUMETINIB;L01EE04;Drug;0:12:0
PA166305021;SEMAGLUTIDE;A10BJ06;Drug;0:4:1
PA133888890;SEMATILIDE;;Drug;0:0:0
PA131887911;SEMAXANIB;;Drug;0:0:0
PA151958365;SEMUSTINE;L01AD03;Drug;0:0:0
PA164713258;SENSITIVITY TESTS, DISCS AND TABLETS;V07AR;Drug Class;0:0:0
PA164713259;SENSITIZERS USED IN PHOTODYNAMIC/RADIATION THERAPY;L01XD;Drug Class;0:0:0
PA164713260;SENSORY ORGANS;S;Drug Class;131:635:0
PA166104277;SERGLIFLOZIN;;Drug;0:0:0
PA164749110;SERMORELIN;H01AC04, V04CD03;Drug;0:0:0
PA164713261;SEROTONIN (5HT3) ANTAGONISTS;A04AA;Drug Class;17:66:0
PA164713262;SEROTONIN ANTAGONISTS;C02KD;Drug Class;0:0:0
PA164713263;SEROTONIN ANTAGONISTS AND DIURETICS;C02LN;Drug Class;0:0:0
PA164748328;SERTACONAZOLE;D01AC14, G01AF19;Drug;0:0:0
PA164784002;SERTINDOLE;N05AE03;Drug;0:0:0
PA451333;SERTRALINE;N06AB06;Drug;22:136:2
PA164781197;SEVELAMER;V03AE02;Drug;0:0:0
PA451341;SEVOFLURANE;N01AB08;Drug;60:48:1
PA164713264;SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03;Drug Class;15:75:0
PA164713265;SHORT-ACTING SULFONAMIDES;J01EB;Drug Class;0:30:0
PA451355;SILICONE PRODUCTS;D02AA;Drug Class;0:0:0
PA165291889;SILODOSIN;G04CA04;Drug;0:0:0
PA166198582;SILTUXIMAB;;Drug;0:0:0
PA164713266;SILVER COMPOUNDS;D08AL;Drug Class;0:0:0
PA451357;SILVER NITRATE;;Drug;0:0:0
PA164744951;SILVER SULFADIAZINE;D06BA01;Drug;0:0:0
PA166327061;SILYMARIN;A05BA03;Drug;0:0:0
PA451363;SIMVASTATIN;C10AA01;Drug;55:209:1
PA166248861;SIMVASTATIN / SITAGLIPTIN;A10BH51;Drug;0:0:0
PA166316261;SINTILIMAB;;Drug;0:0:0
PA166203961;SIRUKUMAB;L04AC15;Drug;0:0:0
PA166115581;SITAMAQUINE;;Drug;0:1:0
PA165958361;SITAXENTAN;C02KX03;Drug;0:0:0
PA162168179;SJG-136;;Drug;0:0:0
PA164713267;SKELETON;V09B;Drug Class;0:0:0
PA166178554;(S)-METHADONE;;Drug;0:11:1
PA166363761;SOCAZOLIMAB;;Drug;0:0:0
PA451369;SODIUM ACETATE;;Drug;0:0:0
PA166163262;SODIUM ASCORBATE;;Drug;0:0:0
PA451374;SODIUM BENZOATE;A16AX11;Drug;0:0:0
PA166176020;SODIUM BENZOATE / SODIUM PHENYLACETATE;A16AX30;Drug;0:0:0
PA451375;SODIUM BICARBONATE;B05CB04, B05XA02;Drug;0:0:0
PA451377;SODIUM BISULFITE;;Drug;0:0:0
PA451379;SODIUM CARBONATE;;Drug;0:0:0
PA451382;SODIUM CHLORIDE;;Drug;0:0:0
PA451384;SODIUM CITRATE;;Drug;0:0:0
PA166184492;SODIUM FERULATE;;Drug;0:0:0
PA451388;SODIUM FLUORIDE;;Drug, Small Molecule;0:0:0
PA451398;SODIUM LAURYL SULFATE;;Drug;0:0:0
PA166279461;SODIUM NITRATE;;Drug;0:0:0
PA166115361;SODIUM NITRITE;V03AB08;Drug;0:0:0
PA166236501;SODIUM OXYBATE;N01AX11;Drug;0:0:0
PA166114316;SODIUM PHENYLBUTYRATE;A16AX03;Drug;0:0:0
PA451414;SODIUM PHOSPHATE;;Drug;0:0:0
PA451429;SODIUM SELENITE;;Drug;0:0:0
PA164743129;SODIUM STIBOGLUCONATE;P01CB02;Drug;0:0:0
PA451434;SODIUM SUCCINATE;;Drug;0:0:0
PA451435;SODIUM SULFATE;;Drug;0:0:0
PA164746759;SODIUM TETRADECYL SULFATE;C05BB04;Drug;0:0:0
PA166182732;SODIUM VALPROATE;;Drug;0:0:0
PA166163416;SOFOSBUVIR / VELPATASVIR;J05AP55;Drug;0:0:0
PA166177517;SOFOSBUVIR / VELPATASVIR / VOXILAPREVIR;J05AP56;Drug;0:0:0
PA450787;SOFT PARAFFIN DRESSINGS;A06AA, D02AC, D09AX;Drug Class;0:0:0
PA166289881;SOLANIDINE;;Drug;0:2:0
PA164783810;SOLIFENACIN;G04BD08;Drug;0:0:0
PA166165147;SOLITHROMYCIN;;Drug;0:1:0
PA164713268;SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE;B05BB;Drug Class;0:0:0
PA164713269;SOLUTIONS FOR PARENTERAL NUTRITION;B05BA;Drug Class;0:0:0
PA164713270;SOLUTIONS PRODUCING OSMOTIC DIURESIS;B05BC;Drug Class;0:0:0
PA164713271;SOLVENTS AND DILUTING AGENTS, INCL. IRRIGATING SOLUTIONS;V07AB;Drug Class;0:0:0
PA166178990;SOMATOSTATIN;;Drug, Biological Intermediate;0:0:0
PA164713272;SOMATROPIN AND SOMATROPIN AGONISTS;H01AC;Drug Class;3:3:0
PA166331541;SORIVUDINE;;Drug;0:0:0
PA166255841;SOTROVIMAB;J06BD05;Drug;0:0:0
PA451472;SPARFLOXACIN;J01MA09;Drug;0:0:0
PA164713273;SPECIFIC ANTIRHEUMATIC AGENTS;M01C;Drug Class;0:0:0
PA164713274;SPECIFIC IMMUNOGLOBULINS;J06BB;Drug Class;0:0:0
PA164781342;SPECTINOMYCIN;J01XX04;Drug;0:0:0
PA164781199;SPERMINE;;Drug;0:0:0
PA164776913;SPIRAPRIL;C09AA11;Drug;0:0:0
PA152408000;SR144528;;Drug;0:0:0
PA165958391;STANOZOLOL;A14AA02;Drug;0:0:0
PA451492;STARCH;;Drug;0:0:0
PA165109623;STAUROSPORINE;;Drug;0:0:0
PA164748630;STEPRONIN;R05CB11;Drug;0:0:0
PA164713275;STEROID ANTIBACTERIALS;J01XC;Drug Class;0:0:0
PA166175778;STIRIPENTOL;;Drug;0:0:0
PA164924486;ST. JOHN'S WORT;;Drug;0:0:0
PA164713276;STOMATOLOGICAL PREPARATIONS;A01, A01A;Drug Class;97:359:0
PA164713278;STOMI EQUIPMENT;V07AS;Drug Class;0:0:0
PA164713279;STREPTOGRAMINS;J01FG;Drug Class;0:0:0
PA164754919;STREPTOKINASE;B01AD01;Drug;0:0:0
PA451512;STREPTOMYCIN;A07AA04, J01GA01;Drug;8:66:1
PA164713280;STREPTOMYCINS;J01GA;Drug Class;8:66:0
PA451514;STREPTOZOCIN;L01AD04;Drug;0:0:0
PA166302961;STRONTIUM RANELATE;;Drug;0:0:0
PA164713281;STROPHANTUS GLYCOSIDES;C01AC;Drug Class;0:0:0
PA164713282;SUBSTITUTED ALKYLAMINES;R06AB;Drug Class;0:0:0
PA164713283;SUBSTITUTED ETHYLENE DIAMINES;R06AC;Drug Class;0:0:0
PA451521;SUCCIMER;;Drug;0:0:0
PA164713284;SUCCINIMIDE DERIVATIVES;N03AD;Drug Class;1:3:0
PA451522;SUCCINYLCHOLINE;M03AB01;Drug;59:88:1
PA451524;SUCRALFATE;A02BX02;Drug;0:0:0
PA451525;SUCROSE;;Drug, Biological Intermediate;0:0:0
PA451529;SUGAR;;Drug;0:0:0
PA451536;SULFACETAMIDE;D10AF06, S01AB04;Drug;0:0:0
PA164754808;SULFACYTINE;;Drug;0:0:0
PA451539;SULFADIAZINE;J01EC02;Drug;0:0:0
PA165958357;SULFADIMETHOXINE;J01ED01;Drug;0:0:0
PA164776842;SULFAMERAZINE;D06BA06, J01ED07;Drug;0:0:0
PA451542;SULFAMETHAZINE;J01EB03;Drug;0:18:0
PA164781307;SULFAMETHIZOLE;B05CA04, D06BA04, J01EB02, S01AB01;Drug;0:0:0
PA10715;SULFAMETHOXAZOLE / TRIMETHOPRIM;J01EE01;Drug;9:53:0
PA165958417;SULFAMOXOLE;J01EC03;Drug;0:0:0
PA451545;SULFANILAMIDE;D06BA05, J01EB06;Drug;0:2:0
PA130231310;SULFAPHENAZOLE;J01ED08;Drug;0:0:0
PA164779050;SULFAPYRIDINE;J01EB04;Drug, Metabolite;0:10:1
PA165958356;SULFATHIAZOLE;D06BA02, J01EB07;Drug;0:0:0
PA164748964;SULFISOXAZOLE;J01EB05, S01AB02;Drug;0:0:0
PA166279942;SULFOCIPROFLOXACIN;;Drug, Metabolite;0:0:0
PA164713290;SULFONAMIDES AND CORTICOSTEROIDS;G01BE;Drug Class;0:0:0
PA164713291;SULFONAMIDES AND POTASSIUM IN COMBINATION;C03BB, C03CB;Drug Class;0:0:0
PA164713289;SULFONAMIDES AND TRIMETHOPRIM;J01E;Drug Class;12:106:0
PA164713293;SULFONAMIDES, COMBINATIONS WITH OTHER DRUGS;C03BK;Drug Class;0:0:0
PA164713288;SULFONAMIDES (HETEROCYCLIC);A10BC;Drug Class;0:0:0
PA10741;SULFONAMIDES, PLAIN;C03BA, C03CA;Drug Class;24:49:1
PA164713295;SULFONIUM DERIVATIVES;C02BA;Drug Class;0:0:0
PA164776911;SULFOXONE;;Drug;0:0:0
PA451558;SULFUR;;Drug;0:0:0
PA164713297;SULFUR-CONTAINING IMIDAZOLE DERIVATIVES;H03BB;Drug Class;2:8:0
PA164713296;SULFUR CONTAINING PRODUCTS;P03AA;Drug Class;5:13:0
PA164746343;SULODEXIDE;B01AB11;Drug;0:0:0
PA164745485;SULPIRIDE;N05AL01;Drug;0:0:0
PA166175792;SULTHIAME;;Drug;0:0:0
PA166330981;SUNOBINOP;;Drug;0:0:0
PA166361121;SUNVOZERTINIB;;Drug;0:0:0
PA164713298;SUPERPARAMAGNETIC CONTRAST MEDIA;V08CB;Drug Class;0:0:0
PA451569;SUPROFEN;M01AE07;Drug;0:0:0
PA10292;SURAMIN;;Drug;0:0:0
PA166399561;SURAXAVIR MARBOXIL;;Prodrug;0:0:0
PA164713299;SURGICAL AIDS;S01K;Drug Class;0:0:0
PA164713300;SURGICAL DRESSINGS;V20;Drug Class;0:0:0
PA166049191;SUXIBUZONE;;Drug;0:0:0
PA166364461;SUZETRIGINE;;Drug;0:0:0
PA164713305;SYMPATHOMIMETICS, COMBINATIONS EXCL. CORTICOSTEROIDS;R01AB;Drug Class;2:11:0
PA164713302;SYMPATHOMIMETICS EXCL. ANTIGLAUCOMA PREPARATIONS;S01FB;Drug Class;2:11:0
PA164713303;SYMPATHOMIMETICS IN GLAUCOMA THERAPY;S01EA;Drug Class;2:6:0
PA164713306;SYMPATHOMIMETICS, LABOUR REPRESSANTS;G02CA;Drug Class;1:18:0
PA164713307;SYMPATHOMIMETICS, PLAIN;R01AA;Drug Class;2:11:0
PA164713304;SYMPATHOMIMETICS USED AS DECONGESTANTS;S01GA;Drug Class;1:6:0
PA164713308;SYNTHETIC ANTICHOLINERGIC AGENTS IN COMBINATION WITH ANALGESICS;A03DA;Drug Class;0:0:0
PA164713309;SYNTHETIC ANTICHOLINERGIC AGENTS IN COMBINATION WITH PSYCHOLEPTICS;A03CA;Drug Class;0:0:0
PA164713310;SYNTHETIC ANTICHOLINERGICS, ESTERS WITH TERTIARY AMINO GROUP;A03AA;Drug Class;0:0:0
PA164713311;SYNTHETIC ANTICHOLINERGICS, QUATERNARY AMMONIUM COMPOUNDS;A03AB;Drug Class;0:0:0
PA164713312;SYNTHETIC ANTISPASMODICS, AMIDES WITH TERTIARY AMINES;A03AC;Drug Class;0:0:0
PA166238763;SYNTHETIC CONJUGATED ESTROGENS, A;;Drug;0:0:0
PA164713313;SYNTHETIC ESTROGENS, PLAIN;G03CB;Drug Class;0:0:0
PA164713314;SYSTEMIC HORMONAL PREPARATIONS, EXCL.;H;Drug Class;42:170:0
PA166182866;TAC;;Drug;0:0:0
PA451576;TACRINE;N06DA01;Drug;0:0:0
PA451578;TACROLIMUS;D11AH01, L04AD02;Drug;82:1108:2
PA10333;TADALAFIL;G04BE08;Drug;0:0:0
PA166184562;TAFAMIDIS;N07XX08;Drug;0:0:0
PA166334923;TAFASITAMAB;L01FX12;Drug;0:0:0
PA165958432;TAFLUPROST;S01EE05;Drug;0:0:0
PA164779051;TALBUTAL;N05CA07;Drug;0:0:0
PA165109542;TALOTREXIN;;Drug;0:0:0
PA164743464;TAMIBAROTENE;;Drug;0:0:0
PA451583;TAMSULOSIN;G04CA02;Drug;0:9:1
PA165291490;TANESPIMYCIN;;Drug;0:0:0
PA451585;TANNIC ACID;;Drug;0:0:0
PA165282096;TARIQUIDAR;;Drug;0:0:0
PA164713315;TARS;D05AA;Drug Class;0:0:0
PA166163227;TASELISIB;;Drug;0:0:0
PA164769057;TASOSARTAN;C09CA05;Drug;0:0:0
PA451590;TAURINE;;Drug;0:0:0
PA164746821;TAZAROTENE;D05AX05;Drug;0:0:0
PA164764504;TAZOBACTAM;J01CG02;Drug;0:0:0
PA164713316;TECHNETIUM (99MTC) COMPOUNDS;V09AA, V09BA, V09CA, V09DA, V09GA, V09HA, V09IA;Drug Class;0:0:0
PA164713323;TECHNETIUM (99MTC), INHALANTS;V09EA;Drug Class;0:0:0
PA10196;TECHNETIUM (99MTC) MERTIATIDE;;Drug;0:0:0
PA164713324;TECHNETIUM (99MTC), PARTICLES AND COLLOIDS;V09DB;Drug Class;0:0:0
PA164713325;TECHNETIUM (99MTC), PARTICLES FOR INJECTION;V09EB;Drug Class;0:0:0
PA10335;TECHNETIUM (99MTC) SULFUR COLLOID;;Drug;0:0:0
PA164713326;TECHNICAL DISINFECTANTS;V07AV;Drug Class;0:0:0
PA166295601;TECLISTAMAB;;Drug;0:0:0
PA452620;TEGAFUR;L01BC03, L01BC53;Prodrug;10:42:2
PA130413154;TEGASEROD;A06AX06;Drug;0:0:0
PA166413021;TEGILERIDINE;;Drug;0:0:0
PA166365823;TEGOPRAZAN;A02BC09;Drug;0:0:0
PA164746244;TEICOPLANIN;J01XA02;Drug;0:0:0
PA165958354;TELAPREVIR;J05AE11;Drug;3:34:0
PA165980595;TELATINIB;;Drug;0:0:0
PA164760861;TELBIVUDINE;J05AF11;Prodrug;0:3:1
PA166321022;TELCAGEPANT;;Drug;0:0:1
PA10202;TELITHROMYCIN;J01FA15;Drug;0:0:0
PA451608;TEMAZEPAM;N05CD07;Drug, Metabolite;0:0:1
PA164776757;TENECTEPLASE;B01AD11;Drug;0:0:0
PA166249401;TENELIGLIPTIN;;Drug;0:4:0
PA451611;TENIPOSIDE;L01CB02;Drug;0:1:0
PA166258723;TENOFOVIR ALAFENAMIDE;;Prodrug;0:1:0
PA131890625;TENOXICAM;M01AC02;Drug;1:3:0
PA451612;TERAZOSIN;G04CA03;Drug;0:0:0
PA451614;TERBINAFINE;D01AE15, D01BA02;Drug;0:2:0
PA164768834;TERCONAZOLE;G01AG02;Drug;0:0:0
PA451619;TERFENADINE;R06AX12;Drug;0:3:0
PA166256301;TERIFLUNOMIDE;;Drug, Metabolite;0:0:0
PA451620;TERIPARATIDE;H05AA02;Drug;0:0:0
PA164781020;TERLIPRESSIN;H01BA04;Drug;0:0:0
PA165817950;TERODILINE;;Drug;0:0:0
PA164713327;TERTIARY AMINES;N04AA;Drug Class;0:1:0
PA165980596;TERUTROBAN;;Drug;0:0:0
PA164743056;TESTOLACTONE;;Drug;0:0:0
PA164713328;TESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS;G04CB;Drug Class;0:0:0
PA164751373;TESTOSTERONE PROPIONATE;;Drug;0:0:0
PA164713329;TESTS FOR ALLERGIC DISEASES;V04CL;Drug Class;0:0:0
PA164713330;TESTS FOR BILE DUCT PATENCY;V04CC;Drug Class;0:0:0
PA164713331;TESTS FOR DIABETES;V04CA;Drug Class;5:27:0
PA164713332;TESTS FOR FAT ABSORPTION;V04CB;Drug Class;0:0:0
PA164713333;TESTS FOR FERTILITY DISTURBANCES;V04CM;Drug Class;0:0:0
PA164713334;TESTS FOR GASTRIC SECRETION;V04CG;Drug Class;0:0:0
PA164713335;TESTS FOR LIVER FUNCTIONAL CAPACITY;V04CE;Drug Class;0:0:0
PA164713336;TESTS FOR PANCREATIC FUNCTION;V04CK;Drug Class;0:0:0
PA164713337;TESTS FOR PITUITARY FUNCTION;V04CD;Drug Class;0:0:0
PA164713338;TESTS FOR RENAL FUNCTION;V04CH;Drug Class;0:1:0
PA164713339;TESTS FOR THYREOIDEA FUNCTION;V04CJ;Drug Class;0:0:0
PA451632;TETANUS ANTITOXIN;;Drug;0:1:0
PA451636;TETANUS TOXOID;;Drug;0:0:0
PA451634;TETANUS VACCINES;J07AM;Drug Class;0:0:0
PA451638;TETRACAINE;C05AD02;Drug;0:0:0
PA451640;TETRACYCLINE;A01AB13, D06AA04, J01AA07, S01AA09, S02AA08, S03AA02;Drug;0:0:0
PA164713340;TETRACYCLINE AND DERIVATIVES;D06AA;Drug Class;0:0:0
PA164713341;TETRACYCLINES;J01A, J01AA;Drug Class;1:2:0
PA161990676;TETRAHYDROBIOPTERIN;A16AX07;Drug;0:0:0
PA164745110;TETRAHYDROFOLIC ACID;;Drug, Biological Intermediate;0:0:2
PA164713342;TETRAHYDROPYRIMIDINE DERIVATIVES;P02CC;Drug Class;0:0:0
PA166335621;TEZEPELUMAB;R03DX11;Drug;0:0:0
PA451646;THEOBROMINE;C03BD01, R03DA07;Drug, Metabolite;0:0:1
PA451647;THEOPHYLLINE;R03DA04;Drug, Metabolite;0:6:2
PA164713343;THERAPEUTIC RADIOPHARMACEUTICALS;V10;Drug Class;0:0:0
PA164746466;THIABENDAZOLE;D01AC06, P02CA02;Drug;0:0:0
PA451652;THIAMINE;;Drug;0:0:0
PA164746997;THIAMYLAL;;Drug;0:0:0
PA10432;THIAZIDE DERIVATIVES;C02DA;Drug Class;0:0:0
PA164713344;THIAZIDES AND POTASSIUM IN COMBINATION;C03AB;Drug Class;50:120:0
PA164713345;THIAZIDES, COMBINATIONS WITH OTHER DRUGS;C03AX;Drug Class;50:120:0
PA164713346;THIAZIDES, COMBINATIONS WITH PSYCHOLEPTICS AND/OR ANALGESICS;C03AH;Drug Class;0:0:0
PA164748882;THIETHYLPERAZINE;R06AD03;Drug;0:0:0
PA166313081;THIOACETAZONE;J04AK07;Drug;0:0:0
PA10209;THIOACETAZONE AND ISONIAZID;J04AM04;Drug;0:0:0
PA164713348;THIOCARBAMIDE DERIVATIVES;J04AD;Drug Class;0:0:0
PA451663;THIOGUANINE;L01BB03;Drug;15:45:1
PA451664;THIOPENTAL;N01AF03, N05CA19;Drug;0:0:0
PA164754875;THIOPROPERAZINE;N05AB08;Drug;0:0:0
PA164713349;THIOSEMICARBAZONES;J05AA;Drug Class;0:0:0
PA451669;THIOTHIXENE;N05AF04;Drug;0:0:0
PA164713350;THIOURACILS;H03BA;Drug Class;1:5:0
PA10499;THIOXANTHENE DERIVATIVES;N05AF;Drug Class;1:10:0
PA164713351;THIRD-GENERATION CEPHALOSPORINS;J01DD;Drug Class;3:10:0
PA164713353;THROAT PREPARATIONS;R02, R02A;Drug Class;26:91:0
PA164748387;THYMALFASIN;;Drug;0:0:0
PA164754910;THYROGLOBULIN;;Drug;0:0:0
PA164713354;THYROID;V09F;Drug Class;0:0:0
PA10500;THYROID HORMONES;H03AA;Drug Class;0:8:0
PA451680;THYROID PREPARATIONS;H03A;Drug Class;0:8:0
PA164713355;THYROID THERAPY;H03;Drug Class;3:21:0
PA10211;THYROTROPIN;H01AB;Drug Class;1:1:0
PA151070295;THYROXINE;;Drug;0:0:0
PA451682;TIAGABINE;N03AG06;Drug;0:0:0
PA164764503;TIAPROFENIC ACID;M01AE11;Drug;0:0:0
PA451684;TICARCILLIN;J01CA13;Drug;0:0:0
PA164746412;TIGECYCLINE;J01AA12;Drug;0:0:0
PA166363881;TIGILANOL TIGLATE;;Drug;0:0:0
PA152132897;TILARGININE;;Drug;0:0:0
PA166347781;TILDRAKIZUMAB;L04AC17;Drug;0:4:0
PA166212682;TILIDINE;N02AX01;Drug;0:6:0
PA166222901;TIMBETASIN;;Drug;0:0:0
PA10813;TINIDAZOLE;J01XD02, P01AB02;Drug;0:0:0
PA451694;TINZAPARIN;;Drug;0:0:0
PA164746156;TIOCONAZOLE;D01AC07, G01AF08;Drug;0:0:0
PA166184566;TIPIRACIL / TRIFLURIDINE;L01BC59;Drug;0:0:0
PA163522473;TIPRANAVIR;J05AE09;Drug;0:0:0
PA166182622;TIPRANAVIR / RITONAVIR;;Drug;0:0:0
PA451698;TIROFIBAN;B01AC17;Drug;0:0:1
PA166347543;TIRZEPATIDE;A10BX16;Drug;0:0:0
PA164713356;TISSUE ADHESIVES;V03AK;Drug Class;0:0:0
PA451701;TIZANIDINE;M03BX02;Drug;0:0:0
PA451704;TOBRAMYCIN;J01GB01, S01AA12;Drug;2:7:1
PA451706;TOCAINIDE;C01BB03;Drug;0:0:0
PA166211901;TOFACITINIB;;Drug;0:0:0
PA166313342;TOFERSEN;;Drug;0:0:0
PA165958428;TOFISOPAM;N05BA23;Drug;0:0:0
PA164774902;TOLAZAMIDE;A10BB05;Drug;0:0:0
PA451716;TOLAZOLINE;C04AB02, M02AX02;Drug;0:0:0
PA451720;TOLCAPONE;N04BX01;Drug;0:5:0
PA166049189;TOLFENAMIC ACID;;Drug;0:0:0
PA451721;TOLMETIN;M01AB03, M02AA21;Drug;0:0:0
PA164752438;TOLNAFTATE;D01AE18;Drug;0:0:0
PA166268821;TOLUIDINE BLUE;;Drug;0:0:0
PA164713357;TONICS;A13, A13A;Drug Class;0:0:0
PA164713360;TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02, M02A;Drug Class;22:136:0
PA145007158;TORCETRAPIB;;Drug;0:0:0
PA451731;TOREMIFENE;L02BA02;Drug;0:1:1
PA166316101;TORIPALIMAB;;Drug;0:0:0
PA164748364;TOSITUMOMAB;;Drug;0:0:0
PA166413043;TPN171;;Drug;0:0:0
PA165958349;TRABECTEDIN;L01CX01;Drug;0:5:0
PA161660849;TRADIPITANT;;Drug;0:0:0
PA451735;TRAMADOL;N02AX02;Drug;38:144:1
PA164750514;TRANEXAMIC ACID;B02AA02;Drug;0:0:0
PA451741;TRANYLCYPROMINE;N06AF04;Drug;0:12:0
PA164781371;TRAVOPROST;S01EE04;Drug;0:0:0
PA451744;TRAZODONE;N06AX05;Drug;0:4:1
PA164768801;TREPROSTINIL;B01AC21;Drug;0:0:0
PA165107992;TRIADIMEFON;;Drug;0:0:0
PA451752;TRIAMTERENE;C03DB02;Drug;0:0:1
PA451753;TRIAZOLAM;N05CD05;Drug;0:0:1
PA164713361;TRIAZOLE DERIVATIVES;G01AG, J02AC;Drug Class;4:167:0
PA164752426;TRICHLORMETHIAZIDE;C03AA06;Drug;0:0:0
PA451755;TRICHLOROACETIC ACID;;Drug;0:0:0
PA151929741;TRICHOSTATIN A;;Drug;0:0:0
PA165958661;TRICIRIBINE;;Drug;0:0:0
PA164746229;TRIDIHEXETHYL;A03AB08;Drug;0:0:0
PA451773;TRIFLUPROMAZINE;N05AA05;Drug;0:0:0
PA165958430;TRIFLUSAL;;Drug;0:0:0
PA164747026;TRIHEXYPHENIDYL;N04AA01;Drug;0:1:0
PA164748507;TRILOSTANE;H02CA01;Drug;0:0:0
PA164744009;TRIMEPRAZINE;R06AD01;Drug;0:0:0
PA164744924;TRIMETHADIONE;N03AC02;Drug;0:0:0
PA451784;TRIMETHAPHAN;C02BA01;Drug;0:0:1
PA164764516;TRIMETHOBENZAMIDE;R06AA10;Drug;0:0:0
PA451788;TRIMETHOPRIM;J01EA01;Drug;0:5:0
PA164713363;TRIMETHOPRIM AND DERIVATIVES;J01EA;Drug Class;0:5:0
PA451790;TRIMETREXATE;P01AX07;Drug;0:0:0
PA451791;TRIMIPRAMINE;N06AA06;Drug;3:13:1
PA164747186;TRIOXSALEN;D05AD01, D05BA01;Drug;0:0:0
PA166220603;TRIPARANOL;;Drug;0:0:0
PA164764429;TRIPELENNAMINE;D04AA04, R06AC04;Drug;0:0:0
PA451797;TRIPROLIDINE;R06AX07;Drug;0:0:0
PA164749164;TRISALICYLATE-CHOLINE;;Drug;0:0:0
PA166313324;TROFINETIDE;;Drug;0:0:0
PA127840611;TROLEANDOMYCIN;J01FA08;Drug;0:0:0
PA451802;TROMETAMOL;;Drug;0:0:0
PA164749389;TROPICAMIDE;S01FA06;Drug;0:0:0
PA161925594;TROPISETRON;A04AA03;Drug;2:6:1
PA164748976;TROSPIUM;G04BD09;Drug;0:0:0
PA164749184;TROVAFLOXACIN;J01MA13;Drug;0:0:0
PA451806;TRYPSIN;;Drug;0:0:0
PA166185380;TUBASTATIN A;;Drug;0:0:0
PA152530738;TUBERCIDIN;;Drug;0:0:0
PA164713364;TUBERCULOSIS DIAGNOSTICS;V04CF;Drug Class;0:0:0
PA164713365;TUBERCULOSIS VACCINES;J07AN;Drug Class;0:0:0
PA451811;TUBOCURARINE;M03AA02;Drug;0:0:0
PA164713367;TUMOUR DETECTION;V09I;Drug Class;0:0:0
PA166363701;TUNODAFIL;;Drug;0:0:0
PA164743726;TYLOXAPOL;R05CA01;Drug;0:0:0
PA165958422;TYMAZOLINE;R01AA13;Drug;0:0:0
PA164713368;TYPHOID VACCINES;J07AP;Drug Class;0:0:0
PA164713369;TYPHUS (EXANTHEMATICUS) VACCINES;J07AR;Drug Class;0:0:0
PA164713370;TYROSINE HYDROXYLASE INHIBITORS;C02KB;Drug Class;0:0:0
PA166320901;UBROGEPANT;N02CD04;Drug;0:0:1
PA164776753;UDENAFIL;G04BE11;Drug;0:0:0
PA166208561;ULINASTATIN;;Drug;0:2:0
PA166320341;ULOTARONT;;Drug;0:1:0
PA164713371;ULTRASOUND CONTRAST MEDIA;V08D, V08DA;Drug Class;0:0:0
PA166184235;UMECLIDINIUM / VILANTEROL;R03AL03;Drug;0:0:0
PA166197241;UMIFENOVIR;;Drug;0:0:0
PA164713373;UNCLASSIFIED;;Drug Class;0:0:0
PA451830;URACIL MUSTARD;;Drug;0:0:0
PA451831;UREA;;Drug;0:0:0
PA130230921;URIDINE;;Drug;0:0:0
PA166357322;URIDINE TRIACETATE;A16AX13;Drug;0:0:0
PA164713374;URINARY ANTISPASMODICS;G04BD;Drug Class;3:12:0
PA164713375;URINARY CONCREMENT SOLVENTS;G04BC;Drug Class;0:0:0
PA164713376;URINE TESTS;V04B;Drug Class;0:0:0
PA451836;UROKINASE;B01AD04;Drug;0:0:0
PA164713377;UROLOGICALS;G04;Drug Class;11:35:0
PA451837;URSODEOXYCHOLIC ACID;A05AA02;Drug;0:0:0
PA164713378;VACCINES;J07;Drug Class;0:0:0
PA451839;VALACICLOVIR;J05AB11;Drug;0:0:0
PA166170051;VALBENAZINE;N07XX13;Drug;0:0:0
PA10226;VALDECOXIB;M01AH03;Drug;0:0:0
PA166413004;VALEMETOSTAT;;Drug;0:0:0
PA151917011;VALINOMYCIN;;Drug;0:0:0
PA164748616;VALRUBICIN;L01DB09;Drug;0:0:0
PA451848;VALSARTAN;C09CA03;Drug;0:0:0
PA164924565;VALSPODAR;;Drug;0:0:0
PA166337402;VAMOROLONE;H02AB18;Drug;0:0:0
PA166118341;VANDETANIB;L01EX04;Drug;0:3:2
PA451852;VANILLIN;;Drug;0:0:0
PA166128169;VANIPREVIR;;Drug;0:0:0
PA166362422;VANZACAFTOR;;Drug;0:0:0
PA164743146;VAPREOTIDE;H01CB04;Drug;0:0:0
PA164713379;VARICELLA ZOSTER VACCINES;J07BK;Drug Class;0:0:0
PA164713380;VARIOUS;V;Drug Class;125:427:0
PA164713381;VARIOUS ALIMENTARY TRACT AND METABOLISM PRODUCTS;A16AX;Drug Class;20:22:0
PA164713382;VARIOUS DIAGNOSTIC RADIOPHARMACEUTICALS;V09XX;Drug Class;0:0:0
PA164713383;VARIOUS PAIN PALLIATION RADIOPHARMACEUTICALS;V10BX;Drug Class;0:0:0
PA164713384;VARIOUS THERAPEUTIC RADIOPHARMACEUTICALS;V10XX;Drug Class;0:0:0
PA164713385;VARIOUS THYROID DIAGNOSTIC RADIOPHARMACEUTICALS;V09FX;Drug Class;0:0:0
PA166305901;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR (VEGFR) TYROSINE KINASE INHIBITORS;L01EK;Drug Class;1:15:0
PA164713386;VASODILATORS USED IN CARDIAC DISEASES;C01D;Drug Class;1:3:0
PA451858;VASOPRESSIN;H01BA01;Drug;0:0:0
PA164713387;VASOPRESSIN AND ANALOGUES;H01BA;Drug Class;0:0:0
PA164713388;VASOPRESSIN ANTAGONISTS;C03XA;Drug Class;0:0:0
PA164713389;VASOPROTECTIVES;C05;Drug Class;23:95:0
PA7001;VATALANIB;;Drug;0:0:0
PA166364441;VATIQUINONE;;Drug;0:0:0
PA164748865;VECURONIUM;M03AC03;Drug;0:0:0
PA451862;VEGETABLE OIL;;Drug;0:0:0
PA166306001;VEGF/VEGFR (VASCULAR ENDOTHELIAL GROWTH FACTOR) INHIBITORS;L01FG;Drug Class;23:154:0
PA166115366;VELAGLUCERASE ALFA;A16AB10;Drug;0:0:0
PA166131609;VELIPARIB;;Drug;0:0:0
PA166153473;VENETOCLAX;L01XX52;Drug;0:1:1
PA451866;VENLAFAXINE;N06AX16;Drug;37:135:1
PA166416681;VEPDEGESTRANT;;Drug;0:0:0
PA166317421;VERICIGUAT;C01DX22;Drug;0:0:0
PA165109661;VERLUKAST;;Drug;0:0:0
PA166184233;VERNAKALANT;C01BG11;Drug;0:0:0
PA451871;VERTEPORFIN;S01LA01;Drug;0:0:0
PA451876;VIDARABINE;J05AB03, S01AD06;Drug;0:0:0
PA10231;VIGABATRIN;N03AG04;Drug;0:0:0
PA166305301;VILANTEROL;;Drug;0:0:0
PA165958365;VILAZODONE;;Drug;0:0:0
PA166251581;VILOXAZINE;N06AX09;Drug;0:1:0
PA150481188;VINCA ALKALOIDS AND ANALOGUES;L01CA;Drug Class;29:175:0
PA452612;VINYL CHLORIDE;;Drug;0:0:0
PA164713390;VIRAL VACCINES;J07B;Drug Class;0:0:0
PA166271941;VIRAMIDINE;;Prodrug;0:0:1
PA164713391;VISCOELASTIC SUBSTANCES;S01KA;Drug Class;0:0:0
PA166048558;VISMODEGIB;L01XJ01;Drug;0:0:0
PA451884;VITAMIN A;D10AD02, R01AX02, S01XA02;Drug, Biological Intermediate;0:0:0
PA164713392;VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO;A11C;Drug Class;0:4:0
PA164713393;VITAMIN A AND D IN COMBINATION;A11CB;Drug Class;0:0:0
PA164713394;VITAMIN A, PLAIN;A11CA;Drug Class;0:0:0
PA449069;VITAMIN B12 AND FOLIC ACID;B03B;Drug Class;7:24:0
PA164713403;VITAMIN B12 (CYANOCOBALAMIN AND ANALOGUES);B03BA;Drug Class;1:1:0
PA164713400;VITAMIN B1 IN COMBINATION WITH VITAMIN B6 AND/OR VITAMIN B12;A11DB;Drug Class;0:0:0
PA164713402;VITAMIN B1, PLAIN;A11DA;Drug Class;0:0:0
PA164713401;VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12;A11D;Drug Class;0:0:0
PA164713399;VITAMIN B-COMPLEX, OTHER COMBINATIONS;A11EX;Drug Class;0:0:0
PA164713395;VITAMIN B-COMPLEX WITH ANABOLIC STEROIDS;A11ED;Drug Class;0:0:0
PA164713396;VITAMIN B-COMPLEX WITH MINERALS;A11EC;Drug Class;0:0:0
PA164713397;VITAMIN B-COMPLEX WITH VITAMIN C;A11EB;Drug Class;0:0:0
PA451898;VITAMIN C;G01AD03, S01XA15;Drug;0:2:2
PA451899;VITAMIN D AND ANALOGUES;A11CC;Drug Class;0:5:0
PA450961;VITAMIN K;B02BA01;Drug, Biological Intermediate;0:0:1
PA164713405;VITAMIN K AND OTHER HEMOSTATICS;B02B;Drug Class;0:1:0
PA164713406;VITAMIN K ANTAGONISTS;B01AA;Drug Class;118:1519:0
PA164713407;VITAMINS;A11, B05XC;Drug Class;0:6:0
PA164713410;VITAMINS, OTHER COMBINATIONS;A11JC;Drug Class;0:0:0
PA164713409;VITAMINS WITH MINERALS;A11JB;Drug Class;0:0:0
PA165958347;VOACAMINE;;Drug;0:0:0
PA164752433;VOGLIBOSE;A10BF03;Drug;0:0:0
PA166250441;VONOPRAZAN;A02BC08;Drug;0:0:0
PA166330121;VORAPAXAR;B01AC26;Drug;0:0:0
PA10233;VORICONAZOLE;J02AC03;Drug;4:165:1
PA164748224;VORINOSTAT;L01XX38;Drug;0:0:0
PA166122595;VORTIOXETINE;N06AX26;Drug;1:3:1
PA166189802;VOXELOTOR;B06AX03;Drug;0:0:0
PA166220605;VOXTALISIB;;Drug;0:0:0
PA166277621;VUTRISIRAN;N07XX18;Drug;0:0:0
PA451906;WARFARIN;B01AA03;Drug;90:1220:2
PA164713411;WART AND ANTI-CORN PREPARATIONS;D11AF;Drug Class;0:0:0
PA164713412;WASHING AGENTS ETC.;V07AX;Drug Class;0:0:0
PA164713413;WATERSOLUBLE, HEPATOTROPIC X-RAY CONTRAST MEDIA;V08AC;Drug Class;0:0:0
PA164713414;WATERSOLUBLE, NEPHROTROPIC, HIGH OSMOLAR X-RAY CONTRAST MEDIA;V08AA;Drug Class;0:0:0
PA164713415;WATERSOLUBLE, NEPHROTROPIC, LOW OSMOLAR X-RAY CONTRAST MEDIA;V08AB;Drug Class;0:0:0
PA166248061;WEE1 INHIBITOR;;Drug;0:0:0
PA166182517;WUZHI CAPSULE;;Drug;0:0:0
PA152432579;XANOMELINE;;Drug;0:0:0
PA166353841;XANOMELINE / TROSPIUM;;Drug;0:0:0
PA164713418;XANTHINE DERIVATIVES;C03BD, N06BC;Drug Class;9:111:0
PA164713420;XANTHINES;R03DA;Drug Class;0:6:0
PA164713421;XANTHINES AND ADRENERGICS;R03DB;Drug Class;0:0:0
PA164748318;XANTHOPHYLL;;Drug;0:0:0
PA452604;XENOBIOTICS;;Drug Class;0:6:1
PA451935;XENON;;Drug;0:0:0
PA161748474;XIMELAGATRAN;B01AE05;Drug;0:0:0
PA164924566;XR9051;;Drug;0:0:0
PA164713416;X-RAY CONTRAST MEDIA, IODINATED;V08A;Drug Class;0:0:0
PA164713417;X-RAY CONTRAST MEDIA, NON-IODINATED;V08B;Drug Class;0:0:0
PA165958368;XYLOMETAZOLINE;R01AA07, R01AB06, S01GA03;Drug;0:0:0
PA164713422;YELLOW FEVER VACCINES;J07BL;Drug Class;0:0:0
PA451946;YOHIMBINE;G04BE04;Drug;0:0:1
PA164713423;YTTRIUM (90Y) COMPOUNDS;V10AA;Drug Class;0:0:0
PA451950;ZALCITABINE;J05AF03;Drug;0:0:0
PA451952;ZALEPLON;N05CF03;Drug;0:0:0
PA166357061;ZAMICASTAT;;Drug;0:0:0
PA164740891;ZANAMIVIR;J05AH01;Drug;0:0:0
PA166204001;ZANUBRUTINIB;L01EL03;Drug;0:0:0
PA166327621;ZAVEGEPANT;;Drug;0:0:0
PA166184503;ZIDOVUDINE / LAMIVUDINE / ABACAVIR;J05AR04;Drug;0:0:0
PA166328901;ZILUCOPLAN;L04AJ06;Drug;0:0:0
PA451956;ZINC;;Drug;0:0:0
PA164713425;ZINC BANDAGES;D09AB;Drug Class;0:0:0
PA451965;ZINC OXIDE;;Drug;0:0:0
PA164713426;ZINC PRODUCTS;D02AB;Drug Class;0:0:0
PA451971;ZINC SULFATE;;Drug;0:0:0
PA166366521;ZIPALERTINIB;;Drug;0:0:0
PA451975;ZOLMITRIPTAN;N02CC03;Drug;0:7:1
PA451976;ZOLPIDEM;N05CF02;Drug;0:0:0
PA166049188;ZOMEPIRAC;;Drug;0:0:0
PA166399581;ZONGERTINIB;;Drug;0:0:0
PA10236;ZOPICLONE;N05CF01;Drug;0:0:0
PA166355061;ZORIFERTINIB;;Drug;0:0:0
PA164924567;ZOSUQUIDAR;;Drug;0:0:0
PA452606;ZOXAZOLAMINE;;Drug;0:0:0
PA452629;ZUCLOPENTHIXOL;N05AF05;Drug;1:10:0
